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Pluripotent embryonic stem (ES) cells are heterogeneous mixtures of 
naïve and lineage-primed states defined by distinct transcription factor 
expression profiles. However, the events that prime pluripotent cells for 
differentiation are not well understood. Id proteins, which are inhibitors of 
basic helix-loop-helix (bHLH) transcription factors, contribute to 
pluripotency by blocking differentiation. Using Yeast-Two-Hybrid screening, 
our lab identified Tcf15 as an Id-regulated transcription factor.  
In this study, I first examined the expression of Tcf15 during 
differentiation in vitro and during early development in vivo in the mouse. 
Tcf15 expression is higher in primed pluripotent embryonic stem (ES) cells 
than in naïve ES cells or epiblast stem cells (EpiSCs). In addition, Tcf15 is 
expressed heterogeneously in ES cells and is also detected in the inner cell 
mass (ICM) of E4.5 mouse embryos. Expression of Tcf15 was upregulated 
during early stages of differentiation and downregulated before cells 
committed to any specific lineage. Using Tcf15-Venus reporter cells, I found 
that expression of Tcf15 is specifically associated with a novel subpopulation 
of ES cells primed for somatic lineages.  
Gain of function and loss of function studies were then performed to 
perturb Tcf15 expression in ES cells in order to assess the function of Tcf15 in 
self-renewal and during differentiation. An inducible Id-resistant form of 
Tcf15 accelerates somatic lineage commitment by maturating naïve 
pluripotent ES cells transit toward primed epiblast and later on epiblast-
derived somatic lineages whilst suppressing differentiation towards 
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extraembryonic endoderm. Preliminary loss of function studies also suggest 
that down-regulation of Tcf15 may promote a naïve state within pluripotent 
cells. 
I investigated the mechanism by which Tcf15 expression becomes 
associated with the epiblast-primed state by identifying the upstream 
regulators and downstream targets of Tcf15. Tcf15 expression is dependent 
on FGF signalling. Microarray analysis identified that Tcf15 downregulates 
the naïve pluripotency determinant Nanog and upregulates the epiblast 
determinant Otx2. Taken together, our results suggest that Tcf15 acts in 
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1.1: Embryonic stem cells  
Studying the biological properties and clinical potential of embryonic 
stem (ES) cells has drawn continued scientific, commercial, and public 
attention in the hope that it will shed new light on the development of 
regenerative medicine. Mouse embryonic stem (mES) cells are immortal cell 
lines derived from the inner cell mass (ICM) of pre-implantation blastocysts 
and represent a clonal pluripotent cell line with two defining properties: the 
ability to generate identical copy of themselves (“self-renewal”) and the 
capacity to differentiate into all cell types of the developing embryo and 
adult (“pluripotency”) (Evans and Kaufman, 1981; Martin, 1981). A 
functional proof of pluripotency of ES cells is their ability to form multi-
differentiated teratocarcinomas consisting of derivatives from all three germ 
layers when grafted to adult mice (Stevens, 1970). Their full potency is 
revealed by blastocyst injection, which yields chimaeric mice with extensive 
contribution from the injected ES cells progeny to all tissues, including 
functional colonization of the germline (Bradley et al., 1984). Combined with 
genetic manipulations techniques such as gene targeting, ES cells serve as an 
excellent tool for studying gene function, enabling in-depth investigation of 
the genetic basis of disease and providing a platform for drug screening. For 
these reasons, the 2007 Nobel Prize in Physiology or Medicine was awarded 
jointly to Mario R. Capecchi, Sir Martin J. Evans and Oliver Smithies for the 
discovery of "Principles for introducing specific gene modifications in mice 
by the use of embryonic stem cells".  
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In vivo, pluripotent cells only exist transiently in the epiblast of the 
developing embryo. Therefore, ES cells could represent an in vitro model for 
studying early epiblast development. 
 
1.1.1: Pluripotent populations  
The field of pluripotent stem cells biology is a series of historical 
discoveries which led to the present achievement, like standing on the 
shoulders of giants. The discovery of embryonic stem cells depended on 
prior decades of research on mouse embryonal carcinoma (EC) cells. More 
recently, the derivation of mouse epiblast stem cells (EpiSCs) and induced 
pluripotent stem cells (iPSCs) relied on prior studies on mouse and human 
embryonic stem cells.  
 
1.1.1.1: Embryonal carcinoma (EC) cells  
The field of study on pluripotent stem cells began in the 1950s with the 
study of teratocarcinomas and the pluripotent cells that they harbour, the 
embryonal carcinoma (EC) cells. Teratocarcinomas are malignant germ cell 
tumours that comprise a differentiated component that can include all three 
germ layers (ectoderm, mesoderm and endoderm) and an undifferentiated 
EC component which was able to seed a new tumour when transplanted into 
a secondary recipient (Kleinsmith and Pierce, 1964; Stevens and Little, 1954).  
In their key experiment, Kleinsmith and Pierce (1964) demonstrated that a 
single EC cell is capable of both unlimited self-renewal and multi-lineage 
differentiation, providing the framework for ES cell biology: the 
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clonogenicity of single cells, their heterogeneity, and their pluripotency 
(potential to differentiate into cells in different germ layers). 
EC cell lines that could be stably propagated in vitro as adherent 
monolayers in basal medium supplemented with serum, in the presence or 
absence of a layer of feeder cells were established in the early 1970s (Kahan 
and Ephrussi, 1970; Rosenthal et al., 1970). Although EC cells form malignant 
teratocarcinomas when transplanted to ectopic sites, when re-introduced into 
a blastocyst, they are able to incorporate and contribute to tissues of the 
developing embryo (Brinster, 1974). This indicates that the proliferation of 
undifferentiated EC cells can be brought under control in response to the 
appropriate environmental cues. These mice which harbour tissues derived 
from different genetic backgrounds (in this case, the EC cells and the original 
blastocysts) are known as chimaeras. The “ability to generate chimaera upon 
blastocyst injection” thus becomes a key criteria for evaluating the 
pluripotency of ES cells, and provides a crucial link between in vitro cell lines 
and in vivo development.  
The ground-breaking work performed by studying EC cells was pivotal 
for the subsequent isolation of pluripotent cells from the embryo proper. A 
critical point was the finding that pluripotent cells heavily benefitted by their 
co-culture with fibroblasts (Martin and Evans, 1975). The same authors later 
reported the isolation of pluripotent stem cells lines from mouse blastocyst 
(Evans and Kaufman, 1981; Martin, 1981). To denote their tissue of origin, 





1.1.1.2: Mouse embryonic stem (ES) cells  
Mouse ES cells are pluripotent populations isolated from the ICM of 
mouse blastocysts at embryonic days 3.5-4.5 (E3.5-4.5). ES cells represent the 
naïve pluripotent epiblast in the pre-implantation embryo. More importantly, 
unlike EC cells, these karyotypically normal ES cells can contribute at a high 
frequency to a variety of tissues in chimaeras, including germ cells, thus 
providing a practical way to introduce modifications to the mouse germline 
(Robertson et al., 1986) .  
The derivation and culture of ES cells has been achieved using 
combinations of cytokines, growth factors, hormones, serum, serum extracts, 
conditioned media and feeders. In short, extrinsic factors including 
leukaemia inhibitory factor (LIF) and bone morphogenetic protein (BMP) can 
support the propagation of ES cells due to their specific ability to stimulate or 
protect the gene regulatory network controlling pluripotency. Considerable 
evidence indicates that ES cell self-renewal and pluripotency is governed by 
a transcriptional network centred on Oct4, Sox2 and Nanog (Boyer et al., 
2005; Chen et al., 2008b; Loh et al., 2006). These core nuclear regulators target 
genes encoding transcription factors, signal transduction components and 
chromatin-modifying enzymes that promote self-renewal, while suppressing 
differentiation (Chambers et al., 2007; Chambers and Tomlinson, 2009; Niwa 
et al., 2000). The detailed molecular basis for maintaining self-renewing ES 
cells will be discussed in section 1.1.2. 
The ES cell genome can be manipulated with precision and relative ease 
(Thomas and Capecchi, 1986). Moreover, ES cells genetically modified with 
random or targeted transgene integrations could successfully contribute to 
live animals and their offspring following blastocyst injection (Hooper et al., 
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1987; Robertson et al., 1986), thereby enabling the generation of mice with 
defined genetic modifications. Thus, the in vitro transgenesis in ES cells 
served as useful tool for the in vivo study of the phenotype of transgenic mice. 
 
1.1.1.3: Post-implantation mouse epiblast stem cells (EpiSCs) 
Epiblast stem cells (EpiSCs) represent the in vitro equivalent of the post-
implantation pluripotent epiblast. EpiSCs were isolated from E5.5 to E6.5 
post-implantation mouse embryos that differ significantly from mouse ES 
cells but share key features with human ES cells  with regard to their 
molecular properties, growth factor requirements, colony morphology, X-
chromosome inactivation status, and culture dynamics (Brons et al., 2007; 
Tesar et al., 2007). For example, EpiSC derivation failed in the presence of LIF 
and/or BMP4, the two factors required for the derivation and self-renewal of 
mouse ES cells (see section 1.1.2.2). In contrast, similar to human ES cells, 
fibroblast growth factor (FGF) and Activin/Nodal signalling appear critical 
for EpiSC derivation. Despite distinct signalling requirements for self-
renewal, EpiSCs are capable of differentiating into derivatives of all three 
primary germ layers when subjecting to embryoid body and teratoma 
formation assays (Brons et al., 2007; Tesar et al., 2007). Moreover, although 
EpiSCs are unable to contribute to chimaeras upon blastocyst injection or 
morula aggregation, it is recently reported that EpiSCs efficiently form 
chimaeras in gastrulation-stage embryos (Huang et al., 2012). Thus, EpiSCs 
do share the two key features characteristic of ES cells: prolonged 




Morphologically, mES cells grow in more three-dimensional, tightly 
packed colonies whereas mEpiSCs form flattened two-dimensional colonies. 
Also, like most human ES cell lines, mEpiSCs cannot be passaged as single 
cells by trypsin digest (Chenoweth et al., 2010), unless adding Rho-associated 
kinase (ROCK) inhibitor into culture medium to reduce dissociation-induced 
apoptosis (Watanabe et al., 2007). EpiSCs express the core set of genes that 
regulate the pluripotent state including Oct4 (Pou5f1), Nanog, and Sox2. 
Additionally, EpiSCs express genes known to be involved in early 
gastrulation and somatic cell specification including Brachyury (T) and 
Fibroblast growth factor 5 (Fgf5), suggesting that EpiSCs are poised for 
differentiation upon receiving instructive signals. Hierarchical clustering of 
global gene expression data from mES cells and mEpiSCs strongly suggests 
that these two cell types are in two distinct pluripotent states (Bao et al., 2009; 
Brons et al., 2007; Tesar et al., 2007). ES cells have been described as the naïve 
pluripotent state due to their functional similarity to the pre-implantation 
epiblast, whereas EpiSCs represent a distinct state of pluripotency from ES 
cells. Their pluripotent state has been described as ‘‘primed’’ based on their 
transcriptional and epigenetic profiles that are most similar to their source, 
the post-implantation epiblast (Nichols and Smith, 2009) (see section 1.1.5.2). 
 
1.1.1.4: Induced pluripotent stem cells (iPSCs) 
The ground-breaking discovery by Kazutoshi Takahashi and Shinya 
Yamanaka at 2006 showing that terminally differentiated somatic cells could 
be reprogrammed to a pluripotent state by means of ectopic overexpression 
of four transcription factors: Klf4, Myc, Oct4 and Sox2 (Takahashi and 
Yamanaka, 2006). The type of cell generated by this method was termed 
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induced pluripotent stem cells (iPSCs). iPSCs are morphologically 
indistinguishable from ES cells, display a similar gene expression pattern, 
can contribute to chimaeras upon blastocyst injection and can be transmitted 
to the germline of the chimaeric embryos (Okita et al., 2007; Takahashi and 
Yamanaka, 2006; Wernig et al., 2007). The derivation of iPSCs from human 
cells (Park et al., 2008; Takahashi et al., 2007) provides an incredible tool not 
only for the study of patient-specific disease phenotypes in culture but also 
for the generation of patient-specific cell types for transplantation. 
iPSCs can be established with a variety of methods. There are several 
differences among the original cell source, induction method, 
reprogramming factors usage, and culture conditions including small 
molecule supplements (Okita and Yamanaka, 2011). Although using iPSCs 
for research could avoid ethical problems associated with embryonic stem 
cell generation, iPSCs do present problems of their own. The reprograming 
process occurs at low frequency (0.1% to 1%) and over a long period of time 
(a few weeks). Also, the possibility of transgene integration and alteration of 
the endogenous genomic organization could cause a negative safety issue 
when considering medical applications. More comprehensive knowledge of 
the reprogramming process is therefore crucial for future clinical 
applications of iPSCs (reviewed in Bayart and Cohen-Haguenauer (2013)). 
 
1.1.2: Maintaining pluripotency of ES cells 
The popularity of mES cell research has led to a wealth of large and 
small scale studies on the regulatory mechanisms that act to maintain the 
pluripotent state in vitro. ES cell pluripotency is maintained during self-
renewal by the prevention of differentiation and the promotion of 
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proliferation and it is now clear that a complex interplay between intrinsic 
and extrinsic factors exist.  
1.1.2.1: Intrinsic determinants governing ES cells self-renewal  
The transcription factors Oct4, Sox2 and Nanog are among the 
pluripotency-associated factors that maintain ES cells (Boiani and Scholer, 
2005; Chambers et al., 2007; Masui et al., 2007; Niwa et al., 2000). Their targets 
have been mapped by chromatin immuno-precipitation (ChIP)-based 
technologies, revealing their extensive co-binding in both mES cells and hES 
cells. This has led to the proposal that these factors constitute a core 
transcriptional regulatory network. This core transcriptional network is a key 
regulator of its own expression as well as regulating various other 
transcription factors and epigenetic regulators that are involved in self-




Oct4, which is encoded by Pou5f1, is a POU domain-containing 
transcription factor that is expressed in pluripotent mES cells and the early 
embryo.  It was essential for the maintenance of both in vivo and in vitro 
pluripotent populations (Nichols et al., 1998; Yeom et al., 1996). Although 
Pou5f1-null embryos reach blastocyst stage, the inner cell mass of these 
mutants only produces differentiated cells of trophoblast lineages when 
cultured in vitro. Oct4 has been reported to directly prevent differentiation 
towards trophectoderm by interacting with Cdx2, a trigger for 
trophectoderm differentiation, to form a reciprocal repression complex for 
lineage specification (Niwa et al., 2005).  
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The expression level of Oct4 is tightly regulated in the developing 
embryo and mES cells, for the maintenance of pluripotency and specification 
of fate. A two fold increase in the levels of Oct4 causes differentiation into 
primitive endoderm, while repression induces dedifferentiation into 
trophectoderm. This indicates that there are different sets of genes associated 
with differentiated states/specific lineages expressed at either high or low 
levels of Oct4 and that pluripotency genes are only expressed when Oct4 is 
maintained at levels endogenous to self-renewing mES cells (Niwa et al., 
2000). A recent study suggested that reduced Oct4 expression resulting from 
heterozygosity directs a robust pluripotent state with distinct signaling 
activity and increased enhancer occupancy by Oct4 and Nanog. These Oct4-
heterozygous ES cells also display delayed differentiation kinetics compared 
to wild-type ES cells. Therefore, a defined Oct4 level controls the 
establishment of naïve pluripotency as well as commitment to all embryonic 
lineages (Karwacki-Neisius et al., 2013). Similar observations were also made 
in induced pluripotent stem cells (Radzisheuskaya et al., 2013). 
In addition to being an essential regulator of pluripotency, Oct4 plays an 
important role in somatic reprogramming. Oct4 overexpression is sufficient 
to induce pluripotency when in combination with small molecules (Li et al., 
2011; Yuan et al., 2011), or when using somatic cell types endogenously 
expressing the remaining reprogramming factors (Kim et al., 2009; Tsai et al., 
2011; Wu et al., 2011). It was recently demonstrated that reactivation of 
endogenous Oct4 expression plays a critical role in somatic cell reprograming, 
as several factors (Nr5a1/Nr5Aa2, TET1/Nanog) which were shown to induce 
pluripotency in the absence of Oct4 actually function through regulating 
Oct4 regulatory region (Costa et al., 2013; Gao et al., 2013b; Gu et al., 2005; 
Heng et al., 2010). Moreover, overexpression of an artificial transcription 
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factor targeting the Oct4 distal enhancer leads to strong activation of the 
endogenous Oct4 locus and efficient reprograming of iPSCs in the absence of 
exogenous Oct4 (Gao et al., 2013a).  
 
1.1.2.1.2: Sox2  
Sox2 belongs to the family of SRY (Sex-related HMG box) transcription 
factors that is essential for early mouse development (Avilion et al., 2003). 
Sox2 interacts with Oct4 at both protein and DNA level (Ambrosetti et al., 
1997; Ambrosetti et al., 2000) cooperatively to drive the transcription of target 
genes. These targets include Fgf4 (Yuan et al., 1995), the pluripotency factors 
Nanog and Utf1 (Kuroda et al., 2005; Nishimoto et al., 1999), as well as Oct4 
and Sox2 themselves (Okumura-Nakanishi et al., 2005; Tomioka et al., 2002). 
Sox2 is also required for ES cell pluripotency, as its loss leads to the 
downregulation of Oct4 and the upregulation of markers of the 
trophectodermal lineage (Ivanova et al., 2006; Masui et al., 2007).  
Surprisingly, the expression of many Oct4/Sox2 target genes was not greatly 
affected by the loss of Sox2. Furthermore, restoring Oct4 levels in Sox2-
depleted cells by introduction of a Oct4 transgene can rescue, at least in part, 
the expression of Oct4/Sox2 targets, the differentiation phenotype of the cells 
and capability of the cells to contribute to chimaeric embryos (Masui et al., 
2007). Therefore, Sox2 appears to be to maintain Oct4 expression and other 
Sox factors such as Sox4, Sox11 and Sox15 can, to a certain extent, substitute 
for Sox2 in this context with their ability to bind to the Oct4/Sox2 target sites 





1.1.2.1.3: Nanog   
Nanog is a homeobox-containing transcription factor identified by 
several groups in 2003 using different approaches: in a screen for molecules 
that can support self-renewal and pluripotency (Chambers et al., 2003), by 
degenerate PCR for homeobox-containing genes involved in early embryonic 
development (Wang et al., 2003), and in a bioinformatics screen for mES cell 
associated transcripts (Mitsui et al., 2003). Overexpression of Nanog can 
confer cytokine-independent self-renewal to ES cells, and for this reason the 
gene was named after the mythological Celtic Land of Youth, Tír na nÓ g 
(Chambers et al., 2003). 
During mouse development, Nanog expression is first detected in 
morulae, being most obvious in cells in the interior of the embryo. High 
levels of Nanog (mRNA/protein) persist in the early blastocyst, but declines 
prior to implantation. Following implantation, Nanog is expressed in a 
subset of epiblast cells with highest levels in the proximal posterior region; 
upon entry into the primitive streak, Nanog is rapidly downregulated 
(Chambers and Smith, 2004; Malaguti et al., 2013). It is reported to be 
required for the specification of the pluripotent epiblast in vivo (Frankenberg 
et al., 2011; Mitsui et al., 2003; Silva et al., 2009). In vitro, Nanog displays a 
stronger pluripotency-inducing phenotype than Oct4 and Sox2, and does not 
induce differentiation when overexpressed, but cannot rescue 
trophectodermal specification in Oct4-null or Sox2-depleted cells (Chambers 
et al., 2003; Ivanova et al., 2006). However, Nanog is dispensable for ES cell 
self-renewal. Nanog-null ES cells can be maintained in culture, retain multi-
lineage differentiation capacity and can contribute to chimaeras, although 
they display lower clonogenicity than wild-type cells and express markers of 
embryonic and extraembryonic endoderm (Chambers et al., 2007; Mitsui et 
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al., 2003). These findings indicate that Nanog is an extremely potent 
pluripotency determinant as transient downregulation of Nanog appears to 
predispose cells towards differentiation but does not mark commitment, but 
that it is neither sufficient nor required for ES cell self-renewal and 
differentiation. 
Nanog protein can be divided loosely into 3 domains: an N-terminal 
domain; a homeobox-containing domain; and a C-terminal domain that 
contains the well-conserved tryptophan (Trp) repeat domain (Mullin et al., 
2008). The Trp-repeat domain is essential for Nanog homodimerisation to 
bind DNA (Mullin et al., 2008; Wang et al., 2008) and for direct interaction of 
Nanog with pluripotency factor Sox2 (Gagliardi et al., 2013). Nanog, Oct4 
and Sox2 share a significant number of targets, including Nanog, Oct4 and 
Sox2 themselves (Chen et al., 2008a; Costa et al., 2013; Kim et al., 2008; Liang 
et al., 2008; Wang et al., 2006). Together, Nanog, Oct4 and Sox2 form the core 
network of transcription factors supporting embryonic stem cell self-renewal. 
Nanog expression is subject to a similar level of complex regulation as 
seen at the Oct4 locus, with both functional Oct4/Sox2 and germ cell nuclear 
factor (GCNF) motifs as well as binding sites for STAT3, Tcf3, FoxD3, p53 
and T-Brachyury  (Pan and Thomson, 2007). Two recent publications have 
demonstrated an unexpected role for Nanog in the auto-repression of its own 
transcription.  While Oct4 and Sox2 promote the transcription of Nanog, 
Nanog binds its enhancer region independently of Oct4 and Sox2 and drives 
the downregulation of its expression. This auto-repression exists in the 
LIF/serum culture as well as in the 2i/LIF medium (Fidalgo et al., 2012; 
Navarro et al., 2012) (see section 1.1.2.2.5 for 2i culture). In addition, several 
factors known to regulate the Nanog locus, such as Oct4, FoxD3 and p53, can 
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act as either activators or repressors depending on their co-factor context 
indicating dynamic control of Nanog expression in mES cells. 
 
1.1.2.1.4: Esrrb 
The estrogen related receptor-β (Esrrb) is an orphan nuclear receptor 
that has been reported to be an important component of the complex 
pluripotency network (van den Berg et al., 2008; Zhang et al., 2008). Esrrb is 
involved in ES cell self-renewal and its expression is reduced upon Nanog 
and Oct4 knockdown and induced by Nanog overexpression (Ivanova et al., 
2006; Loh et al., 2006).  When ectopically expressed in conjunction with Oct4 
and Sox2, Esrrb has been shown to promote reprogramming of mouse 
embryonic fibroblasts (Feng et al., 2009). Esrrb can interact with Nanog to 
promote Oct4 expression and interact with Oct4 to promote Nanog 
expression, and it can also interact with Sox2 (Hutchins et al., 2013; van den 
Berg et al., 2008; Zhang et al., 2008). Most recently, Esrrb has been reported as 
the transcript which is upregulated quickest and to the highest levels 
following tamoxifen-mediated nuclear translocation of Nanog-ERT2 in 
Nanog-null ES cells. Also, Esrrb overexpression can sustain LIF-independent 
self-renewal even in the absence of Nanog, and Esrrb-null cells cannot sustain 
LIF-independent self-renewal upon Nanog overexpression, suggesting Esrrb 
is a crucial Nanog target (Festuccia et al., 2012). 
 
1.1.2.1.5: Krüppel-like factors (Klfs) 
The Krüppel-like factors (Klfs) are zinc-finger proteins that share 
homology with the Drosophila melanogaster segmentation gene, Krüppel 
(Schuh et al., 1986). Klf2, Klf4 and Klf5 are expressed in ES cells and have been 
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shown to promote pluripotency, whereas Klf2 and Klf4 are not expressed in 
EpiSCs (Brons et al., 2007; Tesar et al., 2007). Loss of all three factors drives 
differentiation of ES cells (Jiang et al., 2008). Expression of Klf factors in ES 
cells is induced by pluripotency factors: Klf2 transcription is driven by Oct4, 
Klf4 and Klf5 expression is driven by the LIF-JAK/STAT3 pathway (Hall et al., 
2009; Niwa et al., 2009). The expression level of Klf factors is critical for 
maintaining different state of pluripotency: ectopic expression of Klf4 can 
convert EpiSCs into mES cell-like cells (Guo et al., 2009), whereas Klf2 is 
essential for sustaining ground state pluripotency (Yeo et al., 2014). Klf 
factors could bind to the enhancer region of Oct4 and Nanog, share many 
common targets with the core pluripotency factors (Oct4, Nanog and Sox2) 
(Chen et al., 2008b; Jiang et al., 2008; Parisi et al., 2008) and can substitute 
each other in somatic cell reprogramming (Nakagawa et al., 2008), 
suggesting some functional redundancy between the Klf factors. 
 
1.1.2.1.6: Rex1  
Rex1 (also referred to as ZFP42) is a zinc-finger transcription factor that 
was initially showed to be expressed in F9 embryonal carcinoma (EC) cells 
and is down-regulated after retinoic acid treatment to induce differentiation 
(Hosler et al., 1989). The expression of Rex1 was later confirmed in the germ 
cells of the testis and in ES cells (Rogers et al., 1991). Rex1 has been 
commonly used as a marker of the naïve pluripotent state (Toyooka et al., 
2008), with its expression being either activated or repressed by Oct4 (Ben-
Shushan et al., 1998), or being activated by Nanog (Shi et al., 2006). 
Unexpectedly, Rex1 function is likely dispensable for both the maintenance 
of pluripotency in ES cells and the development of embryos, as neither 
knockout nor overexpression of Rex1 in ES cells affect cell pluripotency. 
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Moreover, Rex1-null embryos develop normally until after E17.5 (Masui et al., 
2008). Rex1 also has an essential role in the reactivation of the inactive X 
chromosome by promoting the transcription of Tsix and inhibiting Xist 
(Gontan et al., 2012; Navarro et al., 2010). Therefore, the loss of Rex1 
expression from pre- to post-implantation epiblast is coupled with random 
X-chromosome inactivation during this process. 
 
1.1.2.2: Extrinsic factors governing ES cell self-renewal  
1.1.2.2.1: LIF-STAT3 
The initial derivation of mES cells was dependent on soluble molecules 
presented in serum, or secreted by a layer of mitotically inactivated 
embryonic fibroblasts (Evans and Kaufman, 1981; Martin, 1981), or Buffalo 
rat liver cells-conditioned medium, a culture medium which allowed for the 
dispensation of the feeder layer (Smith and Hooper, 1987). The subsequent 
identification of the leukemia inhibitory factor (LIF) as the peptide secreted 
by feeder cells, necessary for the maintenance of undifferentiated mES cells 
in culture, opened a new window for investigating the molecular 
mechanisms regulating pluripotency (Smith et al., 1988; Williams et al., 1988). 
LIF belongs to the interleukin family of cytokines and activates a 
heterodimeric receptor consisting of two related receptors, the LIF receptor 
(LIFR), and the GP130 receptor (Boulton et al., 1994; Gearing et al., 1992), 
resulting in the activation of both Janus Kinase/Signal Transducers and 
Activators of Transcription (JAK/STAT) and MAPK pathways (Stahl et al., 
1994). The primary STAT molecule activated by LIF signaling is STAT3 and 
overexpression of a constitutively active version of this molecule (STAT3-ER) 
allows mES cells to self-renew in the absence of LIF (Matsuda et al., 1999). In 
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addition, lack of STAT3 activity results in ES cell differentiation (Burdon et 
al., 1999; Niwa et al., 1998). Although LIF is required in vitro to derive and 
maintain mES cells, mouse blastocysts lacking Lif could implant in wild type 
female uteri but not in Lif-null uteri in vivo, suggesting embryonic LIF is not 
essential (Chen et al., 2000; Stewart et al., 1992).  
Although LIF signalling is thought to maintain ES cell pluripotency, it is 
insufficient to maintain pluripotency in defined culture conditions without 
the presence of serum (Ying et al., 2003). Culturing ES cells in serum-free 
N2B27 medium with LIF results in emergence of Sox1+ neural precursors, 
indicating that there are other soluble factors present in serum that are 
essential for the maintenance of the undifferentiated state. 
 
1.1.2.2.2: BMP4  
The components of serum used for routine cell culture (in this study, 
FCS for fetal calf serum) are undefined, and sometimes vary from one batch 
to another. The differentiation-inhibiting factor present in FCS was identified 
in 2003 as bone morphogenic protein 4 (BMP4) (Ying et al., 2003). ES cells 
cultured in serum-free N2B27 medium supplemented with LIF and BMP4 
can self-renew, retain their ability of multi-lineage differentiation and can 
contribute to chimaeras. LIF and BMP acts concurrently to preserve 
pluripotency in ES cells, as ES cells cultured in BMP4 alone differentiate into 
non-neural fates (Ying et al., 2003). 
BMPs are members of the transforming growth factor-β (TGF-β) 
superfamily of secreted signaling molecules which is known to have 
important functions in many biological contexts. They bind to specific 
heterodimeric transmembrane serine/threonine kinase receptors, which 
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transduce the signal to the nucleus through similar to mothers against 
decapentaplegic homologue (SMADs) proteins (reviewed in van Bubnoff and 
Cho, 2001), intracellular signal transduction molecules that fall into three 
categories: receptor-regulated SMADs (R- SMADs), cooperating SMADs (Co- 
SMADs) and inhibitory SMADs (I- SMADs). BMP activation of SMAD4, the 
sole Co- SMAD known in mammals, culminates in the expression of inhibitor 
of differentiation (Id) proteins, which act to block differentiation in a lineage 
specific manner, as BMPs have been shown to have powerful anti-neural 
activity in vivo (Di-Gregorio et al., 2007). Overexpression of Id proteins in 
mES cells can substitute for BMP4 or serum in maintaining self-renewal of ES 
cells (Ying et al., 2003). 
 
1.1.2.2.3: Wnt/GSK-3β 
Wnt signaling has been reported as a complex signalling pathway to be 
involved in a vast number of functions in tissue homeostasis and 
development. There are two types of Wnt signaling pathways, canonical and 
non-canonical. Canonical Wnt signaling involves the presence of β-catenin, 
while non-canonical Wnt signaling operates without it. In canonical Wnt 
signaling, Wnt proteins bind the cell surface receptor Frizzled (Fz)/ low 
density lipoprotein (LDL) receptor-related protein (LRP) complex at the cell 
surface. These receptors transduce a signal to several intracellular proteins 
that include Dishevelled (Dsh), glycogen synthase kinase-3β (GSK-3β), Axin, 
Adenomatous Polyposis Coli (APC), and the transcriptional regulator, β-
catenin. Cytoplasmic β-catenin levels are normally kept low through 
continuous proteasome-mediated degradation, which is controlled by a 
complex containing GSK-3β/APC/Axin. When cells receive Wnt signals, the 
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degradation pathway is inhibited, and consequently β-catenin accumulates 
in the cytoplasm and nucleus. Nuclear β-catenin interacts with transcription 
factors such as lymphoid enhancer-binding factor 1/T cell-specific 
transcription factor (LEF/TCF) to affect transcription (Logan and Nusse, 
2004). 
It has been shown that GSK-3β, a component of the destruction complex, 
is the kinase responsible for β-catenin phosphorylation. Furthermore, it was 
also demonstrated that direct inhibition of GSK-3β could mimic Wnt 
signaling (Finlay et al., 2004). Inhibition of GSK-3β also allows nuclear re-
localization of β-catenin and promotes expression of the pluripotency factor 
Rex1 (Sato et al., 2004). The inhibition of GSK-3β-induced enhancement of ES 
cell self-renewal is through the modulation of TCF3 (Wray et al., 2011). 
Stimulation of ES cells with Wnt3, Wnt3a, Wnt5a and Wnt6 was also shown 
to promote pluripotency (Hao et al., 2006; Ogawa et al., 2006), and this 
positive effect on self-renewal could be stimulated further with a 
combination of Wnt and LIF or FGF inhibition (Singla et al., 2006). 
 
1.1.2.2.4: Fibroblast growth factor (FGF) signaling 
FGF signaling plays an important role in regulating pluripotency and 
lineage segregation in both the early mouse embryo and in pluripotent 
mammalian stem cells. The importance of FGF signaling in the early mouse 
embryo is well established, as mutations in Fgf4, Fgfr2, Frs2a, Grb2 and Erk2 
(Mapk1) all result in peri-implantation lethality (reviewed in Lanner and 
Rossant, 2010). FGF4 is the predominantly expressed ligand in the early 
embryo and has been shown to be under the direct regulation of the 
pluripotency factors Oct4 and Sox2 (Yuan et al., 1995). 
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Although FGF4 is produced in an autocrine fashion by undifferentiated 
ES cells (Ma et al., 1992), it is dispensable for the maintenance of the 
undifferentiated state of mouse ES cells, as ES cells lacking Ffg4 are viable 
and display no obvious proliferative defect under self-renewing conditions 
(Wilder et al., 1997). FGF signalling appears to negatively affect ES cell self-
renewal, and its inhibition promotes and homogenizes the expression of 
transcription factors associated with pluripotency (Burdon et al., 1999; 
Kunath et al., 2007; Wilder et al., 1997; Ying et al., 2008). Study on the Fgf4-
null and Erk2-null ES cells demonstrated that FGF/ERK signaling is required 
to instruct ES cells to exit from the self-renewal program and to begin 
differentiation (Kunath et al., 2007). A similar phenotype was observed in 
vivo as the ICM of Fgf4-null blastocysts become uniformly positive for the 
epiblast determinant Nanog and fails to correctly segregate primitive 
endoderm (Chazaud et al., 2006; Nichols et al., 2009b), suggesting FGF4/ERK 
is also required for ES cells to exit to primitive endoderm (PrE) fate. Canham 
et al. showed that PrE lineage-primed, Hex-expressing population within ES 
cells can be reduced by inhibiting ERK signaling or promoted by stimulating 
phosphorylation with sodium vanadate (Canham et al., 2010). Moreover, 
inhibition of FGF/ERK signaling promotes epiblast maintenance, whereas 
excess FGF instructs the formation of primitive endoderm (Yamanaka et al., 
2010). Therefore, FGF/ERK signaling pathway is critical for early lineage 
segregation in pre-implantation embryos and plays an important role in 







Figure 1.1: FGF signalling is involved in the regulation of dynamic state of 
mouse ES cells (modified from Lanner and Rossant, 2010) 
ES cells exhibit great heterogeneity, whereby some cells appear to be 
transiently primed for differentiation. At least three states have been 
suggested: (A) unprimed cells (Nanog+/Stella+/Rex1+); (B) cells primed for 
primitive endoderm (PrE) (Gata6+/Hex+); and (C) cells primed for germ layer 
differentiation (Fgf5+/Brachyury+). FGF4 signalling has been shown to 
maintain both primed states. LIF and BMP appear to promote ES self-
renewal by counterbalancing the pro-differentiation autocrine FGF4/ERK 
signal. The grey box highlights the cell populations that readily revert back 




1.1.2.2.5: 2i culture and the ‘Ground State’ hypothesis  
As described above, all of these signalling pathways are capable of 
affecting the self-renewal ability of embryonic stem cells, either positively or 
negatively, but no single pathway stimulation or inhibition can maintain ES 
cells in a pluripotent state.  Therefore, a combination of these pathways is 
required for long-term maintenance of pluripotency.  
Based on the observation that FGF/ERK was the primary auto-inductive 
cue that caused mES cells to commit to specific lineages and block β-catenin 
phosphorylation could enhance ES cell self-renewal, Ying and colleagues 
developed a self-renewal medium containing only two small molecule 
inhibitors to block MEK (PD0352901) and GSK-3β (CHIR99021) , a medium 
they termed “2i” (Ying et al., 2008). ES cells cultured in 2i are shielded from 
differentiation triggers and ES cells express pluripotency factors more 
homogeneously (Wray et al., 2011). 2i culture also enabled derivation of 
germline-competent ES cells from refractory mouse strains (Hanna et al., 
2009; Kiyonari et al., 2010; Nichols et al., 2009a). The same culture conditions 
have been applied to derive ES cell lines from the rat that are capable of 
contributing to adult chimaeras and passing through the germ line (Buehr et 
al., 2008; Li et al., 2008).  
From this data, the authors propose a model that 2i culture conditions 
allowed ES cells to remain in a “ground state”, and suggested that ES cells 
are a basal cell state that is intrinsically self-maintaining if shielded 
effectively from inductive differentiation stimuli including autocrine FGF4 
(Ying et al., 2008). Addition of LIF is not required for self-renewal in 2i; 
however, its addition reinforces the ground state through further 
upregulation of Klf4 and Tcfcp2l1 (Martello et al., 2013). Providing any two of 
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the three 2i/LIF components is sufficient to support the formation of 
undifferentiated colonies (Wray et al., 2010), implying complementary inputs 
to a flexible gene regulatory network.  
In summary, maintaining pluripotency within ES cells can be achieved 
by either activating of inhibiting different combination of signaling pathways. 
However, no single pathway activation/inhibition is sufficient for long-tern 
propagation of self-renewing colonies. The flexibility of ES cells to adapt to 
different culture conditions implied the ability of cells within the ICM, the in 
vivo counterpart of ES cells, to maintain a robust pluripotent state while 
being exposed to a variety of extrinsic signals. 
 
1.1.3: Cellular heterogeneity 
In recent years, using fluorescent reporters and single cell analysis, 
reports have emerged of heterogeneous expression of transcription factors in 
ES cells. These include several genes known to have roles in the 
establishment and/or maintenance of pluripotency, as well as lineage 
specification: Nanog (Chambers et al., 2007), Rex1 (Toyooka et al., 2008), Stella 
(Hayashi et al., 2008), Klf4 (Festuccia et al., 2012; Niwa et al., 2009) and Hex 
(Canham et al., 2010). Using fluorescence-activated cell sorting (FACS), 
sorted fractions can re-establish the parental steady-state heterogeneous 
distribution when return to culture conditions supporting self-renewal,  
suggesting that the expression of these factors is dynamic within ES cells.  
Heterogeneity of gene expression might have a functional role in cell 
fate decisions. Rex1-GFP-positive cells plated in serum generate colonies of 
undifferentiated cells, whereas Rex1-GFP-negative cells produce 
predominantly small and differentiated colonies (Toyooka et al., 2008). 
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Nanog-GFP-high cells are associated with a reduced probability of 
differentiation whereas Nanog-GFP-low cells were shown to be more prone 
to differentiate (Chambers et al., 2007). In the case of Stella, the ES cells 
required co-culture with fibroblasts to display heterogeneity. Stella-GFP-
positive ES cells are like the pre-implantation inner cell mass (ICM), whereas 
Stella-GFP-negative cells were like the post-implantation epiblast-derived 
stem cells (EpiSCs) (Hayashi et al., 2008). Hex-GFP-positive cells have an 
increased propensity to contribute to extra-embryonic endoderm when 
reintroduced into blastocysts, with the opposite propensity observed for 
Hex-GFP-negative cells (Canham et al., 2010). Therefore, the heterogeneous 
expression of these transcription factors reflects distinct cell states that 
coexist within the population despite their genetic homogeneity and raise the 
notion that pluripotency may inherently be a metastable condition (Graf and 
Stadtfeld, 2008; Hayashi et al., 2008) (Figure 1.1). 
Heterogeneity of pluripotent cells may arise via different modes of 
transcriptional regulation, as well as post-transcriptional events such as 
protein synthesis and cell cycle dynamics, but the contribution of these 
different steps to heterogeneity is largely unknown (Torres-Padilla and 
Chambers, 2014). Recent advances in understanding transcription factor 
heterogeneity have come from work that focuses on the regulation of Nanog. 
Nanog protein was shown to decrease the level of transcription of the Nanog 
gene (Navarro et al., 2012), suggesting feedback loops among the gene 
regulation network components regulate ES cells heterogeneity. Non-
transcriptional regulation of heterogeneity might also occur, for example 
through modulation of signalling pathways. It is shown that ES cells cultured 
in 2i/LIF expressed Nanog and Rex1 more homogeneously (Wray et al., 2010; 
Ying et al., 2008), suggesting that modulating signaling pathways could 
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stabilize ES cells in the naïve ground state which is not intrinsically 
fluctuating. 
Taken together, revealing the molecular basis of the heterogeneity is not 
only important for understanding the flexible nature of the pluripotent state 
but might also help to dissect functional implications for the developmental 
potential of the cell. 
 
1.1.4: Epigenetic regulation of mES cell identity 
Recent analysis of specific epigenetic features of human and mouse stem 
cells has provided important insights into the unique properties of 
pluripotent and lineage-restricted stem cells. It is considered that 
transcription factors initiate lineage-specific gene expression programmes 
and epigenetic regulation contributes to stabilization of expression patterns. 
Epigenetic regulation of gene expression consists of several layers, including 
DNA methylation status, histone modifications, nucleosome packaging and 
rearrangement of higher-order chromatin structures and implementation of 
RNAi pathways and non-protein-coding RNAs (ncRNA) (Li et al., 2012; 
Lunyak and Rosenfeld, 2008). Perturbation of epigenetic regulation may 
cause alterations in the pluripotent stem cells identity, such as their self-
renewal and differentiation potentials.  
 
1.1.4.1: Changes in DNA methylation 
One well-studied epigenetic process is DNA methylation of cytosine at 
CpG dinucleotides, which constitutes the first layer of the epigenetic code 
that is important for lineage specification and reprogramming to 
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pluripotency. It is shown that approximately 70% of all CpG dinucleotides 
are methylated and associated with regions of heterochromatin (Bird, 2002). 
The remaining 30% of un-methylated CpG dinucleotides are generally 
associated with the gene promoter regions and referred to as CpG islands. 
Although the global CpG content in ES cells is similar (Meissner et al., 2005), 
the distribution of the mark is unlike that of any other somatic cell type and 
also very distinct from the hypomethylated ICM (Meissner et al., 2008).  
The DNA methylation pattern of the mammalian genome is maintained 
by DNA methyltransferases (DNMTs). DNMT3a and DNMT3b, the de novo 
DNA methyltransferase, were involved in re-methylating the genome 
following implantation (Okano et al., 1999). ES cells can be established and 
maintained in the absence of DNMTs and DNA methylation (Tsumura et al., 
2006). However, Dnmt-deficient ES cells (Dnmt [3a-/-, 3b-/-], Dnmt1-/-) are 
markedly deficient in differentiation (Jackson et al., 2004), which is likely due, 
at least in part, to their inability to completely silence genes encoding Oct4 
and Nanog (Li et al., 2007). 
DNA demethylation also plays important roles in development and 
reprogramming. Ten-eleven translocation (TET) family of enzymes convert 
5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in DNA. Of the 
three mammalian TET proteins, TET1 and TET2 are the major regulators of 
5hmC levels in mouse embryonic stem cells. TET1 and TET2 are Oct4-
regulated enzymes that together sustain 5hmC in mouse ES cells (Koh et al., 
2011). During ES cell differentiation, the amount of TET1 and 5hmC 
decreases (Tahiliani et al., 2009), and TET1 knockdown impairs the self-
renewal and maintenance of ES cells (Ito et al., 2010). In somatic 
reprogramming, demethylation of pluripotency gene promoters is a rate-
limiting step towards the fully reprogrammed iPSCs state. Two recent papers 
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provide a link between the activation of the pluripotency network and 
changes in DNA hydromethylation status by examining the role of TET 
proteins (Costa et al., 2013; Gao et al., 2013b). 
 
1.1.4.2: Histone modifications 
In ES cells, most differentiation-related genes are regulated by 
chromatin-mediated mechanisms rather than by DNA methylation. 
Regulation of gene expression at the chromatin level involves histone 
modifications and rearrangement of nucleosomes and higher-order 
chromatin structures. Compared to DNA methylation, these epigenetic 
modifications are more dynamically regulated during development (Li et al., 
2012).  
Various histone modifications have been extensively studied in 
pluripotent stem cells. Polycomb group (PcG) and Trithorax group (TrxG) 
proteins are major effectors of histone modifications. PcG proteins are 
transcriptional repressors that have a role in maintaining repression of 
developmental regulator genes from plants to mammals (Beisel and Paro, 
2011). PcG proteins catalyses H3K27 methylation (H3K27me3), a major 
repressive histone modification, at promoters of many key developmental 
regulators (Guenther et al., 2010). In pluripotent stem cells, PcG and TrxG 
proteins are essential for maintaining the balance between self-renewal and 
differentiation. PcG proteins are not necessary for maintenance of embryonic 
stem cell self-renewal (Chamberlain et al., 2008). However, cells lacking 
PRC2 are more prone to differentiation, which might due to increase the 
transcription of many development-associated PRC2 targets (Boyer et al., 
2006). The activity of TrxG proteins opposes the action of PcG proteins 
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during development, by catalysing H3K4 methylation (H3K4me3), a major 
activating epigenetic mark (Mikkelsen et al., 2007; Zhao et al., 2007). 
Genome-wide ChIP analysis performed independently by several groups 
revealed that H3K27me3 modifications are often found at developmental 
gene promoters that are also marked with H3K4me3 (Bernstein et al., 2006; 
Schubeler et al., 2004), termed “bivalency”. Bivalency is thought to keep 
developmental genes silenced yet poised for activation. A significant number 
of ‘bivalent’ domains are enriched for binding sites for at least one of the 
three pluripotency associated factors, Oct4, Nanog and Sox2, which implies 
that their formation and/or maintenance might be regulated through these 
‘master regulators’.  
Chromatin in pluripotent stem cells is increasingly being recognized as 
open when compared with somatic cells, implying that its overall structure is 
less condensed and that the ratio between euchromatin and heterochromatin 
is higher than in differentiating cells  (Efroni et al., 2008; Meshorer et al., 
2006). The open ES cell chromatin structure, which is enriched in non-
compact euchromatin, allows easy access for transcription factors and the 
transcriptional machinery and may explain the observed global ‘hyper-
transcription’. By contrast, lineage commitment is accompanied by the 
accumulation of regions of highly condensed, transcriptionally inactive 
heterochromatin (Efroni et al., 2008; Meissner, 2010). The formation of 
heterochromatin at the pericentric and telomeric regions as well as the 
variation and propagation of epigenetic states to a dynamic chromatin 
template have been extensively studied (reviewed in Fodor et al., 2010). In 
addition, several histone methylases and deacetylases play essential 
functions in remodelling of heterochromatin in pluripotent stem cells and in 
development. The histone methyltransferases G9a and Eset catalyse histone 
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H3 lysine 9 methylation (H3K9me) and contribute to gene regulation in the 
early embryo (Dodge et al., 2004; Feldman et al., 2006). In ES cells, knocking 
down G9a increases the efficiency of iPSCs generation (Epsztejn-Litman et al., 
2008) whereas Eset-Oct4 interaction regulates pluripotency and represses 
trophectoderm differentiation (Lohmann et al., 2010; Yeap et al., 2009).  
The nucleosome remodelling and deacetylase (NuRD) complex 
containing both a nucleosome remodelling ATPase and histone deacetylases 
(HDACs) has also been implicated in the establishment of the epiblast 
lineage. Loss of NuRD components such as Mbd3 de-represses 
trophectoderm markers and impairs ES cell differentiation (Fazzio and 
Panning, 2010; Kaji et al., 2007). Recently, a genome-wide study has shown 
that TET1 (5hmC) overlaps with Mbd3-binding sites in ES cells, suggesting 
crosstalk between the Mbd3 and 5hmC pathways (Yildirim et al., 2011). 
These studies demonstrate the dedicated interplay of different layers of 
epigenetic regulation in controlling pluripotency and differentiation. 
 
1.1.5: Transition from naïve to primed pluripotency in the embryo 
and in culture 
During early mammalian development, as the pluripotent cells that give 
rise to all of the tissues of the body proliferate and expand in number, they 
pass through transition states marked by a stepwise restriction in 
developmental potential and by changes in the expression of key regulatory 
genes. In vitro, pluripotency can be maintained indefinitely through 
derivation of stem cell lines derived from different stages of mouse 
development to mimic these transition states. Different classes of pluripotent 
stem cell have distinct culture requirements and gene expression programs, 
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likely reflecting the dynamic development of the epiblast in the embryo 
(Nichols and Smith, 2012). 
1.1.5.1: Early mouse development 
Embryogenesis begins from a “totipotent” zygote that will give rise to 
the entire embryo and to the extra-embryonic lineages followed by 
progressive loss of developmental capacity. The zygote undergoes several 
rounds of stereotyped cleavage divisions without increasing in volume but 
half individual cell size at every division then form blastocyst, with a fluid 
filled cavity, known as the blastocoel cavity (Rossant and Tam, 2009). Two 
distinct lineages have emerged from the early blastocyst that exhibit 
morphological and molecular differences: trophectoderm (TE) and inner cell 
mass (ICM). The TE, which is characterized by expression of the transcription 
factor caudal type homeobox 2 (Cdx2) among other specific markers (Beck et 
al., 1995), and by its epithelial nature, will contribute primarily to the 
placenta. The ICM further segregates into the pluripotent epiblast (which 
give rise to ES cells) and the primitive endoderm (PrE). Oct4 is expressed by 
all cells in the ICM and is essential to establish the distinct identity of the 
ICM. In the absence of Oct4, ICM cells loss their pluripotency and eventually 
differentiate along the trophoblast lineage (Nichols et al., 1998). Oct4 
expression is negatively correlated with Cdx2 and this appears to be critical 
for the segregation of trophectoderm and ICM (Niwa et al., 2005). The 
epiblast and PrE cells express distinct molecular signatures: the epiblast is 
characterized by the expression of the transcription factor Nanog, and the 
PrE cells by the expression of the transcription factors Gata6 and Gata4 
(Chambers et al., 2003; Chazaud et al., 2006; Plusa et al., 2008). Nanog and 
Gata6 may act in a mutually antagonistic manner to determine the two 
lineages (Plusa et al., 2008).  
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The acquisition of epiblast identity coincides with the reactivation of the 
inactive X chromosome in female mouse embryos (Mak et al., 2004; Okamoto 
et al., 2004; Silva et al., 2009). Reactivation occurs transiently in the 
pluripotent lineage prior to implantation (Heard, 2004), X reactivation is 
therefore a hallmark of the successful formation of ES cells (Silva and Smith, 
2008). 
The segregation of the epiblast and primitive endoderm is mediated by 
FGF signalling. Chemical inhibition of the FFG/ERK pathway entirely 
suppresses PrE development and concomitantly expands the epiblast 
(Nichols et al., 2009b; Yamanaka et al., 2010). Conversely, administering high 
concentrations of FGF4 to early embryos can drive the entire ICM to form 
PrE cells (Yamanaka et al., 2010). The segregation of the two lineages may be 
consolidated by reciprocal expression of FGF receptor in the PrE cells and 
FGF4 in the epiblast (Guo et al., 2010). 
Following implantation, which is around E4.5 for mouse embryo, the 
mouse epiblast grows from a ball of cells into a cup-shaped epithelium, 
known as the egg cylinder. In addition, random X-inactivation occurs in 
female embryo throughout the epiblast at E5.5 (Rastan, 1982). This 
morphological change is accompanied by the reduced expression of naïve 
pluripotency transcription factors such as Nanog and Rex1 and by the 
upregulation of Fgf5 and T-Brachyury (Chambers et al., 2003; Pelton et al., 
2002). Post-implantation epiblast cells are pluripotent, as they maintain the 
capacity to give rise to teratocarcinomas and EC cells (Solter et al., 1970; 
Stevens, 1970). Although post-implantation epiblast cells are unable to 
contribute to blastocyst chimaeras, it could be they are incompetent to 
respond to developmental cues in the blastocyst, as lineage tracing using 
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vital dye labeling of single cells during early gastrulation ex vivo reveals 
progeny in all three germ layers (Lawson et al., 1991).  
1.1.5.2: Comparison between naïve ES cells, primed ES cells and post-
implantation Epiblast stem cells (EpiSCs) 
ES cells are derived from the epiblast of the pre-implantation embryos, 
as described in section 1.1.1.2, representing a more naïve pluripotent state 
when compared with EpiSCs derived from post-implantation epiblast (see 
section 1.1.1.3). However, ES cells cultured routinely in the medium 
containing serum and LIF do display heterogeneous gene expression (see 
section 1.1.3). The heterogeneity of gene expression reflects distinct cell states 
within a pluripotent culture and these metastable states show biases in their 
differentiation potentials (Graf and Stadtfeld, 2008; Hayashi et al., 2008) 
(Figure 1.1). Culturing ES cells in two inhibitors (2i), PD0325901 (MEK 
inhibitor) and CHIR99021 (GSK-3β inhibitor), shield pluripotent cells from 
differentiation triggers:  FGF4 stimulation of the MEK-ERK pathway and 
endogenous repressor activity of TCF3 (Kunath et al., 2007; Wray et al., 2011). 
Thus, ES cells cultured in 2i are considered as in “ground state” of 
pluripotency with rather homogeneous gene expression (see section 1.1.2.2.5) 
(Wray et al., 2010; Ying et al., 2008).  
The naïve ES cells (ground state, 2i-ESC) differ from primed ES cells 
(serum-ESC) at both transcriptional and epigenetic levels. 2i-ESC express 
lower level of lineage affiliated genes (Pax6, Runx1, T-Brachyury), reduced 
repressive histone mark H3K27me3 at promoters, and fewer bivalent 
domains, which mark genes are inactivated but poised for activation or 
repression (see section 1.1.4) (Marks et al., 2012).  Therefore, 2i culture is 
likely to “erase” epigenetic marks generated in serum culture, as cells 
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cultured in different batch of serum sometimes do display different 
differentiation potential (unpublished data in the lab).  
Despite the difference between naïve ES cells and primed ES cells, there 
are more studies focusing on the differences between pre-implantation 
epiblast-derived ES cells and post-implantation epiblast derived EpiSCs 
(Nichols and Smith, 2009). EpiSCs can also be derived from ES cells by 
extensive passaging from serum-containing ES cell medium to EpiSC 
medium which is serum-free medium supplemented with Activin/FGF2 
(Guo et al., 2009), or by directly conversion from 2i/LIF culture to EpiSC 
medium within few days (Hayashi et al., 2011). The differences between 
naïve and primed states of epiblast are summarized in table 1.1. It is worth 
noting that there can be some differences in the use of terminology, for 
example in the table 1.1 the naïve pluripotent state is considered as a general 
state for pre-implantation epiblast-derived ES cells and the primed state as 
post-implantation epiblast derived EpiSCs, whereas above ES cells cultured 
in serum-containing medium were considered to be in a primed state, as 
distinct from cells cultured in 2i.  
In summary, morphologically, EpiSCs share with ES cells a large 
nuclear-to-cytoplasmic ratio and prominent nucleoli, but their morphology is 
more two-dimensional and epithelial. The transition from naïve to primed 
pluripotent state is accompanied with DNA methylation and X-inactivation 
and loss of E-cadherin expression. The transition from naïve to primed 
pluripotent state is not irreversible, as it is reported that post-implantation 
epiblast cells and established EpiSCs can ‘overcome’ a robust epigenetic 
barrier and undergo reversion to ES-like cells, either by culturing E5.5-E7.5 
pluripotent epiblast in ES cell medium containing LIF and serum on feeder 
cells (Bao et al., 2009), or by overexpression of either Nanog or Klf4 together 
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with a change in culture conditions (Guo et al., 2009; Osorno et al., 2012; Silva 
et al., 2009). 
The transition from a naïve to primed pluripotent state, and in more 
detail, the transition from naïve ES cells to primed ES cells, is the initial 
important step for the commitment to differentiation. Therefore, 
understanding the genetic and epigenetic mechanisms controlling these 
transitions is important, yet these mechanisms are not well understood and 




Table 1.1: Comparison of naïve and primed pluripotent states (adapted 
from Nichols and Smith, 2009) 
Property Ground state Primed state 
Embryonic tissue  early epiblast egg cylinder; embryonic disc 
Culture stem cell rodent ES cells  rodent EpiSCs  
primate “ES cells” 
Chimaeras blastocyst gastrulation stage embryo 
Teratomas yes yes 
Differentiation bias none  variable 
Pluripotency factors Oct4, Nanog, Sox2, 
Klf2, Klf4 
Oct4, Sox2, Nanog (low) 
Naïve markers  Rex1, NrOb1, Fgf4 absent 
Specification markers absent  Fgf5, T 
Response to LIF/STAT3  self-renewal  none 
Response to FGF/Erk  differentiation  self-renewal 
Clonogenicity  high low 
XX status  XaXa  XaXi 
Response to 2i  self-renewal  differentiation/death 





1.1.6: Embryonic stem cells as a model for lineage specification 
The study of differentiating embryonic stem cells represents a 
convenient experimental tool for the analysis of the molecular events that 
accompany lineage specification: 
• mES cells are easy to grow and can be maintained in chemically 
defined culture medium, which simplified the complexity of understanding 
extracellular signalling pathways in their maintenance and differentiation.  
• mES cells double rapidly (12-15 hours) which can be useful for 
biochemical studies where large amounts of materials are needed.  
• mES cells exhibit a high frequency of homologous recombination (10-5-
10-6 per electroporated cell) (Templeton et al., 1997) which allow rapid and 
straightforward transgenesis experiments for genetic studies.  
mES cells can be differentiated into various cell types with high 
efficiency. Three basic methods have been developed to promote 
differentiation of ES cells in vitro: (1) the formation of three-dimensional 
aggregates known as embryoid bodies (EBs), (2) the culture of ES cells as 
monolayers on extracellular matrix proteins, and (3) the culture of ES cells 
directly on supportive stromal layers. 
 
1.1.6.1: Embryoid body (EB) formation 
The most reliable method for generating multi-lineage differentiated cell 
types is the induction of EB formation, through which ES cells spontaneously 
develop into three-dimensional, multi-cellular aggregates of differentiated 
and undifferentiated cells. An EB consists of ectodermal, mesodermal, and 
endodermal tissues, which recapitulate many aspects of cell differentiation 
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during early mammalian embryogenesis and differentiate into derivatives of 
all the three germ layers (Desbaillets et al., 2000). A common technique used 
is to simply deprive ES cells of contact with feeder cells, or from the presence 
of LIF, and culture ES cells under the condition in which they are unable to 
adhere to the surface of the culture dishes. There are several basic methods to 
induce EB formation from pluripotent ES cells: suspension culture in 
bacterial-grade dishes, culture in methylcellulose semisolid media, or culture 
in hanging drops (Hopfl et al., 2004; Kurosawa, 2007).  
The features of formed EBs are considered to be not homogeneous 
embryologically and morphologically. However, EBs could be classified as 
simple EBs or cystic EBs according to the stage of differentiation (Kurosawa, 
2007). For mouse ES cells, spherical ES cell aggregates with morula-like 
structures formed in 2-4 days in suspension culture are called simple EBs. 
The outside of the simple EBs is lined by endoderm, and the inside cells 
contain variable mixtures of mesoderm and ectoderm. In the case of cystic 
EBs, a central cavity forms in EBs in 4-5 days in suspension culture. Cystic 
EBs resemble an embryo in the blastula or egg-cylinder stage, consisting of a 
double-layered structure with an inner ectodermal layer and an outer of 
endoderm enclosing the cavity. After 8–10 days in suspension culture, cystic 
EBs expand to larger cystic structures homologous to the visceral yolk sac of 
post-implantation embryos. 
EBs recapitulate many aspects of cell differentiation during early 
embryogenesis, and play an important role in the differentiation of ES cells 
into a variety of cell types in vitro. However, EBs do present disadvantages. 
The consistent of mixed cell types within single EB makes the culture too 
heterogeneous to easily study the specification of particular lineage. Also, the 
3-dimensional structure of EBs makes them less practical for imaging in vivo. 
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Thus, although the multi-lineage differentiation potential of EBs served as a 
great tool for generating non-biased environment for analysing ES cells 
differentiation, other differentiation methods is needed for accessing cell 
differentiation for single lineage analysis.  
  
1.1.6.2: Monolayer differentiation in N2B27 medium  
Differentiating ES cells in adherent monolayers provides the solution for 
all of the problems discussed in the previous section. The monolayer 
differentiation was first established by culturing ES cells on feeder cells to 
induce specification of different lineages (Kawasaki et al., 2000; Nakano et al., 
1994). However, the presence of feeder cells in these protocols made the 
culture as a non-chemically defined context and thus the differentiation 
efficiency varied from time to time. Feeder-free ES cell differentiation 
protocols were then developed by culturing cells on extracellular matrix-
coated surface supplemented with different cytokines (Coraux et al., 2003; 
Nishikawa et al., 1998). 
A currently routinely used medium for ES cell differentiation was 
devised in 2003 by Smith and colleagues by combining N2 and B27-
supplemented serum-free basal media and named the new culture medium 
N2B27 (Ying and Smith, 2003). Culture of ES cells as an adherent monolayer 
plated on gelatine in N2B27 medium enable the conversion of mouse ES cells 
to either terminally differentiated neurons and glia or self-renewing but 
lineage-restricted neural stem cell lines (Pollard et al., 2006; Ying et al., 2003). 
This N2B27 medium was able to support cell survival and proliferation 
without providing lineage specifying signals, which support the “default 
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model of differentiation“ of neural induction in the mouse (Tropepe et al., 
2001).  
Differentiation of mES cells in N2B27 seems to follow the same  
molecular transitions that occur in vivo: downregulation of naïve pluripotent 
markers followed by transient upregulation of post-implantation epiblast 
transcript and subsequent acquisition of neural ectoderm gene expression 
pattern, indicating that N2B27 culture is a developmentally relevant in vitro 
differentiation system (Aiba et al., 2009; Aiba et al., 2006). Moreover, addition 
of particular combinations of cytokines in N2B27 medium redirects ES cells 
to differentiate toward endodermal, mesodermal or epithelial fates (Hansson 
et al., 2009; Malaguti et al., 2013; Ying et al., 2003), and supplementation of 
the medium with factors that promote self-renewal enables long-term 
maintenance of ES cells and EpiSCs (Brons et al., 2007; Tesar et al., 2007; 
Wray et al., 2010; Ying et al., 2003). Therefore, the N2B27 culture appears to 
be a well-defined and powerful tool for monitoring the in vitro differentiation 
process. 
 
1.2: Basic helix-loop-helix (bHLH) family of transcription factors 
The basic helix-loop-helix (bHLH) family of transcriptional regulatory 
proteins are key players in a wide array of developmental processes (Massari 
and Murre, 2000). Members of this family hold a highly conserved functional 
domain containing a stretch of basic amino acids adjacent to two 
amphipathic α-helices separated by a loop. The bHLH transcription factors 
can form either homo- or hetero- dimers depend on their different classes 
described below. The dimerized bHLH factors bind specifically to a hexa-
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nucleotide sequence (CANNTG) called E-box, which is found in the control 
regions of many lineage-specific genes. 
This family is found in a variety of eukaryotic organisms, ranging from 
the yeast to humans, and in the mouse it comprises over 100 genes, which are 
involved in a multiplicity of biological processes including cell 
differentiation, lineage commitment, and sex determination (Massari and 
Murre, 2000; Skinner et al., 2010). bHLH factors are required for a multitude 
of important developmental processes, including NeuroD in neurogenesis 
(Lee et al., 1995), MyoD in myogenesis (Lassar et al., 1989; Sassoon et al., 
1989), SCL/TAL-1 in hematopoiesis (Porcher et al., 1996), and NGN3 in 
pancreatic development (Whelan et al., 1990), with these factors being well 
conserved between different model organisms.  
 
1.2.1: bHLH superfamily classification 
bHLH proteins are classified by tissue distribution, dimerization 
capabilities, and DNA-binding specificities into 7 classes (I to VII) (Murre et 
al., 1994).  
Class I bHLH proteins (also known as the E proteins) include E12, E47, 
HEB, E2-2, and Daughterless. E12 and E47 represent spliced variants of Tcf3 
(also called TcfE2A) gene (Aronheim et al., 1993). E proteins are ubiquitous 
expressed in many tissues and capable of forming either homo- or hetero-
dimers. Class II bHLH proteins include members such as Twist, MyoD, 
myogenin, Mash1 and NeuroD, and show a tissue-restricted pattern of 
expression. With very few exceptions (one exception being Twist (Connerney 
et al., 2008)), they are not able to form homodimers but preferentially 
dimerizing with class I proteins (Massari and Murre, 2000).  
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Class III bHLH proteins include the Myc family of transcription factors. 
Proteins of this class contain a leucine zipper adjacent to the bHLH motif. 
Class IV bHLH proteins define a family of molecules, including Mad, Max, 
and Mxi that are capable of dimerizing with the Myc proteins or with one 
another.  
A group of bHLH proteins that lack a basic trans-activation region, 
including Id and Emc, define the class V bHLH proteins. Class V members 
are negative regulators of class I and class II bHLH proteins (Benezra et al., 
1990).  
Class VI HLH proteins have as their defining feature a proline in their 
basic region. This group includes the Drosophila proteins Hairy and 
Enhancer of Split (Hes).  Finally, the class VII bHLH proteins are categorized 
by the presence of the bHLH-PAS domain and include members such as the 
aromatic hydrocarbon receptor, the AHR nuclear-translocator (ARNT) and 
hypoxia-inducible factor 1α (HIF-1α) (Massari and Murre, 2000).  
  
1.2.2: Id as a negative regulator of bHLH transcription factors 
The inhibitor of DNA binding/inhibitor of differentiation (Id) protein-1 
was first identified in a screen for nucleotide sequences homologous to those 
encoding the second α-helix of the bHLH factors Myc, Myod and Myog 
(Benezra et al., 1990). There are 4 Ids in mammals with overlapping 
expression profiles: Id1, Id2 (Sun et al., 1991), Id3 (Christy et al., 1991) and 
Id4 (Riechmann et al., 1994). Id proteins, lacking the basic domain required 
for DNA-binding, acts by binding to ubiquitously expressed class I bHLH 
transcription factor co-factors (E proteins) and blocking their dimerization 
with tissue-specific class II proteins (Benezra et al., 1990). The Id-E protein 
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complex lacks DNA binding ability to the tissue-specific target promoters. 
Therefore, Id is dominant-negative regulator of class II bHLH transcription 
factors. The bHLH domain of Id1 was shown to be necessary and almost 
sufficient for the repression of the DNA binding activity of TcfE2A (E12/E47) 
and MyoD (Pesce and Benezra, 1993). 
Id proteins play key roles in the regulation of lineage commitment, cell 
fate decisions and in the timing of differentiation during neurogenesis, 
lymphopoiesis and angiogenesis (Norton, 2000). Because of their overlapping 
expression patterns, single knockout of Id1 has no effect on the viability of 
mice and results in no obvious phenotypic defect (Yan et al., 1997). Id1-/-/Id3-/- 
double-null mice display aberrant neurogenesis with premature withdrawal 
of neuroblasts from the cell cycle and inappropriate expression of neural-
specific markers (Norton, 2000). Knockout of any 4 out of 6 alleles of Id1, Id2 
and Id3 (only one of the three genes is knocked out on both alleles, such as 
Id1-/-;Id2+/-;Id3+/-) results in embryonic lethality due to defects in cardiogenesis 
from as early as E9.5 and no triple-knockout embryos survived to E11.5 
(Fraidenraich et al., 2004). However, there has been no mouse made with all 
four Id genes knocked out. Therefore, it is possible that an earlier role for Id 
genes is masked by redundancy with Id4, although its expression in wild-
type embryo is essentially restricted to the developing nervous system, 
whereas expression of Id1–Id3 is much more widespread during mouse 
embryogenesis (Jen et al., 1997; Riechmann and Sablitzky, 1995). 
In mouse ES cells, Id genes are down-stream targets of BMP signalling 
(Ying et al., 2003). BMP induced Id-upregulation prevents neural 
differentiation (Zhang et al., 2010). Forced over-expression of Id enables ES 
cells to bypass the requirement for either BMP or serum to maintain self-
renewal ability (Ying et al., 2003). Expression of Id1 is rapidly downregulated 
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at the onset of differentiation, both in N2B27 serum-free monolayer 
differentiation and in serum-free embryoid body differentiation (Aiba et al., 
2009; Aiba et al., 2006), consistent with its role in the maintenance of ES cell 
self-renewal. 
Since Id proteins function through antagonism of bHLH transcriptional 
regulators, it is of interest to study Id-bHLH interactions in the regulation of 
mammalian cell fate determination. 
 
1.2.3: Identification of Id protein binding partners in mouse ES cells 
The transcription factors that act downstream of the FGF signalling 
pathway in order to drive epiblast cells toward differentiation-primed state 
are not known (Figure 1.2A). A clue to their identity comes from the finding 
that Id proteins are able to block the transition of ES cells to epiblast stem 
cells (EpiSCs) (Zhang et al., 2010). Therefore, epiblast priming could be 
driven by specific bHLH factors that are expressed in pluripotent cells but 
held in an inactive state through the action of Id proteins (Figure 1.2B). As 
soon as Id proteins are downregulated, the bHLH activity of these ‘‘primed’’ 
cells would be released from inhibition, allowing epiblast maturation to 
proceed. 
Our previous lab member Dr. Owen Davies set out to identify the 
targets of Id inhibition by determining the direct binding partners of both Id 
and E proteins in ES cells. To achieve this, a series of yeast-two-hybrid (Y2H) 
screens for binding partners of Id1, E47, and E12 within a library generated 
from the mRNA of pluripotent mouse ES cells were performed. The only 
validated Id1-binding partners identified were E47 and E12. Id1 is therefore 
likely to function in ES cells through E protein sequestration, with 
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downstream bHLH targets constituting direct binding partners of E47/E12. 
Further Y2H screening identified five validated interacting partners for the 
HLH domain of E47/E12, two correspond to Id1 and Id3, confirming the 
results of the Id1 screen; the remaining three correspond to bHLH 
transcription factors Tcf15, Twist1, and NeuroD1 (Figure 1.3). These bHLH 
transcription factors are candidates for mediating the effect of Id1 in 
pluripotent cells.  
Functional studies of NeuroD1 and Twist1 in pluripotent stem cells were 
carried out by other colleagues in the lab (Paul Nistor for Twist1 and Mattias 
Malaguti for NeuroD1). Therefore, this project will mainly focus on 








Figure 1.2: Id might act as an intrinsic factor to drive lineage specification  
(A) FGF signalling primes pluripotent cells for differentiation. Id inhibits 
subsequent transitions: first to epiblast and then to neuroectoderm. Thus, 
unknown Id-regulated transcription factors (TF) might be expressed in 
epiblast-primed cells to regulate this process. 
(B) The function of Id proteins is to block dimerisation between ubiquitously 
expressed E proteins and class II bHLH transcription factors. Therefore, 
the binding partners of E proteins in ES cells are likely to play important 





Figure 1.3: Yeast-two-hybrid screen to identify transcription factors 
regulated by Id1 in ES cells 
High-stringency Y2H analysis of interactions among Id1, E47HLH, and E12 HLH, 
and genes identified through library screens. Positive interactors are 
determined by growth selection and positive X-Gal reaction.  
Y2H screen of Id1 binding partners identified coding sequences of the TcfE2A 
gene products E47. Y2H of the HLH domains of E47/E12 identified five 
validated interacting partners for E47/E12: Id1, Id3 (confirming the results of 
the Id1 screen) and bHLH transcription factors Tcf15, Twist1, and NeuroD1.  
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1.2.4: Tcf15 expression during mouse embryogenesis 
Transcription factor 15 (Tcf15), also called Paraxis, is a bHLH 
transcription factor belongs to the Twist family (Barnes and Firulli, 2009). 
Prior to this study, the earliest expression of Tcf15 reported in mouse embryo 
was at E7.5 in a sub-domain of primitive mesoderm detected by in situ 
hybridisation. Between E8.0 to E12.5, the expression proceeds in a rostral to 
caudal wave in newly formed epithelial somites before the first detectable 
expression of the myogenic bHLH genes. Later in the mature somite, Tcf15 
expression is down-regulated with expression gone after E13.5 (Burgess et al., 
1995). The Tcf15-null embryo has segmented somites, but the newly formed 
somites are not fully epithelialized and fail to form a normal epithelial 
dermomyotome, suggesting that Tcf15 play important role in the 
morphological mesenchymal to epithelial transition (MET) during 
somitogenesis (Burgess et al., 1996). Although these Tcf15 mutant embryos 
survive to birth, they die shortly afterward as a consequence of muscular-
skeletal defects due to the failure in somite morphogenesis earlier in 
development. Moreover, Tcf15 is necessary for regulating anterior/posterior 
polarity in somites (Johnson et al., 2001). 
Although Tcf15 has been thought as a developing somite marker in the 
post-implantation embryos, it was recently been reported that its expression 
was up-regulated during derivation of ES cells from E3.5 blastocysts (Tang et 
al., 2010). This result suggested that Tcf15 might play another important role 
in the pre-implantation embryos in addition to its known function in 
somitogenesis. Since many bHLH transcription factors such as MyoD or 
NeuroD play important roles in controlling the lineage-commitment of ES 
cells (Lassar et al., 1989; Lee et al., 1995), the early expression of Tcf15 might 
act as a lineage-priming pro-differentiation factor within ES cells. 
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1.3: Aims of this thesis  
Despite a known function in controlling somite development (Burgess et 
al., 1996), a role for Tcf15 at earlier development stage has not been studied. 
Identification of Tcf15 as a putative Id1 target in ES cells suggests Tcf15 
might mediate the effect of Id in pluripotent cells. Id proteins classically 
function through the inhibition of active bHLH transcription factors and are 
able to block the transition of ES cells to epiblast stem cells (EpiSCs) (Zhang 
et al., 2010). Therefore, the function of Tcf15 in ES cells could be driving 
epiblast priming, however, held in an inactive state through the action of Id 
proteins. As soon as Id proteins are downregulated, the bHLH activity of 
these ‘‘primed’’ ES cells would be released from inhibition, allowing epiblast 
maturation to proceed. 
Since there is no report addressing the function of Tcf15 in early 
development, the aim of this thesis is to characterize the function of Tcf15 in 
pluripotent ES cells and during differentiation.  
In this thesis, the expression of Tcf15 during differentiation in vitro and 
during early development in vivo will be described. In addition, Tcf15-Venus 
reporter cells were used to further investigate Tcf15 expression at single cell 
level. Gain of function and loss of function studies were performed to 
perturb Tcf15 expression in ES cells in order to assess the function of Tcf15 in 
self-renewal and during differentiation. Finally, the investigations into the 
mechanisms that regulate Tcf15 expression and the downstream targets of 




Materials and Methods 
 
2.1: Materials 
All restriction enzymes were from either New England Biolabs (NEB) or 
Roche. All chemicals were obtained from either Sigma or Fisher Scientific. 
Synthetic oligonucleotides (primers) were synthesized by Eurogentec, with 
either sePOP desalt or PAGE for cloning primers. RNase/DNase free water 
from Gibco and Hyclone were used for DNA/RNA suspension and 
RNA-related solution preparation.  
 
2.1.1: Kits and Reagents 
2.1.1.1: Kits  
Agilent- Absolutely RNA Purification Kits 
Ambion-Illumina TotalPrep RNA Amplification Kit 
Amersham- Illustra ProbeQuant™ G-50 Micro Columns 
Amersham- MegaPrime™ DNA Labelling System 
Invitrogen- Quant-iT™ Protein Assay Kit 
Invitrogen- Zero Blunt®  TOPO®  PCR Cloning Kit 
Promega- pGEM® -T and pGEM® -T Easy Vector Systems 
Qiagen- QIAprep™ Spin Miniprep Kit 
Qiagen- QIAfilter Plasmid Midi Kit 
Qiagen- QIAquick Gel Extraction Kit 
Qiagen- QIAquick PCR Purification Kit 
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Qiagen- RNeasy™ Mini Kit 
Qiagen- RNeasy™ Micro Kit 
Qiagen- DNeasy™ Blood and Tissue Kit 
Sigma- Leukocyte Alkaline Phosphatase Assay Kit 
 
2.1.1.2: Reagents 
Ambion- tRNA  
Ambion- RNaseZap®  RNase Decontamination Solution  
BD- LB agar and broth  
Bio-Rad- Protein Assay Dye Reagent Concentrate  
Invitrogen- DH5α  
Invitrogen- dNTP Mix  
Invitrogen- LDS Sample Loading Buffer  
Invitrogen- MOPS SDS Running Buffer  
Invitrogen- M-MLV Reverse Transcriptase  
Invitrogen- NuPAGE®  Novex®  Bis-Tris Gel  
Invitrogen- Platinum®  Pfx DNA Polymerase  
Invitrogen- Random primers  
Invitrogen- RNaseOUT Recombinant Ribonuclease Inhibitor  
Invitrogen- SeeBlue™ Prestained Protein Standard 
Invitrogen- SuperScript®  III Reverse Transcriptase 
Invitrogen- SYBR®  Safe DNA Gel Stain 
Invitrogen- Trizol Reagent 
Invitrogen- UltraPure™ Agarose 
NEB- 100 bp and 1kb DNA Size Standards  
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NEB- λ DNA-HindIII Digest  
NEB-RNase H  
NEB- T4 DNA Polymerase  
NEB- T4 DNA Ligase  
Pierce- SuperSignal™ West Pico/Femto Chemiluminescent Substrate 
Promega- DNaseI 
Qiagen- Taq DNA Polymerase 
Roche- Complete Protease inhibitors (EDTA Free) 
Roche- DIG RNA Labelling Mix 
Roche- LightCycler®  480 Probes Master Mix 
Roche- UPL Set, Mouse 
Roche- Proteinase K 
Roche- rAPid Alkaline Phosphatase 
Roche- SP6 RNA Polymerase 
Roche- T7 RNA Polymerase 
Sigma- Benzonase®  Nuclease 
Sigma- Bovine plasma fibronectin 
Sigma- Deoxyribonucleic acid from herring sperm 
Sigma- Donkey serum 
Sigma- GMEM 
Sigma- Pefabloc  
Sigma- PerfectHyb™ Plus Hybridization Buffer 
Sigma- PBS 
Sigma- RIPA buffer 
Thermo- RiboLock RNase Inhibitor  
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2.1.2: Solutions  
Milli-Q filtered and deionized water (>18 mΩ-cm resistance) was used 
for making all stock solutions. (Except N2 was made in sterile DMEM-F12 
media) 
Solution Formulation 
PBS 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 
mM KH2PO4 
1x TAE 40 mM Tris Base, 0.114 % Acetic Acid, 1 mM EDTA.  
pH 8.0 
10x TBE 450 mM Tris Base, 450 mM Boric acid, 10 mM EDTA.  
pH 8.0  
6x DNA loading dye 
for TBE gel 
1x TBE, 0.25 % Orange G, 30 % Glycerol  
6x DNA loading dye 
for TAE gel 
1x TAE, 0.25% Bromophenol blue, 15% Ficoll 400 
Protein lysis buffer RIPA buffer, 1x Complete protease inhibitor cocktail, 
0.5 mM Pefabloc, 1 mM DTT  
Western blot  
transfer buffer 
12 mM Tris pH 7.5, 96 mM Glycine, 10 % methanol 
Western blot 
wash buffer (PBST) 
PBS, 0.1 % Tween-20  
Western blot 
blocking buffer 




72.5 mM Tris pH 7.5, 125 mM 2-Mercaptoethanol, 2% 
SDS 
ICC blocking buffer PBS, 0.1 % Triton X-100, 3-5 % species specific serum 
ICC wash buffer PBS, 0.1 % Triton X-100 
gDNA lysis buffer 10 mM Tris-HCl pH 7.5, 10 mM EDTA, 10mM NaCl, 
1% SDS, 1 mg/mL Protease K 
20x SSC  
(Southern blot) 
3 M NaCl, 340 mM Tri-Sodium Citrate pH 7.4 










500 mM Tris, 1.5 mM NaCl, pH 8.0 
Southern blot  
wash buffer 
2x SSC, 0.1 % SDS and 0.5x SSC, 0.1 % SDS 
Southern blot 
stripping buffer 
0.2 M NaOH, 0.1% SDS 
N2 supplement 2.5 mg/mL Insulin from bovine pancreas, 10 mg/mL 
Apo-transferrin, 7.5 mg/mL BSA, 0.002 mg/ml 
Progesterone, 1.6 mg/ml Putrescine and 3 μM 
Sodium Selenite 
Citrate solution 18 mM Citric Acid, 9 mM Sodium Citrate, 12 mM 
NaCl  
FACS buffer PBS, 10% FCS 
TBS 0.2 M Tris base, 1.5 M NaCl, pH 7.4 




50 % Ultrapure formamide, 25 % 20x SSC pH 4.5, 50 




ISH pre-hybridisation buffer, 100 μg/ml herring 





50 % Ultrapure formamide, 10 % 20x SSC pH 4.5, 0.1 
% Tween-20 (in Nuclease-free water) 
ISH alkaline 
phosphatase buffer 







Name Antibiotic Purpose Reference 
pBluescript II 
SK(+)_Tcf15 
Amp Tcf15 ISH probe 





















For lineage labelling 





2.1.4.1: RT-qPCR primers sequences and UPL probe numbers 


















































































































































































































































































































































2.1.4.2: Other primers 





Southern blot probe 





Southern blot probe 





Southern blot probe 






Southern blot probe 


















Forward primer for 







Reverse primer for 





siRNAs were reconstituting from lyophilized powder in nuclease-free 
water according to manufacturer’s instruction. 
 
2.1.5.1: siRNA from Qiagen 
FlexiTube GeneSolution Tcf15 predesigned siRNA tube 1-4 (GS21407) 
was obtained from Qiagen.  
AllStars Negative Control siRNA conjugated with Alexa-488 (1027292) 
was used as negative control and for monitoring siRNA transfection 
efficiency. This RNA had been tested and validated as non-silencing siRNA 
against any known mammalian gene. 
 
2.1.5.2: siRNA from Dharmacon 
Sequences of ON-TARGETplus SMARTpool, Mouse TCF15 were listed 
as below:  
Sequence 1: gaatg tagta tgtga gcaa  
Sequence 2: accga aagct gtcta agat 
Sequence 3: ggcag ctgct tgaaa gtga 
Sequence 4: acgtg aggct gctga gcga 
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ON-TARGETplus non-targeting negative control siRNA pool contains at 
least 4 mismatches to any human, mouse, or rat gene.  
 
2.1.6: Antibodies 
2.1.6.1: Primary antibodies 
Target  Species  Vendor  Dilution 
Catalogue 
number 





























Nanog Rat eBioscience IHC 1:200 14-5761-80 
Nestin Rat DSHB IHC 1:100 Rat-401 
Oct4 Mouse Santa Cruz IHC 1:200 Sc-5279 
Tcf15 Rabbit Aviva WB 1:150 ARP38503_T100 













2.1.6.1: Secondary antibodies 
Alexa Fluor®  antibodies (Molecular Probes) conjugated to appropriate 
fluorophores were used as secondary antibodies for immunostaining 
experiments. Antibodies were diluted at 1:1000. 
Target species Raised in  Fluorophore  
Catalogue 
number 
Chicken  Goat  FITC  A16055 
Goat  Donkey  568 A11057 
Mouse Donkey  488 A21202 
Mouse Donkey  568 A10037 
Rabbit Donkey  488 A21206 
Rabbit Donkey  568 A10042 
Rat Goat  568 A11077 
Rat Donkey  594 A21209 
 
 
For detection of primary antibodies in Western blots the following three 
secondary antibodies were used: ECL Mouse IgG, HRP-linked whole Ab 
(from sheep) (GE Healthcare, catalogue number NA931-1ML); ECL Rabbit 
IgG, HRP-linked whole Ab (from donkey) (GE Healthcare, catalogue number 
NA934-100UL); Donkey Anti-Goat IgG HRP (Promega, catalogue number 
V8051). All antibodies were used at a 1:4000 dilution.  
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2.1.7: ES cell lines used in this thesis 





Wild type, hypoxanthine 
phosphoribosyltransferase deficient, 
mouse embryonic stem cell line 
129/Ola background (Clonal) 







Doxycycline (dox) inducible 
Flag-Tcf15-E47 expression cell line in 










E14tg2a derived cell line which 
contains the coding sequence for the 
rtTA integrated into the Rosa 26 (R26) 
and expressed from the R26 promoter 
   









Gene trapped Tcf15 reporter cell line 
which a gtx-IRES-Venus cassette was 







Tcf15 targeted Venus reporter cell line 
with Venus to replace 1st exon in Tcf15 
locus 
G418 This study 
Tcf15-Het-FRTed 
Tcf15-Het with selection cassette 
being removed 
 This study 
Tcf15-Het-mK2 
Tcf15-Het-E6-1 with random 
integration of pCAG-mKate-NLS 
puromycin This study 
Tcf15-KO 
Tcf15-null cell line with Venus to 
replace 1st exon in both Tcf15 alleles 





2.1.8: Cell culture media 
 
Medium Description 
mES cell growth 
medium 
Glasgow Modified Eagle's Medium (GMEM), 10% 
foetal calf serum, 1 mM sodium pyruvate, 1x 
non-essential amino acids, 2 mM L-glutamine, 0.1 
mM 2-mercapthoethanol and 100 units/mL LIF  
LIF withdraw medium mES cell growth medium without LIF 
N2B27 medium  50% Neurobasal, 50% DMEM/F12 (without 
L-glutamine), 0.1 mM 2-mercapthoethanol, 2 mM 
L-glutamine, 0.5% modified N2 supplement (made 
in house) and 1% B27 supplement 
Serum-free mES 
self-renewal medium 
N2B27 supplemented with 10 ng/mL BMP4, 
100units/mL LIF 
2i/LIF medium N2B27 supplemented with 3 μM CHIR99021, 1 μM 
PD0325901 and 100 units/ml LIF 
EpiSC medium 
 
N2B27 supplemented with 12 ng/mL FGF2 and 20 
ng/mL Activin A  
2.1.9: Cytokines and inhibitors 
 
Name Description 
Activin A recombinant human, (R&D) 
BMP4 recombinant human (R&D) 
Chiron99021 GSK3β inhibitor (Axon Medchem) 
Fgf2 FGF2, recombinant human bFGF (R&D) 
PD0325901 MEK inhibitor (R&D) 
PD173074 FGFR inhibitor (Sigma) 
LIF In house cell culture unit 
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2.1.10: Cell culture plastics coating 
 





room temperature for 2 
hours or 4 degrees 
overnight 
Laminin from EHS murine 
sarcoma basement 
membrane 
5 μg/mL in PBS 
 
room temperature for 2 
hours or 4 degrees 
overnight 
Fibronectin  
(from bovine plasma) 
7.5 μg/mL in PBS 
 
room temperature for 10 
minutes 
Gelatine 0.1% in PBS   




Name (Manufacturer) Stock concentration working concentration 
Ampicillin (Calbiochem) 100 mg/ml 100 μg/mL  
G418 sulphate (PAA) 200 mg/ml 200 μg/mL 
Puromycin (Sigma) 5 mg/ml 12.5 μg/mL  
Ganciclovir(Sigma) 10 mg/mL 3 μM 
Hygromycin(Sigma) 50 mg/mL 50 μg/mL 
 
2.2: Methods 
2.2.1: DNA techniques 
2.2.1.1: Plasmid DNA isolation from bacteria 
Overnight culture of LB broth, either 5 mL or 100 mL, containing 
appropriate antibiotics (1:1000 dilution from stock, see materials 2.1.11) was 
inoculated with a) a single bacterial colony from previous transformed 
plasmid DNA, or b) glycerol bacterial stock, for mini and midi preparations, 
correspondingly. After approximately 16 hours culture at 37°C with agitation 
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at 200 rpm, bacteria were collected by centrifugation at 4000 x g for 10 
minutes. Plasmid DNA was isolated using QIAprep™ Spin Miniprep, or 
QIAfilter Plasmid Midi Kit for mini or midi preparations according to 
manufacturer’s instructions. DNA was eluted in EB buffer for general use or 
in nuclease-free H20 for restriction enzyme digestion. 
 
2.2.1.2: DNA isolation from mammalian cells 
2.2.1.2.1: Genomic DNA (gDNA) isolation from 24 well plates using 
home-made lysis buffer 
ES cells were grown to confluent in 24 well plates under standard 
culture condition for gDNA isolation. Culture medium were removed and 
cells were washed 2 times with PBS and then lysed in 300 μL of gDNA lysis 
buffer supplemented with fresh added proteinase K to final 0.2 mg/ml. Plates 
were then sealed completely with tape and incubated at 55°C for overnight in 
a sealed humidified box to prevent dry-out of lysis buffer. After overnight 
incubation, cell lysate were transferred to pre-labelled eppendorfs for later 
procedure. gDNA was precipitated by addition of 300 μL precipitation buffer 
(nuclease-free isopropanol) directly into tubes followed by vigorous shaking 
for 15 seconds at room temperature. gDNA was collected by centrifugation at 
13,000 rpm for 15 minutes, and excess salt was removed by 2 washing steps 
with 500 μL of 70% ethanol. DNA pellets were air-dried to remove excess 
ethanol and resuspended in 50 μL ddH20 at room temperature for 2-3 days. 




2.2.1.2.2: gDNA isolation from 6 well plates using commercial kit 
For gDNA isolation from wild-type ES cells or smaller sample size, 
gDNA were isolated using column-binding and spin-elution method. 
Although this method gives quicker isolation and less protein co-purification, 
the DNA yield is much lower than using home-made buffer. Therefore, cells 
must be grown in 6 well plates or larger containers. 
ES cells were grown to ~80% confluence in 6 well plates under standard 
culture condition for gDNA isolation. Cells were trypsinized and cell pellets 
were collected by centrifugation at 1,300 rpm for 5 minutes. Genomic DNA 
was isolated using Qiagen DNeasy®  Blood & Tissue Kit according to 
protocol for blood DNA isolation. Genomic DNA was eluted twice in 200 μL 
elution buffer in order to increase DNA yield. 
 
2.2.1.3: DNA cloning 
2.2.1.3.1: Restriction enzyme digestion 
For general cloning experiment, 2-5 μg plasmids DNA or PCR product 
were digested using relevant enzymes in the buffers provided by the 
manufacturer in 50 µ L reaction volume. For validation of ligation reaction 
using restriction enzyme digestion to check the presence of insert in the 
extracted plasmids, 100 to 200 ng of DNA were digested in a 10-15 µ l reaction. 
Digestion time was typically 3 hours at a temperature appropriate for the 
enzyme being used to prevent star activity.  
For plasmid linearization used for transfection by electroporation, 100 
µ g of plasmid was digested in 500 µ L reaction volume and incubated 
overnight. Digested DNA fragment were isolated using gel extraction 
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method (see section 2.2.1.3.5) or direct precipitation (see section 2.2.1.3.6).  
 
2.2.1.3.2: Dephosphorylation of DNA fragment ends 
In order to reduce the chance of self-ligation, 5’ phosphates groups of 
DNA ends from the digested vector DNA were removed by incubating 1-2 
µ g of digested DNA with 1 unit of alkaline phosphatase according to 
manufacturer’s instructions. Reaction was performed at 37°C for 15 minutes 
and irreversibly inactivated by heat treatment for 2 minutes at 75°C. 
  
2.2.1.3.3: DNA fragment ligation  
DNA fragment with cohesive ends generated by restriction enzyme 
digestion and follow-up purification were ligated using T4 DNA ligase. 
Generally, 50 ng of vector DNA was used for a ligation reaction. Molar ratio 
between vector to insert at 1:3 was used according to manufacturer’s 
instruction. The reaction was performed at room temperature for 2 hours or 
at 4°C overnight. 
 
2.2.1.3.4: DNA electrophoresis  
DNA was separated and analysed by running 0.8 – 2 % (w/v) agarose 
gel electrophoresis depending on the size of DNA to be resolved. 0.5x TBE 
buffer were used for making agarose gel and as running buffer. Samples are 
mixed with 6x DNA loading dye and running at 100 volt for 40 minutes 
alongside with a 100 bp or 1kb DNA marker for size comparison. Gels are 




2.2.1.3.5: DNA extraction from agarose gels 
Agarose gel containing desired DNA fragment was examined under UV 
illumination. Gel slice was excised by clean knife with no longer than 3 
seconds of UV exposure to prevent UV-induced mutation. DNA was 
extracted from gel slices using QIAquick gel extraction kit according to 
manufacturer’s instruction and eluted with 30 µ L of elution buffer.  
 
2.2.1.3.6: DNA ethanol precipitation 
DNA was precipitation by adding 1/10 volume of 3 M Sodium acetate 
(NaOAc, pH 5.2) and 2.4 volume of 100 % ethanol into sample then mix 
thoroughly. This mixture was incubated in -20 °C for ≧ 20 minutes to 
increase DNA yield. Precipitated DNA was recovered by centrifugation at 
13,000 rpm for 15 minutes. Excess salt was removed by washing the DNA 
pellet twice with ice cold 70% ethanol. DNA was then air-dried and 
re-suspended in an appropriate volume of nuclease-free H2O depending on 
the size of pellet. 
 
2.2.1.3.7: DNA/RNA quantification 
Concentration of DNA was quantified by UV spectrometry using a 
NanoDrop®  ND-1000 spectrophotometer or NanoVue Plus 
spectrophotometer. The Beer-Lambert’s law was used to calculate the 
concentration, with extinction coefficients of 50 for dsDNA, 33 for ssDNA 
and 40 for RNA. 
 
2.2.1.3.8: Bacterial transformation 
For transformations using chemically competent DH5α E. Coli cells, 
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either 5 μL of ligation mix or less than 50 ng of plasmid DNA was used for 
setup the transformation. DNA was added to 50 μL of freshly thawed 
competent E. Coli and incubated on ice for 5 minutes. Bacteria were heat 
shocked for 45 seconds at 42°C and immediately placed on ice. 500 μL of LB 
medium without antibiotics was added to the tube and the culture was 
allowed to recover at 37°C for ~40 minutes at 250rpm shaker. For plasmid 
transformation, 20-100 μL of the culture was plated on LB plates with 
appropriate antibiotics. For ligation product transformation, transformed 
samples were centrifuged at 4,000 rpm to pellet down the bacteria and 
re-suspend in 200 μL of LB medium. 100 μL of culture were plated on LB 
plates with appropriate antibiotics and incubated overnight at 37°C. 
For TA ligation product (see section 2.2.1.4.4), bacteria were plated on 
LB plate pre-absorb with 100 μL of 100mM IPTG and 20 μL of 50 mg/ml 
X-Gal over the surface for 30 minutes at 37°C prior to use. 
 
2.2.1.4: Polymerase chain reaction (PCR) 
2.2.1.4.1: Generic PCR 
All PCR reaction was performed on TProfessional Standard 
Thermocycler (Biometra). PCR was performed according to manufacturer 
protocol. A negative control containing no DNA template was used for all 
reactions. 
 
2.2.1.4.1.1: PCR using Taq 
Taq DNA polymerase was used to generate PCR product with 3’-A tail, 
and when high proofreading activity was not essential, such as colony PCR. 
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PCR reactions were generally prepared in 50 μL volumes, with 200 μM 
dNTP. The DNA polymerase was used at 2.5 units/ reaction, primers were 
used at 0.5 μM and reactions were made-up with the reaction buffer supplied 
with the polymerase. Depend on the template be used, generally less than 1 
ng of template DNA was used for plasmid DNA template and 100-200 ng of 
DNA was used for cDNA template.  
PCR reaction was setup as below, primer annealing temperature were 
usually between 55°C and 60°C but optimized for each primer pair. 
  
Initial denaturation step      94°C   1 minute 
Denaturation      94°C   30 seconds 
30 cycles of Annealing        45-65°C  30 seconds 
Extension     72°C   1 minutes per kb 
Final incubation       72°C   5 minutes 
Cool down step        4°C  pause 
 
2.2.1.4.1.1.1: Bacteria colony PCR 
Colony PCR was used for quick PCR check of transformed bacteria 
single colonies in order to determine if ligation is working. Colony PCR 
provided high-throughput screening of colonies when ligation efficiency is 
low. In addition, when single restriction enzyme site were used for ligation, 
colony PCR could be used to check the orientation of insert before plasmid 
extraction. 
Taq PCR master mix was aliquot into 10 μL per reaction. Bacteria single 
colony was picked and streaked to a new LB plate to create stock. Pick 
containing the bacteria was then immersed into PCR master mix for 1 





2.2.1.4.1.2: PCR using Pfx 
Pfx Polymerase was used to generate blunt-end DNA fragment for 
further cloning experiments. 
PCR was performed according to protocol provided by the manufacturer. 
PCR reactions were generally prepared in 50 μL volumes, with 300 μM 
dNTP. Magnesium sulfate was used at final concentrations of 1 mM. The 
DNA polymerase was used at 1 units/ reaction, primers were used at 0.3 μM 
and reactions were made-up with the reaction buffer supplied with the 
polymerase. Amount of template DNA to be used was depended on type of 
template as described above in Taq PCR. 
PCR reaction was setup as below, 
 
Initial denaturation step      94°C   5 minutes 
Denaturation     94°C   15 seconds 
30 cycles of Annealing     45-65°C  30 seconds 
Extension     68°C   1 minute per kb 
Final incubation       68°C   5 minutes 
Cool down step        4°C   pause 
 
2.2.1.4.1.3: Long range gDNA PCR using LongAMP 
The LongAmp Taq PCR kit (NEB) was used to perform long range PCR 
reaction on genomic DNA. 
PCR was performed according to manufacturer protocol. PCR reactions 
were generally prepared in 20 μL volumes, with 300 μM dNTP. The DNA 
polymerase was used at 1 units/ 10 μL reaction, primers were used at 0.4 μM 
and reactions were made-up with the reaction buffer supplied with the 
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polymerase. Amount of template DNA to be used was depended on type of 
template as described above in Taq PCR. 
PCR reaction was setup as below, 
Initial denaturation step      94°C   30 seconds 
Denaturation     94°C   15 seconds 
30 cycles of Annealing     45-65°C  30 seconds 
Extension     65°C   50 seconds per kb 
Final incubation       65°C   10 minutes 
Cool down step        4°C   pause 
 
 
2.2.1.4.2: PCR product purification  
When cDNA was used for PCR template and there is only single PCR 
product after gel electrophoresis, PCR product was purified by QIAquick 
PCR purification kit according to the manufacturer’s instructions. When 
plasmid DNA was used for PCR template, then PCR product must be 
gel-extracted to eliminate template plasmid contamination by using 
QIAquick gel extraction kit.  
 
2.2.1.4.3: A-tailing of blunt-end PCR products  
PCR products generated by Pfx polymerase with blunt-end were 
A-tailed by incubating with Taq polymerase. Purified PCR fragment was 
mixed with reaction buffer, 0.2 mM dATP and 5 units of Taq DNA 
polymerase in a total 10 μL volume. A-tailing reaction was performed at 
70°C for 30 minutes.  
 
2.2.1.4.4: Direct cloning of PCR products 
PCR products with blunt-end were directly cloned using the Invitrogen 
71 
 
Zero Blunt®  TOPO®  PCR Cloning Kit according to the manufacturer’s 
instructions. PCR products with A-tail were TA-cloned into pGEM-T easy 
vectors according to the manufacturer’s instructions.  
 
2.2.1.4.5: Real-time quantitative PCR (RT-qPCR)  
RT-qPCR was performed using the Roche LightCycler®  480 Instrument 
II in 384 well format. First strand cDNA was used as template. Primers were 
designed using the Roche Assay Design Center website 
(http://www.roche-applied-science.com/shop/CategoryDisplay?catalogId=10
001&tab=&identifier=Universal+Probe+Library#tab-3 ) and each primer pair 
had a specific UPL probe. Reactions were performed using the LightCycler®  
480 probes master mix and mouse UPL set (Roche) as outlined by the 
manufacturer. Primers used for qPCR were listed in 2.1.4.1. Total reaction 
volume was 6 μL containing 3 μL of master mix, 0.9 μL of nuclease-free H2O, 
0.54 μL of 5 μM primer mix and 0.06 μL of specific probe. cDNA samples 
were run as triplicate. Relative gene expression was calculated by 
normalization against the house-keeping gene TBP or GAPDH. Relative 
concentrations were calculated from a standard curve from serial diluted 
plasmids. All experiments have been performed at least three times unless 
otherwise stated. Statistic analyses were performed using a paired, two tailed 
Student's T-test and p values below 0.05 were considered as significant. All 
data are represented as mean ±SD. 
 
2.2.1.5: DNA sequencing  
Plasmid DNA was sequenced using the BigDye Terminator Cycle 
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Sequencing Ready Reaction kit at the Genepool sequencing service center 
(University of Edinburgh). Reaction samples were submitted in 6 μL 
volumes containing 500 ng of DNA template with 1 μL of a 3.2 pmole/μL 
primer solution. Sequencing primers were selected according to different 
sample demand. Sequencing results were compared by using Multalin 
website (http://www.sacs.ucsf.edu/cgi-bin/multalin.py). 
 
2.2.1.6: Southern blot analysis 
Restriction fragment length polymorphisms were determined by 
Southern blot analysis (Southern, 1975). 
 
2.2.1.6.1: Sample preparation  
Genomic DNA was isolated as outlined in section 2.2.1.2. 3-5 μg of 
gDNA was digested in 25 μL volumes with 40 units of restriction enzyme. 
For Southern blot of Tcf15 targeting cells, gDNA are digested with high 
concentration EcoRV (Roche) at 37 °C for overnight in an air incubator. 
If gDNA concentration is too low to be digested within 25 μL, increase 
the reaction volume without changing the amount of enzyme and perform 
ethanol precipitation (2.2.1.3.6) of gDNA after digestion. 
 
2.2.1.6.2: DNA electrophoresis and denaturation  
Digested gDNA fragments were separated by 0.8% agarose TAE gel 
electrophoresis alongside a λ DNA-HindIII digest size marker for overnight 
at 20-40 volt in 1x TAE buffer. Gel was stained with SyBR-Safe gel stain 
(1:20,000) for 20 minutes at room temperature on a 40 rpm shaker protected 
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from light. The gel was then transferred to a UV trans-illuminator for 
photographic imaging. The efficiency of digestion was determined by the 
extent of DNA laddering showing by smear. The gel was then incubated in 
denaturing solution for 2 x 20 minutes with gentle rocking. After rinsing with 
ddH20, the gel was then washed with neutralization solution for 2 x 20 
minutes and ready for transfer. 
 
2.2.1.6.3: Sample transfer  
DNA was transferred to a nitrocellulose membrane by capillary action 
(Figure 2.1) for 48 hours. After transfer, the membrane was removed from 
the transfer apparatus, labelled with well position and date of experiment by 
pencil and rinsed in 2x SSC buffer. DNA was cross-linked to the membrane 







Figure 2.1: Diagram of the Southern blot transfer apparatus  
The transfer apparatus was assembled as above. A glass plate was 
suspended over a buffer tray where a paper wick was setup to draw buffer 
from the tray. The bottom 3M filter paper was pre-soak with transfer buffer 
which is 20x SSC. The gel was placed up-side-down on the paper wick and 
all bubbles need to be removed under the gel. The membrane was 
pre-soaked in 2x SSC buffer and placed between the gel and a layer of 
blotting paper. A plastic pipette was used to roll over the membrane and gel 
to remove air bubbles. A stack of tissue paper was placed over the blotting 
paper and secured with a glass plate and weight. The bottom of the transfer 





2.2.1.6.4: Probe preparation and hybridization  
After baking, the membrane could be stored at 4°C or continued to 
probe hybridization process. Membrane was rinsed with 2x SSC and placed 
in a glass hybridization bottle. Either 10ml (small membrane, no exceed 
12x15 cm) or 20 mL (large membrane) Perfect-Hyb solution (Sigma) 
containing 10 μg/mL herring sperm DNA were added and incubated in a 
rolling oven at 65°C for a minimum of 2 hours. During this time the probe 
was labelled. Probe templates were generally between 200-700 bp in length. 
The probe template was amplified by either PCR purification or by 
restriction enzyme digestion from plasmid DNA containing the desired 
genomic sequence from a wild-type mouse genomic library. λ DNA-HindIII 
digest probe was provided by the labelling kit. The probe was labelled using 
the Amersham MegaPrime™ DNA Labelling System according to 
manufacturer’s instructions, using [α-32P] dCTP, 3000 Ci/mmol. After probe 
synthesis, radio-active probes were purified twice by Amersham Illustra 
ProbeQuant™ G-50 Micro Columns to remove unbound primer and 
nucleotide. After boiling at 100°C for 5 minutes, the probes (sample and λ 
DNA-HindIII) were then added to the hybridization tube and incubated with 
the membrane overnight at 65-68°C, according to different probes. 
 
2.2.1.6.5: Membrane washing and exposure 
The radio-active probes solution was disposed and the membrane was 
washed twice in 2x SSC wash buffer at 65°C for 20 minutes. After washes, 
membrane was examined by Geiger counter. If the signal counts were 
between 5 and 20, then the membrane is ready to be exposure. If the signal 
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counts were over 20, then continue the washing steps by using 0.5x SSC wash 
buffer at 65°C for 20 minutes. The membrane was then wrapped in cling film 
and exposed to X-ray film (Kodak) at -80°C in a cassette with intensifying 
screen. For signal counts between 5 and 10, membranes need to be exposed 
for at least 3 days. For signal counts between 10 and 20, overnight to 2 days 
of exposure is enough. After exposure, the film was removed and developed 
in an automated auto-radiographic film processor.  
 
2.2.1.6.6: Stripping of Southern blot membranes 
Membranes could be stripped for 2 to 3 times and re-hybridize with 
other probes. To perform stripping, membranes were incubated with 
stripping buffer (see 2.1.2) in hybridization bottles at 37°C for 30 minutes. 
After stripping, membranes were examined using Geiger counter to make 
sure no radio-active signal was remained. The stripped membrane was then 
wrapped in cling film and exposed to X-ray film (Kodak) at -80°C for 
overnight. The film was developed to make sure no radio-active signal was 
left on the membrane. The membrane was then ready for hybridization of 
new probes. 
 
2.2.1.7: DNA sequence analysis 
All DNA sequence analysis for labelling genomic markers, identifying 
restriction enzyme sites, primer design and plasmid map generation were 
performed using: ApE- A plasmid Editor v2.0.36, copyright ©  2003-2009 M. 
Wayne Davies. Cloning primer sequence was designed and optimized using 
online Primer3 software (http://bioinfo.ut.ee/primer3-0.4.0/). 
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2.2.1.8: Generation of specific constructs and plasmids 
2.2.1.8.1: Adding poly(A) tail to pTcf15_SKO plasmid 
pTcf15_SKO was constructs previously made by Aliaksandra 
Radzisheuskaya for targeting Tcf15 locus in mES cells in the lab. pTcf15_SKO 
construct was designed for introducing Venus to replace first intron of Tcf15. 
This targeting vector contained homology arms with DTA as negative 
selection marker outside the homology arms. The Venus gene was placed at 5’ 
of selection cassette included a PGK_Neomycin resistant gene and a positive 
selection marker MC1_Tk flanking by FRT site. However, after finish 
generating of these constructs, DNA sequencing result showed that the 
poly(A) tail of Venus gene was missing. Therefore, poly(A) was re-cloned into 
the final targeting vector using a restriction enzyme site BsrGI at 3’ end of 
Venus sequence. Briefly, poly(A) sequence was PCR amplified using primer 
pairs with BsrGI site on each side. The PCR product was sub-cloned into 
pGEM-T-Easy vector as described in section 2.2.1.3. Sequence varied clone 
was picked, expanded and digested with BsrGI and gel purified. The 
pTcf15_SKO plasmids was also digested with BsrGI, dephosphorylated and 
gel purified. Insert were then ligated with vector and the orientation of insert 
was verified by colony PCR. Clones with correct orientation of insert were 
then sent to perform sequence analysis to confirm the poly(A) sequence was 
inserted to the end of the Venus gene. The orientation of final targeting 







Figure 2.2: Genomic orientation of pTcf15_SKO construct with poly(A) 
sequence inserted to the end of Venus gene  
The final construct of pTcf15_SKO for targeting the Tcf15 locus contains 
homology arms with DTA as negative selection marker outside the 
homology arms. The Venus gene was placed at 5’ of selection cassette 
included a PGK_neomycin resistant gene and a positive selection marker 
MC1_Tk flanking by FRT site.    
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2.2.1.8.2: Generation of plasmids for Southern blot probes  
In order to perform southern blot on Tcf15 targeting cells. Tcf15-3’-probe, 
Tcf15-internal probe and Venus probe were PCR amplified from wild-type 
gDNA using the primers as listed in section 2.1.4.2. PCR products were 
ligated to pGEM-T-Easy vector. Sequence verified clones were amplified and 
plasmids were isolated using QIAfilter Plasmid Midi Kit (Qiagen). Plasmids 
were digested with EcoRI to release inserts and probe template DNAs were 
purified using gel extraction (see section 2.2.1.3.5). Probe template DNAs 
were then diluted to 25 ng/μL for probe synthesis.  
Tcf15-3’-probe located at 3’ of targeted region and Tcf15-internal probe 
located inside the homology arms. Tcf15-3’ probe and Venus probes were 
designed to identify correctly targeted clones and Tcf15-internal probes was 
designed for detecting the existence of multiple integrations of targeting 
construct.  
 
2.2.2: RNA methods  
For routine RNA work, lab benches were wiped with RNaseZap®  
RNase decontamination solution before starting experiments. Solutions were 
made with RNase/DNase free water (Gibco or Hyclone).  
 
2.2.2.1: Total RNA extraction  
Total RNA was extracted using either Absolutely RNA Purification Kits 





2.2.2.1.1: RNA isolation using Absolutely RNA Purification Kits 
For RNA isolation using Absolutely RNA Purification Kits, cells were 
lysed on plate in RNA lysis buffer containing 2-mercaptoethanol. 350 μL 
lysis buffer with 2.5 μL 2-mercaptoethanol were used for 6 well plates and 
volume was doubled for 10 cm dishes. Lysates were transferred to pre-filter 
columns and centrifuged to homogenise. Genomic DNA was removed by 
on-column purification and the flow-through was loaded onto RNA binding 
columns for RNA purification, on-column DNase I digestion and washing. 
RNA was eluted in 30μL of buffer EB.  
 
2.2.2.1.2: RNA isolation using Trizol 
For cells isolated by Fluorescence-activated cell sorting (FACS) with 
concentration less than 5x105 cells/sample, RNA was extracted manually 
using Trizol reagent according to manufacturer protocol. Cells were pellet 
down by centrifuged at 2,000 rpm for 5 minutes and re-suspended in 1 ml 
Trizol. 200 µ L of chloroform was added to each sample and vigorous mixing 
to achieve a homogenous solution. After 5 minutes of incubation at room 
temperature, the sample was centrifuged at 12,000 x g for 15 minutes at 4°C. 
Upper aqueous phase was moved carefully to a new tube and 650 µ L of 
nuclease-free isopropanol were added and mixed. The mixture was 
incubated at -20°C for at least 2 hours with 5 µ g/mL carriers DNA to increase 
RNA yield. RNA was precipitated by centrifugation at 12,000 x g for 15 
minutes at 4°C. RNA pellet was then washed twice with ice-cold 70% ethanol 




2.2.2.2: First strand cDNA synthesis 
First strand cDNA synthesis was performed on TProfessional Standard 
Thermocycler (Biometra) using 500 ng to 1 µ g of total RNA as template. 
M-MLV reverse transcriptase was used according to manufacturer’s 
instructions. Reverse transcription reaction was primed using random 
hexamers in the presence of RiboLock RNase Inhibitor (Thermo) in a reaction 
volume of 20 µ L. Following first strand synthesis, the reaction mixture was 
diluted 1:6 in nuclease-free H2O, and 1.5 µ L was used per qPCR reaction. 
No-RT control was performed for each RNA sample by not adding the 
Reverse Transcriptase to the reaction mixture. This is to detect if there is any 
significant levels of genomic DNA contamination in the RNA samples by 
performing qPCR (see section 2.2.1.4.5) using a non-intron spanning pair of 
primers (e.g. Tcf15). The samples were only used if the transcript levels were 
at least 103 times higher in the RT samples compared with No-RT controls.  
 
2.2.2.3: Preparing RNA samples for microarray analysis 
Illumina TotalPrepTM RNA amplification kit was used for generating 
cRNA from RNA samples for microarray analysis of gene expression 
according to manufacturer’s instruction. RNA samples were analysed using 
normal cDNA synthesis followed by qPCR analysis to validate control gene 
expression and the quality of samples before starting cRNA synthesis 
procedure. 
 
2.2.2.3.1: First and second strand cDNA synthesis and purification 
First strand cDNA synthesis was carried out by preparing 100 ng of 
RNA sample with 1x first strand buffer, T7 oligo(dT) primer, dNTP mix, 
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RNase inhibitor and ArrayScript reverse transcriptase in 20 µ L nuclease-free 
H2O in nuclease-free and sterile PCR tubes. The reaction mix was then placed 
into PCR machine for 2 hours at 42°C with lid temperature at 50°C according 
to manufacturer’s instruction.  
After first strand cDNA synthesis, the lid of the PCR machine was set to 
16°C or cooled to room temperature before starting second strand cDNA 
synthesis. 80 µ L of second strand cDNA synthesis master mix consisting with 
1x second strand buffer, dNTP mix, DNA polymerase and RNase H was 
added into samples and mixed well on ice. The reaction was performed at 
16°C for 2 hours.  
Double-stranded cDNA was then purified by Illumina TotalPrepTM RNA 
amplification kit and eluted in 20 μL of 55°C nuclease-free water.  
 
2.2.2.3.2: cRNA synthesis and purification 
Double-stranded cDNA was in vitro transcribed to synthesize cRNA 
according to manufacturer’s instruction. cDNA samples were mixed with 1x 
reaction buffer, T7 Enzyme mix and biotin-NTP mix for synthesize 
biotin-labelled cRNAs. The reaction was performed in 37°C for 14 hours with 
the lid of PCR machine set to 100°C. 
cRNA was purified twice after synthesize, the first purification was to 
removes enzymes, salts and unincorporated nucleotides and the second 
purification was to concentrate the cRNA for sending to perform microarray 
analysis. For the first purification, Illumina TotalPrepTM RNA amplification 
kit was used and cRNA was eluted with 200 μL 55°C nuclease-free water. 
For the second purification, RNeasy™ micro kit (Qiagen) was used by 
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following the protocol for RNA clean-up and concentration. The cRNA was 
eluted in 14 μL of nuclease-free water with total concentration around 2-3 μg. 
 
2.2.2.4: Synthesis of digoxigenin-labelled RNA probe for in situ 
hybridization (ISH) 
2.2.2.4.1: Plasmid linearization 
Plasmid vectors used as in vitro transcription templates should be 
linearized by restriction enzyme digestion in order to provide defined length 
of RNA transcripts. For Tcf15 ISH anti-sense probe, pBluescript II SK(+)_Tcf15 
plasmid (see section 2.1.3) was linearized using EcoRI site. Linearized 
plasmid was ethanol precipitated (see section 2.2.1.3.6) and validated by gel 
electrophoresis. 
 
2.2.2.4.2: Synthesis of Digoxigenin- labelled RNA probes 
The in vitro synthesis of digoxigenin (DIG)-labelled RNA probe was 
performed by using 1 μg of linearized plasmid, 1x transcription buffer, 1x 
DIG-UTP nucleotide mix, 150 units of RNase inhibitor and 20 units of T7 
RNA polymerase for Tcf15 probe. The reaction was in 20 μL volume in 
RNase-free PCR strips. After incubation at 37°C in PCR machine for 2 hours, 
20 units of RNase-free DNase I (Promega) was added for another 30 minutes 
of incubation. The reaction was stopped by adding 1x stopping buffer 
(Promega) and heat-inactivated the enzyme at 65°C for 10 minutes. 
Transcribed RNA probe was ethanol precipitated, dissolved in RNase-free 
H2O and validated by gel electrophoresis. RNA probes were aliquoted into 1 




2.2.3: Protein methods 
All protein work was performed on ice to prevent protein degradation.  
Protease and phosphatase inhibitors were added fresh to all buffers. 
Dithiothreitol (DTT) was also made and added freshly in to all the buffers. 
 
2.2.3.1: Total protein isolation from mammalian cells using RIPA 
buffer 
Cells were trypsinized, counted and collected in eppendorfs. In general, 
60 µ L of RIPA lysis buffer were used to lyse 106 cells. After mixing cell pellets 
with RIPA buffer, samples were vortexed for 15 seconds and incubated on 
ice for 10 minutes. This step was repeated for 4 times. 1 µ L of Benzonase 
nuclease was added and incubated at room temperature for 10 minutes 
before samples were centrifuged at 13,000 rpm for 15 minutes at 4°C. 10-20 
µ L lysate (or 30-50 µ g of total proteins) was used for Western blot analysis. 
 
2.2.3.2: Protein quantification  
Protein concentration was quantified by either traditional Bradford 
assay or using Quant-iT ™ Protein Assay Kit (Invitrogen). 
 
2.2.3.2.1: Protein quantification using Bradford assay 
Protein concentration was quantified by Bradford assay according to 
reagent guidelines (Bradford, 1976). Briefly, cell lysates were diluted at least 
1:10 in ddH2O to reduce reading background generated by detergents in the 
lysis buffer. Protein standards ranging from 0.05-2 mg/mL of BSA (0.05 mg, 
0.1 mg, 0.25 mg, 0.5 mg, 1 mg, and 2 mg) were prepared in ddH2O as well. 
Protein assay dye (Bio-Rad) was diluted 1:5 in ddH2O and 200 µ L/well of 
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diluted dye was added into flat bottom 96 well plates. 2.5 µ L of diluted 
samples or BSA standards was mixed with assay dye together in triplicate 
format. Controls including blank well, 10x diluted lysis buffer, and ddH2O 
were also included in the plate for comparison. Samples were incubated at 
room temperature for approximately 10 minutes. The absorbance was read 
using Glomax Multi Detection System (Promega) at 595 nm and sample 
concentrations were calculated from the standard curve derived from protein 
standard measurements.  
 
2.2.3.2.2: Protein quantification using Quant-iT ™ Protein Assay Kit 
Where possible, protein concentration was determined using the 
Quant-iT™ protein assay kit with the Qubit™ fluorometer (Invitrogen) 
according to manufacturer’s instruction. In short, 1 – 20 µ L of 10x diluted 
protein samples and protein standard #1 to #3 were mixed with Quant-iT™ 
working solution to make 200 µ L reaction mixtures in assay tubes. Samples 
were vortex for 3 seconds and incubated at room temperature for 15 minutes. 
After calibration of the Qubit™ fluorometer using Standard #1, #2 and #3, 
samples were read on the fluorometer with excitation and emission filters 
appropriate for fluorescein or Alexa Fluor 488 dyes. Sample concentration 
was calculated automatically by the Qubit™ fluorometer. 
 
2.2.3.3: Western blot analysis 
2.2.3.3.1: Protein separation by SDS-PAGE  
SDS-PAGE electrophoresis was performed using the NuPAGE system 
(Invitrogen) with 4-12% Bis-Tris gradient gels. Samples with similar amount 
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of protein concentration were adjusted to same volume (< 20 µ L) using RIPA 
buffer in order to obtain equal salt concentration. Samples were then mixed 
with 4x LDS loading dye with final 100 mM of DTT and boiled for 5 minutes 
to obtain denatured and reduced proteins. The electrophoresis apparatus 
was assembled as outlined by the manufacturer. Gel wells were washed free 
from storage buffer using 1x NuPAGE MOPS running buffer. Samples were 
loaded alongside with 8 µ L of SeeBlue™ pre-stained protein marker 
(Invitrogen) for size estimation. 
Gels were run at 100 volt for 15 minutes to obtain initial separation 
followed by 150 volt until the 3 kDa band of the protein marker reached the 
end of the gel (typically within 1.5 hours). The apparatus was then 
disassembled. Gel was removed from the casing, washed briefly with ddH20 
and bottom part of gel was cut for preparing for transfer. 
 
2.2.3.3.2: Protein transfer to nitrocellulose membrane  
Hybond™ ECL nitrocellulose membrane was used for protein transfer. 
The transfer apparatus was assembled using the Novex MultiCell gel tank. In 
short, gel was stacked within 2 pieces of 3M filter paper and sponge at each 
side, with nitrocellulose membrane on the anode side to capture the 
anion-containing protein molecules. All blotting papers and sponges must be 
well soaked in transfer buffer and air bubbles should be avoided. The 
proteins were transferred to the membrane at 200 mA for 60-90 minutes in 
transfer buffer depending on desired molecular weight of target protein. 
Protein transfer efficiency was determined by staining the membrane 
with Ponceau S solution. Membrane was incubated in Ponceau S for 2 
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minutes at room temperature followed by gradually washing with ddH2O to 
reveal protein bands.  
 
2.2.3.3.3: Membrane blocking, probing and washing  
Membranes were blocked with 5% non-fat dry milk in PBST at room 
temperature for at least 1 hour or 4°C overnight. After blocking, if necessary, 
membrane was crosscut into strips in order to probe different primary 
antibodies from the same samples. Primary antibodies incubation were 
performed as advised by the manufacturer (see section 2.1.6), generally 
overnight at 4°C in blocking buffer. After primary antibody incubations, the 
membrane was washed with PBST for 15 minutes and repeated for 4 times at 
room temperature on a shaker. Appropriate secondary HRP-conjugated 
antibody (Promega or GE) were added at 1:4000 in blocking buffer at room 
temperature for 1 hour. The membrane was then again washed 4 times for 15 
minutes each with PBST at room temperature. 
 
2.2.3.3.4: Signal detection 
After washing off secondary antibodies, chemoluminescent signal was 
detected by using Super Signal West Pico Chemiluminescent Substrate 
(Pierce). Equal amount of each solution was mixed for 1 minute and applied 
to membranes for 1 minute. The membrane was then wrapped in cling film 
and placed into a cassette, ready for exposure. Amersham Hyperfilm ECL 
was used for developing the signal. The developing time is ranging from 3 
seconds to 10 minutes depending on the strength of the antibody signal. 
Films were developed using automatic film processor.  
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2.2.4: Tissue culture  
All cells were grown at 37°C with 5% CO2 supply in a humidified 
incubator. All solutions were either prepared sterile in the SCRM tissue 
culture facility or obtained directly from manufacturer. All cell 
manipulations were performed in a sterile laminar flow hood. Media and 
buffers were stored at 4°C and not used for longer than 2 months. All cells 
were kept in penicillin/streptomycin-free media except cells after FACS. 
Culture plastics were coated by different substrates with concentrations and 
duration as listed in section 2.1.10. All newly derived lines and clonal lines 
were karyotyped before used in experiments. 
 
2.2.4.1: Routine culture of pluripotent mouse cells  
2.2.4.1.1: Routine culture of mouse embryonic stem cells  
Mouse embryonic stem cells were routine cultured on gelatine-coated 
plastics until 80% confluence in complete mES cell growth medium (see 
section 2.1.8). Culture medium was aspirated off and the cell monolayer was 
rinsed with room temperature Dulbeco’s PBS (Gibco). 0.125 % (w/ v) trypsin 
was used for passage mES cells. In general, 1 mL of trypsin was added per 
T75 flask, and scaled accordingly for other sized flasks. The flask was 
incubated at 37°C and then tapped to disassociate the cells. 9 mL of complete 
culture medium was then added to quench trypsin. Cells suspension was 
then centrifuged at 1,300 rpm for 3 minutes. Cells were split 1:3 for being 
passage every second day or 1:5 for every third day. In the case when precise 
cell number was required, cells were counted using haemocytometer and 
plated to desired containers. Culture medium is changed every second day. 
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Foe serum-free pluripotent culture, cells were cultured in N2B27 
containing LIF and BMP4 as described in section 2.1.8 with same passaging 
method as above except N2B27 was used to quench trypsin. 
 
2.2.4.1.2: Routine culture of mES cells at ground state (2i) 
For culturing mES cells at ground state, cells were maintained in 
serum-free N2B27 medium supplied with PD03 and Chiron (see section 2.1.8 
for 2i medium) on poly-ornithine and laminin-coated plastics. Accutase 
(Sigma) was used to dissociate 2i cultured cells. Cells were passaged around 
40% confluence every 3-4 days as described in section 2.2.4.1.1, except N2B27 
was used to quench accutase. Culture medium is changed every second day. 
 
2.2.4.1.3: Routine culture of mouse Epiblast stem cells (mEpiSCs) 
Mouse Epiblast stem cells (mEpiSCs) were cultured in EpiSC medium as 
described in section 2.1.8 on fibronectin-coated plastics. mEpiSCs were 
generally maintained in 6 well plate. Cells were initially plated as 105 cells 
per well and passaged every two days. To passage, cells were briefly washed 
with non-supplemented N2B27 and detached using accutase. EpiSCs were 
rinsed with N2B27 gently in order to maintain the cells in small clumps 
rather than dispersing them into single cells. After centrifugation at 1,300 
rpm for 3 minutes, EpiSCs were passaged at 1:4 before passage 7, and 1:10 




2.2.4.2: Transfection of mES cells  
2.2.4.2.1: Transfection by liposomes  
2.2.4.2.1.1: Transfection of plasmid DNA using Lipofectamine 2000 
Transient or sometimes stable transfection was performed using 
Lipofectamine 2000 (Invitrogen) according manufacturer’s instruction. In 
general, 105 cells were plated per well in a 6 well plate and cultured 
overnight in complete media without any antibiotics. 3 μg of plasmid DNA 
was mixed with 3 μL of transfection reagent in 200 μL of GMEM basal 
medium (Sigma) and incubated at room temperature for 15 minutes. For 
transfection controls, DNA was replaced with either water or with a plasmid 
expressing GFP (AGS-684, see section 2.1.3) for monitoring transfection 
efficiency. The liposome-containing medium was then added in drop-wise 
manner to the culture cells and cells were returned to incubator for culture 
overnight. The medium was changed to complete mES cell media on the next 
day and cells were passaged for downstream applications if necessary.  
 
2.2.4.2.1.2: Transfection of siRNA using HiPerfect 
Tcf15 siRNA 1-4 and Alexa488-conjugated non-silencing siRNA control 
were obtained from Qiagen (see 2.1.5.1).  HiPerfect transfection reagent was 
used to transfect Qiagen siRNA into mES cells according to manufacturer’s 
instruction. Briefly, 1.5 x 105 mES cells were plated per well in a 12 well plate 
in mES cell growth medium 5 hours prior of transfection. 3 μL of 2 μM 
siRNA hairpins (75 ng) were mixed with 6 μL of HiPerfect transfection 
reagent in serum-free medium to obtain final 10 nM of siRNA concentration. 
The mixture was incubated at room temperature for 15 minutes before 
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adding drop-wise onto the cells. Cells were returned to incubator for culture 
overnight. The medium was changed to complete mES cell medium on the 
next day of transfection and cells were collected at different time point after 
transfection. 
 
2.2.4.2.1.3: Transfection of siRNA using Dharmafect 
DharmaFECT transfection reagent (Darmacon) was used to deliver 
SMARTpool ON-TARGET plus Tcf15 siRNA and non-targeting control 
siRNA (see section 2.1.5.2) into cultured mES cells according to 
manufacturer’s instruction. mES cells were plated in 12 well plate at 3 x 104 
cells per well in complete ES medium without antibiotics for overnight. The 
next day, 2.5 μL of Dharmafect reagent was mixed with 5 μL of 5 μM siRNA 
stock in 200 μL of serum-free basal GMEM medium and incubated at room 
temperature for 20 minutes. During the incubation, culture medium in the 12 
well plates was aspirated and changed to 800 μL of fresh ES complete 
medium without antibiotics. The siRNA mixture was then added in 
drop-wise manner into designated well and returned to 37°C incubator. All 
transfection experiments were carried out at duplicate and control wells with 
siRNA been substituted by H2O must be included. Culture media were 
changed after 16 to 24 hours after transfection and cells were collected on day 
2 or 3 after transfection for qPCR and/or Western blot analysis. 
 
2.2.4.2.2: Transfection by electroporation  
For electroporation of plasmid DNA into mES cells, 100 μg of plasmid 
DNA was digested with the appropriate enzyme for overnight. Digestion 
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efficiency was assessed by agarose gel electrophoresis after digestion. 
Digested DNA was then precipitated by ethanol and re-suspend in 200 μL 
sterile PBS. 107 cells were needed for each electroporation. Cells were 
collected as general sub-culture procedure. Cell pellets were re-suspended in 
600 μL PBS, mixed with plasmid DNA and transferred to electroporation 
cuvettes (Bio-Rad). A negative control sample was performed by replacing 
DNA with PBS only. After incubation at room temperature for 5 minutes, 
cells were electroporated at 0.8kV and 3 μF giving a time constant between 
0.1 and 0.2. Electroporated cells were then immediately transferred to 
pre-warmed complete ES medium and plated at 1.5x106, 106 and 0.5x106 cells 
per 10 cm dish in ES complete medium. After culturing in 37°C incubator for 
overnight, medium was replaced with antibiotic-containing complete 
medium. For preventing spontaneous differentiation, 0.5 μM of PD03 was 
added into culture medium. Cells were under selection until the emergence 
of single colonies with ~1 mm diameter which were then picked into a 96 
well plate. 
 
2.2.4.3: Picking mES cell colonies  
For picking mES cells single colonies from 10 cm dished to 96 well plates, 
20 μL of trypsin solution was added to each well of a pre-gelatinized 96 well 
plate before starting. Medium was removed from the culture dish and cells 
were washed twice with PBS. 1 mL of PBS was added into the dish to cover 
the colonies. Colony-picking pipette tips fitted with p20 pipette were used to 
lift up the cells. To pick a colony, 10 cm dish was held in horizontal position. 
7 μL of trypsin was taking from the trypsin-containing well and added on 
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the top of the desired colony. The pipette was then touched the cells and 
operated as reverse mode to lift the cells. Once picked the colony was placed 
into the well of the 96 well plates and incubated at room temperature for 5 
minutes. 200 μL of selection medium was then added to the well and pipette 
up-and down to dissociate the cells. Cells were grown in selection medium 
containing PD03 until it reached 80% confluence. Then, cells were passaged 
to 24 well plates using multi-channel pipette for further experiments.  
 
2.2.4.4: Freezing mES cells 
For routine freezing of mES cells, freezing solution of FCS containing 
10% DMSO (v/v) was prepared. Cells were collected as usual by 
centrifugation, re-suspended in freezing medium and transferred to a 
cryovial (Nunc). The tube was detailed-labelled with the cell line, passage 
number, date, owner, and cell concentration. Freezing vials were transferred 
to -80°C freezer and stored in -80°C for less than 2 months or moved to liquid 
nitrogen cell bank after 1 day in -80°C.  
For freezing mES cells in 24 well plates, cells were grown to 90% 
confluence prior to freezing. Cells were washed with PBS and then lifted by 
adding 70 μL trypsin solution for 3 minutes. 430 μL of complete ES medium 
was added in each well using multi-channel pipette to re-suspend the cells. 
250 μL of cell suspension was then transferred to a pre-gelatinized 24 well 
plate containing 250 μL of complete ES media and the plate was placed back 
to incubator for further examination such as gDNA isolation. Then 250 μL of 
ES complete medium containing 50 % FCS and 20 % DMSO (v/v) was added 
into the old plate and mixed homogeneously. The plate was then sealed with 
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tape and place into -80°C freezer until required. 
 
2.2.4.5: Thawing mES cells 
Cells stocks frozen in cryovials were retrieved from either -80°C freezer 
or liquid nitrogen cell bank and quickly thawed at 37°C in waterbath. The 
cell suspension was then added to 9 mL of 37°C pre-warmed complete 
medium and centrifuged at 1,300 rpm for 3 minutes. Cells were 
re-suspended in complete medium and transferred to a pre-gelatinized 
culture plastic according to suitable concentration. The medium was changed 
on the next day.  
For cells frozen in 24 well plates, the entire plate was thawed at 37°C in 
waterbath taking care of not letting water come into the plate. 500 μL of 
pre-warmed complete medium was added to each well. Cells were 
transferred to a universal centrifugation tube for centrifugation at 1,300 rpm 
for 3 minutes. 500 μL of fresh medium was then used for re-suspension and 
cells were transferred to a new gelatinised well of a 24 well plate. The media 
was changed on the second day. 
 
 
2.2.4.6: Induction of doxycycline-dependent transgene 
For doxycycline-dependent transgene induction, TTE15 cells were 
pre-treat with 1 μg/mL of doxycycline 24 hours before differentiation 
experiments. The pre-treatment of doxycycline was considered to induce 





2.2.4.7: Differentiation of mES cells  
2.2.4.7.1: Monolayer neural differentiation  
Monolayer neural differentiation was performed under monolayer 
conditions as outlined in Pollard et al., 2006. mES cells were grown to 80 % 
confluence and passaged 1 day before starting neural differentiation. Cells 
were washed with PBS twice to remove all traces of serum and then 
trypsinized followed by quench with N2B27 serum-free medium (see section 
2.1.8). Cells were then plated on gelatinized tissue culture dish as in N2B27 
serum-free medium. For neural differentiation in 10 cm dishes, 106 cells were 
plated. For neural differentiation in 6 well plates, 1.5 x 105 cells were plated. 
Culture medium was changed every day.  
 
2.2.4.7.2: LIF withdraw 
Non-neural differentiation was performed using complete mES media 
without supplementation of LIF. Cells were passaged using standard 
procedure and 3 x 104 cells were plated per well in a 6 well plate. Cultures 
were assayed for non-neural differentiation by morphology examination and 
gene expression.  
 
2.2.4.7.3: Derivation of Epiblast-like stem cells from mES cells 
cultured in LIF and serum 
mES cells was transformed in vitro to Epiblast-like stem cells by 
culturing in N2B27 supplemented with 20 ng/ml Activin A and 12 ng/ml 
FGF2 (see section 2.1.8) (Brons et al., 2007; Tesar et al., 2007; Zhang et al., 
2010). Briefly, ESCs were seeded on fibronectin-coated 6 well plate at a 
density of 4x104 per well and grow in ES cell complete media for 24 hours. 
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The cells were washed with PBS twice to remove serum and media were 
changed to EpiSC media. The culture was kept in 37°C for 5 days, which 
corresponded to passage 0. Cells were grown until about 70% confluence, 
washed twice with PBS and then incubated in 200 μL of accutase for 5 
minutes. Cells were passaged until reached 70% confluence. Cells were 
transformed to Epiblast-like stem cells by examination on morphology and 
gene expression. 
 
2.2.4.7.4: Derivation of Epiblast-like stem cells from 2i culture 
To derive Epiblast-like stem from 2i culture, 2i-cultured ES cells were 
dissociated by accutase and re-suspend as single cell in N2B27 medium 
containing Activin A (20 ng/ml), FGF2 (12 ng/ml) and KSR (1 %) (Hayashi et 
al., 2011). Cells were plated at 105 cells per well in a 12-well plate coated with 
fibronectin. Cells were cultured in EpiSC media and collected at different 
time point.  
 
2.2.4.7.5: Multi-lineage EB differentiation in hanging drops 
mES cells were differentiated into a mixture of mesoderm, endoderm, 
and ectoderm lineages in hanging drops (Wang and Yang, 2008). Cells were 
collected as usual and re-suspended in mES medium without LIF at a 
concentration of 105 cells/mL. 30 μL of cell suspension were placed on the 
inside of the lid of a 15 cm sterile non-cell culture dish using a multi-channel 
pipette. Each drop was consisted of approximately 1,500 cells and roughly 80 
drops were placed on a lid. PBS was added to the bottom of the dish and the 
lid was inverted, placed back and returned to the incubator. Embryoid-like 
97 
 
bodies were collected using 1 mL pipette tips and spin down for RNA 
isolation at later time point. 
 
2.2.4.8: Removing FRT-containing selection cassette from targeted 
Tcf15-Het cells by FlpO 
To remove the selection cassette, Tcf15-Het cells were transfected with 3 
μg of pFlpO by liposome- mediated transfection. FlpO is a mouse 
codon-optimized flippase which binds to flippase recognition target (FRT) 
sites and trigger homologous recombination. Cells were re-plated to 10 cm 
dish in complete ES culture medium in the presence of 3 μM ganciclovir for 
selection. Although the transfection efficiency of FlpO was known to be low, 
the ganciclovir treatment will kill cells which retain the MC1-tk selection 
cassette. Approximately 30-50 colonies were formed after 7 days of selection 
from each Tcf15-Het clones and 12-15 sub-clones were picked to 96 well plate. 
Cells were expanded from 96 well plates to 24 well plates and passaged 1:3 
into 3 of 24 well plates once confluent: one for frozen at -80°C as cell stock, 
one for back selection with G418 and the last one for genomic DNA isolation. 
 
 
2.2.5: Histological techniques  
2.2.5.1: Alkaline phosphatase (AP) staining 
Alkaline phosphatase (AP) staining was performed using the Leukocyte 
Alkaline Phosphatase Assay Kit (Sigma) as outlined in the product manual. 
Cells were washed with PBS and then fixed in a solution of acetone, citrate 
solution, and formaldehyde (37% v/v) (Sigma) at a ratio of 8.2 : 2.75 : 1. The 
fixation was performed in a ventilation hood. After 1 minute of fixation, the 
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cells were washed with ddH20 twice. Staining solution was made by mixing 
ddH20, sodium nitrate, Napthol AS-B1 and FRV alkaline solution at a ratio of 
45:1:1:1. Staining solution was then added to cover each well, and samples 
were incubated at room temperature in the dark for approximately 15 
minutes. The staining solution was aspirated and the wells were washed 
twice with ddH20. Samples could be kept in ddH20 for microscopic imaging 
or dried for colony counting.  
 
2.2.5.2: Immunocytochemistry staining of cultured cells 
mES cells were washed twice with PBS and fixed in 4% 
paraformaldehyde (w/v) at room temperature for 15 minutes or 4°C for 
overnight. The fixation was aspirated and the wells were washed 2 times 
with PBS. Permeabilisation and blocking was performed simultaneously by 
incubation in ICC blocking buffer (see section 2.1.2) for at least an hour at 
room temperature. Primary antibodies were incubated as recommended by 
the manufacturer at 4°C overnight. For most of primary antibodies, 
antibodies were re-used by adding of 0.02% (w/v) sodium azide and kept in 
the 4°C fridge. Cells were washed 4 times for 15 minutes each in PBS. The 
appropriate Alexa Fluor™ secondary antibody (Invitrogen) was diluted 
1:1000 in ICC blocking buffer and incubated with samples at room 
temperature for at least an hour or 4°C overnight. The antibody solution was 
aspirated and washed 4 times for 15 minutes each with PBS. DNA was 
counter stained with DAPI at a concentration of 1 μg/mL and fluorescence 
was visualized using an Olympus IX51 fluorescent microscope. Images were 
taken and analysed using the Velocity software onsite.   
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2.2.5.3: Flow cytometry analysis and fluorescence-activated cell 
sorting (FACS) 
Flow cytometry analysis was performed using a Becton Dickinson FACS 
Calibur flow cytometer. Fluorescence-activated cell sorting (FACS) was 
carried out on a Becton Dickinson FACS Aria flow cytometer. For collecting 
cells for flow cytometry analysis, cultured cells were washed with PBS and 
dissociated using trypsin. After centrifugation at 1,300 rpm for 3 minutes, 
cells were washed once with ice-cold PBS and spin down again. For live 
monitoring of reporter cells, cells were re-suspended in FACS buffer and 
analysed immediately on FACS Calibur. For staining with PECAM1, cells 
were resuspended in FACS buffer to achieve concentration of 5x106 cells/mL 
and stained with 1:500 dilution of PECAM1-APC antibody for 20 minutes on 
ice protecting for light. Stained cells were centrifuged at 1,300 rpm for 3 
minutes and washed twice with FACS buffer and spin down again. All 
samples were filtered through the Cell-Strainer cap of a 5 ml Polystyrene 
round-bottom tubes (BD Falcon) to remove any cell clumps. Data was 
analyzed using FLOWJO flow cytometry analysis software 
(http://www.flowjo.com/index.php). 
For FACS of Venus-positive cells, PECAM1-stained cells were 
re-suspended in FACS buffer containing 100 ng/mL DAPI to exclude dead 
cells. For sorting of Tcf15-Venus cells, the top 30% and the bottom 30% of 
Venus-positive cells were sorted from within a platelet endothelial cell 
adhesion molecule 1 (PECAM1+) gated population, excluding differentiated 
cells. Cells were sorted into sterile 15 mL tubes containing 1 mL of complete 
ES media in a refrigerated collecting device. Sorting quality was assessed by 
100 
 
performing purity check on sorted populations after FACS and 95% purity 
was achieved every time. After sorting, cells were centrifuged at 1,500 rpm 
for 5 minutes. For collecting RNA, cells were re-suspended in either Trizol or 
RNA lysis buffer. For keep culturing or performing differentiations, cells 
were plated at desired density in 1x penicillin/streptomycin containing 
medium for preventing contamination.  
  
2.2.5.4: In situ hybridization of mouse blastocysts 
All steps were carried out in RNase-free conditions, up-until 
post-hybridisation washed. RNaseZap®  RNase decontamination solution 
was used before starting experiments and RNase-free plastics were used to 
minimise possible contamination. All solutions were prepared in 
Nuclease-free H2O and reactions were carried out in a 12 mm diameter 
transwell (BD) with 8 µ m pore size hanging into a sterile 12-well plate 
(Corning). 
 
2.2.5.4.1: Blastocysts preparation, fixation and dehydration 
MF1 x MF1 F1 morula were flushed on E 2.5 by the SCRM animal facility 
and cultured in KSOM medium in 37°C incubator to reach E3.5 and E4.5 
blastocyst stage. Blastocysts at right developmental stage were transferred to 
transwell by mouth pipette and then fixed in 4 % paraformaldehyde in PBS 
at 4°C overnight. After fixation, blastocysts were rinsed 2 times with 0.1% 
PBST and dehydrated through a series of methanol concentrations (25%, 50%, 
75% and 100% (v/v) methanol in PBS). Blastocysts could be stored in 100% 
methanol at -20°C until required. 
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2.2.5.4.2: Rehydration, post-fixation and hybridization 
Blastocysts were taking out of -20°C, placed on ice and dehydration was 
performed through same methanol series from 100% methanol to PBS. After 
rehydration, blastocysts were rinsed 3 times with PBST and 1 time in PBSTX 
(0.1 % Triton X-100 in PBS). Samples were re-fixed 20 minutes with 4 
% paraformaldehyde and 0.2% glutaraldehyde followed by 3 times of 
washed in PBST. Samples were then immersed to pre-hybridization solution, 
placed into a humidified container with tissue soaking with 1:1 ddH2O: 
formamide lying on the bottom and incubated at 70°C overnight. 
After pre-hybridization, samples were immersed to RNA probe- 
containing hybridization buffer. 1 µ g of probe was denatured at 80°C for 10 
minutes before adding to the buffer. Samples were placed back to 70°C 
hybridization oven for overnight.  
 
2.2.5.4.3: Sample wash and antibody labelling  
After hybridization, samples were washed 5 minutes in post- 
hybridization washing buffer at 65°C followed by another 3 washes for 30 
minutes. To avoid cross-contamination of probes, use different tips for wells 
hybridized with different probes until back at room temperature. After 
post-hybridization washes, samples were cooled to room temperature, rinsed 
3 times with TBST and blocked in TBST containing 10% heat-inactivated 
sheep serum at 4°C overnight. Anti-DIG AP-conjugated Fab fragment in 1% 
sheep serum in TBST was used at 1:2000 for labelling.  
 
2.2.5.4.4: Staining 
Blastocysts samples were washed 3 times in TBST for 5 minutes each 
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followed by 2 hours washes at room temperature on a shaker. TBST was 
removed and samples were further washed 3 times for 10 minutes in alkaline 
phosphatase buffer. Staining solution was prepared by mixing 4.5 µ L NBT 
with 3.5 µ L BCIP (Roche) per ml of alkaline phosphatase buffer. The colour 
reaction was carried out in the dark, assessed several time during the 
reaction until blue colour was formed. When staining is dark enough, stop 
the reaction by rinsing in PBT with 1 mM EDTA. For Tcf15 staining on 
blastocysts, it took around 36 hours to stain the blastocyst. Blastocysts could 
be store at 4°C for later image acquisition.  
 
2.2.5.5: Karyotype analysis of mES cells 
In general, chromosomal counting was performed with the help from 
Theresa O'Connor of the SCRM tissue culture core facility. Briefly, 
metaphase spreads were prepared by adding mES cell medium 
supplemented with colcemid (10μg/ml) to exponentially growing at ~70% 
confluence. Cultures were returned to the incubated for approximately 1 
hour after which time metaphase arrested cells were collected and incubated 
in 2 ml hypotonic solution (0.4% KCl, 0.4% Sodium Citrate) for a further 5 
minutes. Cells were fixed in 2ml fixation buffer (3:1 methanol: acetic acid) at 
RT for 30 minutes. Cells were dropped onto a glass slide, flooded with 
fixative and allowed to dry before staining with Giemsa and chromosome 
counting. 
 
2.2.6: Microarray analysis of gene expression 
TTE15 and parental AW2 cells were plated in 6well plates (IWAKI) one 
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day before stimulation. Cells were stimulated by 1 μg/mL doxycycline for the 
indicated time and lysed for RNA. RNA was prepared using Absolutely RNA 
Purification Kits (see section 2.2.2.1.1). cRNA was synthesized using an 
Illumina TotalPrep RNA Amplification Kit (see section 2.2.2.3). Labelled RNA 
was submitted to the WTCRF MRC Human Genetics Unit (University of 
Edinburgh) for further processing. For each sample, 1500 ng of cRNA in 10 
µ L of elution solution was needed. cRNA quality was checked using a 
Agilent 2100 Bioanalyser and hybridization was performed on an 
MouseWG-6 v2 BeadChip (Illumina). Raw data was processed in R using the 
beadarray (Dunning et al., 2007) and limma (Smyth et al., 2005) packages 
from the Bioconductor suite (Gentleman et al., 2004), with the help from Dr. 
Mattias Malaguti in our lab and Dr. Florian Halbritter in Dr. Simon 
Tomlinson’s lab in University of Edinburgh. Briefly, we removed low-quality 
probes from the input data. The data was subsequently quantile-normalized 
and log2-transformed before assessing differential expression with the limma 
algorithms. We considered genes differentially expressed which had an 
FDR-adjusted p-value of at most 0.05 and a fold change of 1.5 or more for at 
least one time point in comparison to the 0-hour baseline.   
 
2.2.7: Quantification of nuclear immunostaining 
In order to quantify the fluorescence signal in each individual cell, we 
generated an automated pipeline for image analysis. Briefly, RGB pictures 
were registered and pre-processed using a plugin in ImageJ 
(http://rsbweb.nih.gov/ij/) developed by Dr. Guillaume Blin. The 
pre-processing step consisted in a background subtraction in each channel as 
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well as a gamma correction of the blue channel to reveal low intensity nuclei. 
Then, to detect single cell nuclei, the blue channel (DAPI) was segmented 
using a previously published algorithm (Li et al., 2007) with the following 
parameters values: sigma = 0.15, minimum nucleus size = 350 pixels and 
fusion threshold = 1. This algorithm provides a picture within which each 
nucleus is labelled with a unique colour in the image. Using a homemade 
java application that Dr. Guillaume Blin developed with eclipse 
(http://www.eclipse.org), the signal in the red and green channels of the 
pre-processed RGB picture was measured in the superimposed area of each 
nucleus to calculate the average intensity. Finally, the red and green average 








Tcf15 expression during differentiation in vitro and  
during early development in vivo 
 
3.1: Aims of this chapter 
 Tcf15 has recognized functions during somitogenesis and is known to be 
a somite marker (Burgess et al., 1995). However, there are no previously 
identified functions in mouse embryonic stem (mES) cells or in 
pre-implantation embryos. A previous study within our lab using 
quantitative PCR (qPCR) to analyse Tcf15 expression in mouse embryos at 
different developmental stages from E4.5 to E10.5 showed a two-wave 
temporal expression pattern of Tcf15 (Figure 3.1). The first wave was in 
pre-implantation E4.5 stage. Then, the expression of Tcf15 dramatically 
declined when embryo implanted until rising again at E7.5 to E8.5, in 
keeping with the previously reported expression of Tcf15 in the developing 
somites. The newly identified expression of Tcf15 in E4.5 blastocysts raised 
the possibility that Tcf15 might play a role in the pre-implantation embryos 
in addition to its known function during somitogenesis.  
The primary aim of this chapter was to characterize the expression 
pattern of Tcf15 in vivo and in vitro. The in vivo study was performed using 
pre-implantation mouse blastocysts. Mouse ES cells were used as in vitro 
materials for identifying differential expression levels of Tcf15 in pluripotent 
self-renewing cultures from naïve to primed states as well as during the 
differentiation process. Also, two independently generated Tcf15-Venus 
reporter cell lines were characterized and used for monitoring Tcf15 




Figure 3.1: qPCR analysis of Tcf15 expression in mouse embryos at 
different developmental stages  
Expression of Tcf15 during mouse embryogenesis displayed a two-wave 
expression pattern. The first wave was in pre-implantation E4.5 stage. The 
second wave of Tcf15 expression arose at E7.5 to E8.5 stage, in keeping with 
the previously reported expression of Tcf15 in the developing somites. 





















Tcf15 expression in embryos 
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3.2: Results 
3.2.1: Characterization of Tcf15 expression in mouse blastocysts 
3.2.1.1: In situ hybridization identified Tcf15 expression in the inner 
cell mass (ICM) of mouse blastocysts  
As shown in figure 3.1, Tcf15 mRNA was expressed in pre-implantation 
blastocysts. However, pre-implantation blastocysts consist of outer 
trophectoderm (TE) and inner cell mass (ICM). It is therefore important to 
ask where Tcf15 is expressed in pre-implantation blastocyst. 
Due to lack of commercially available antibodies which could recognize 
Tcf15 clearly in mouse embryos by immunostaining, in situ hybridization 
against Tcf15 mRNA was performed to investigate where Tcf15 was expressed 
within the blastocyst. An Oct4 probe was used as positive control to mark 
ICM cells within the blastocyst (Figure 3.2A).  Tcf15 was expressed in the 
E4.5 blastocyst, and was specifically detected in the ICM compartment 
(Figure 3.2B). This also confirmed that the expression of Tcf15 we had 
detected in mouse ES cells (Figure 3.1) is consistent with its expression in the 
in vivo counterpart of ES cells, the ICM. 
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A) Oct4              B) Tcf15 
        
Figure 3.2: Whole mount in situ hybridization of Oct4 and Tcf15 in early 
mouse blastocysts 
MF1 x MF1 mouse morulae were flushed at E2.5 and cultured in KSOM 
medium to reach blastocyst stage. Blastocysts were fixed after hatching in 4% 
paraformaldehyde and transferred to transwells for staining procedures. 
Digoxigenin-labelled anti-Tcf15 riboprobe was synthesized from Tcf15 cDNA 
clones (Burgess et al., 1995) and Oct4 probe was gifted by Dr. Val Wilson’s 
lab. 
(A) Blastocyst staining with Oct4 probe as control. 
(B) Two blastocysts were shown here where Tcf15 expression was 
consistently detected in the ICM. Of 33 blastocysts examined from two 
independent ISH that had reached a similar stage, 31 had a clear signal 
for Tcf15 specifically within the ICM. The remainder of the embryos had 
no detectable expression. Tcf15 was never detected in the trophectoderm.  
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3.2.2: Characterization of Tcf15 expression in mouse embryonic stem 
cells  
After confirming the in vivo expression of Tcf15, both mRNA and protein 
expression of Tcf15 were investigated in vitro using mouse ES cells. 
Expression of Tcf15 was analysed in pluripotent culture conditions as well as 
during differentiation. 
 
3.2.2.1: Expression level of Tcf15 in pluripotent cultures 
3.2.2.1.1: Tcf15 expression is higher in primed pluripotent ES cells 
than in naïve ES cells and EpiSCs 
As shown above, Tcf15 is expressed in the ICM of mouse blastocysts 
(Figure 3.2), as well as ICM-derived pluripotent mES cells (Figure 3.1). In 
addition, single-cell qPCR analysis by others (Tang et al., 2010) has revealed 
that Tcf15 is up-regulated as ES cells are derived from E3.5 blastocysts and 
that Tcf15 is predominantly associated with the Gata6-negative 
subpopulation during the derivation process (Figure 3.3). This suggests that 
Tcf15 may become specifically up-regulated in cells that are maturing into 
epiblast-primed ES cells but not into primitive endoderm, although relatively 
few cells were examined in this study and so firm conclusions cannot be 
drawn.  
In order to understand the relative expression level of Tcf15 in different 
self-renewing pluripotent cultures from naïve to primed and 
post-implantation states, mES cells were established and analysed in three 
different pluripotent culture conditions. mES cells cultured in the serum-free 
N2B27 medium containing 2i mimicked the ground state naïve ES cells in 
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which differentiation cues had been blocked by two pharmacological 
inhibitors (PD0325901 and Chiron99021) against MEK and GSK-3β (Ying et 
al., 2008) (see section 1.1.2.2.5). mES cells cultured in normal culture medium 
containing LIF and serum (FCS) were considered as a mixture of cells in 
naïve and differentiation-primed states in which cells had heterogeneous 
gene expression and some might already be primed for certain lineages 
(Nichols and Smith, 2009). Post-implantation epiblast stem cells (EpiSCs) 
culture was established by maintaining cells in serum-free N2B27 medium 
containing FGF2 and Activin (Tesar et al., 2007). Tcf15 expression was 
compared with naïve pluripotency marker Klf4 and epiblast stem cell marker 
Fgf5 (Figure 3.4A). The result showed cells in a primed state expressed higher 
levels of Tcf15 than cells in a naïve pluripotent state. In addition, EpiSCs 
(which are equivalent to post-implantation pluripotent epiblast cells) also 
expressed lower levels of Tcf15 than ES cells. These findings are consistent 
with the qPCR analysis of embryos which indicates that Tcf15 expression 
drops after embryos implant, i.e. between E4.5 and E5.5 (Figure 3.1).  
 
3.2.2.1.2: Tcf15 expression is transiently up-regulated during the 2i to 
EpiSC transition 
 In order to further investigate how the expression of Tcf15 changes as 
cells move between pluripotent naïve, primed and epiblast states, a 2i to 
EpiSC transition experiment was performed as showed in figure 3.4B. ES 
cells were cultured in 2i conditions supplemented with LIF for two passages 
before starting the experiment. Cells were then re-plated directly onto 
fibronectin coated plates in EpiSC medium containing Activin and FGF2. 
EpiSC medium was also supplemented with 1% knockout serum 
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replacement (KSR) to reduce cell death and to sustain uniform induction of 
ES cells into flattened epithelial structures resembling the EpiSCs over the 
experiment time period (Hayashi et al., 2011). Gene expression was analysed 
during the 2i to EpiSC transition.  
qPCR analysis on marker gene expression was first confirmed that the 
cells behaved as expected under these conditions. As shown in figure 3.4C, 
the expression of naïve pluripotency markers Nanog and Klf4 declined 
dramatically within 24 hours, indicating cells were progressing from a naïve 
state to primed state as expected. Expression of EpiSC marker Fgf5 began at 
day 1, indicating cells start acquiring EpiSC-like gene expression after this 
time point.  
Expression of Tcf15 was then examined under these conditions. Tcf15 
expression was low when culturing in 2i conditions. Expression of Tcf15 
significantly increased rapidly when cells were released from 
anti-differentiation 2i culture conditions and re-plated in Activin/ 
FGF2-containing EpiSC medium. After the initial switch from a naïve to 
primed state, Tcf15 up-regulation persisted for first 12 hours and then started 
decreasing between 12 and 24 hours as cells loss naïve pluripotency markers 
and gradually transited to EpiSC-like state. The epiblast-determinant gene 
Otx2 (Acampora et al., 2012) showed a correlation with Tcf15 during the early 
part of this transition. However, unlike Tcf15, Otx2 remained highly 
expressed in the EpiSC-like state. The transient peak of Tcf15 expression at 
early time points during 2i to EpiSC transition is consistent with the 
steady-state expression pattern in LIF and serum culture conditions which 
represent an intermediate between naïve and post-implantation epiblast 
states. This raises the possibility that Tcf15 might play a role during the 
transition from a naïve pluripotent state to primed state.  
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Figure 3.3: Single cell qPCR from day three ICM outgrowth cells 
Tcf15 and Gata6 expression from Oct4-positive cells after 3 days of ICM 
outgrowth were extracted from the supplementary data from Tang et al., 





















Day3 Outgrowth (Oct4+) 











Figure 3.4: Endogenous expression of Tcf15 in pluripotent cultures 
(A) Mouse ES cells gene expression in self-renewing cultures. Klf4 (naïve 
pluripotency marker) and Fgf5 (EpiSC marker) were used to monitor cell 
identity. Expression of each gene was normalized to highest expression. 
Tcf15 expression was significantly higher in ES cells than in 2i and EpiSC 
cultures.  
(B) The scheme for 2i to EpiSC induction. 
(C) Gene expression during 2i to EpiSC transition. Relative expression was 
normalized to highest expression. This experiment was performed twice 
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3.2.2.2: Expression level of Tcf15 during differentiation 
After analysing Tcf15 expression in self-renewing conditions, the 
expression level of Tcf15 was examined during differentiation of ES cells to 
neural cells under monolayer neural differentiation protocol (Ying et al., 2003) 
(Figure 3.5A) or to non-neural lineages by withdrawing LIF from the culture 
medium (Figure 3.5B). In both differentiation experiments, Tcf15 expression 
persisted after the naïve pluripotency marker Nanog and Rex1 were 
down-regulated. The expression level of Tcf15 was higher in pluripotent ES 
cells than in differentiated cells. Tcf15 expression then declined at around the 
time that cells commit to differentiation, as measured by the up-regulation of 
early neural marker Sox1 (Wood and Episkopou, 1999) and N-cadherin (Riehl 
et al., 1996) in neural differentiation conditions and T-Brachyury in 
non-neural differentiation conditions (Lanner and Rossant, 2010). 
To further study the expression level of Tcf15 during spontaneous 
differentiation, ES cells were cultured in suspension in the absence of 
anti-differentiation factor LIF to form three-dimensional (3D) aggregates 
called embryoid-like bodies (EBs) (Kurosawa, 2007) (Figure 3.5C). ES cells 
could differentiate into derivatives of ectodermal, mesodermal, and 
endodermal tissues which recapitulate many aspects of cell differentiation 
during early mammalian embryogenesis. Tcf15 expression during EB 
formation displayed a similar trend as in the directed differentiation assays 
described above. The expression of Tcf15 persisted after naïve gene Rex1 
declined and down-regulated before lineage specific gene Sox1 
(neuroectoderm), T (mesoderm) and FoxA2 (endoderm) began to be 
expressed. 
These results suggested that the transient up-regulation of Tcf15 prior to 
differentiation is not associated only with the transition to neural fates but is 
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associated with differentiation into all epiblast-derived lineages. Moreover, it 
suggests that any role played by Tcf15 must take place during the early 
stages of differentiation, i.e. during the transition from a naïve pluripotent 













Figure 3.5: Tcf15 expression in different differentiation contexts 
Tcf15 expression persisted after the naïve pluripotency markers Nanog or 
Rex1 were down-regulated and then declined at around the time cells 
commit to differentiation, as marked by lineage specific markers Sox1, 
N-cadherin, T-Brachyury or FoxA2. 
(A) Expression of Tcf15 during serum-free monolayer neural induction 
conditions.  
(B) Expression of Tcf15 during non-neural differentiation condition: LIF 
withdraw from complete medium. (This experiment is performed by 
Xinzhi Zhou in the lab)  































































































3.2.2.3: Tcf15 reporter cells 
After checking the gene expression of Tcf15 in bulk populations, the 
expression pattern of Tcf15 within ES cells was investigated at the single cell 
level using live-fluorescent Tcf15 reporter cell lines.  
 
3.2.2.3.1: Analyzing Tcf15 expression pattern in mES cells by 216D1 
Tcf15-Venus reporter cells 
3.2.2.3.1.1: Tcf15-Venus is heterogeneously expressed within ES cells and is 
negatively correlated with Nanog and Klf4, but not Oct4 
 ES cells cultured in LIF and serum are heterogeneous mixtures of 
primed cells and naïve cells (Nichols and Smith, 2009). Naïve cells within 
these cultures are marked by Klf4 and Nanog. In order to find out whether 
Tcf15 expression was associated with the primed state in these mixed 
cultures, a sensitive reporting strategy for Tcf15 was used based on 
translational amplification of a fluorescent protein, Venus. The 216D1 
Tcf15-reporter cell line (referred hereafter as Tcf15-Venus cell line) was 
generated by the International Gene Trap Consortium (Toronto Centre for 
Phenogenomics) using gene-trapping: a gtx-IRES-Venus cassette (Figure 3.6A) 
was incorporated into the only intron of Tcf15 (Tanaka et al., 2008) (Figure 
3.6B). Tcf15 transcripts were visualized based on the expression of the 
enhanced YFP, Venus, coupled to a unique translational amplifier, gtx-IRES.  
The 216D1 Tcf15-Venus reporter cell line had previously been validated 
as a faithful reporter of Tcf15 expression (Tanaka et al., 2008). In order to 
further confirm this, FACS were used to sort Tcf15-Venus cells from the 
heterogeneous pluripotent LIF and serum cultures through a series of gating 
strategies as showed in figure 3.7A. In short, Tcf15-Venus cells were first 
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gated with FSC and SSC for size and granularity, followed by cell doublets 
exclusion. Then, a live-dead gate was carried out to identify DAPI-negative 
live cells. Furthermore, Platelet endothelial cell adhesion molecule 1 
(PECAM1, CD31) (Furusawa et al., 2004) was used to exclude differentiated 
cells (Figure 3.7A). The top and bottom 30 % of Venus-positive cells were 
sorted from PECAM1-positive population and labelled as Venus-high or 
Venus-low, respectively (Figure 3.7B). Expression of Venus correlates with 
Tcf15 mRNA (assessed by qPCR) and with Tcf15 protein (assessed by western 
blot analysis) (Figure 3.7C and 3.7D). It is worth noting that after screening 
all the commercial available Tcf15 antibodies, the one used in this thesis 
(Aviva) was the only one which is working (data not shown). However, the 
western blot displayed an additional 200kD band along with the predicted 
21kD Tcf15 band. Therefore, it is not suitable for performing immunostaining 
using this antibody. 
Next, the distribution of Venus within populations of ES cells cultured in 
LIF and serum was examined. Expression of Venus protein showed a 
heterogeneous distribution within this pluripotent cell culture (Figure 3.8A). 
Moreover, co-immunostaining of pluripotency factors Oct4, Nanog and Klf4 
with Tcf15-Venus showed that Tcf15-Venus expression was higher in 
Nanog-low cells as well as in Klf4-low cells and lower in Nanog-high and 
Klf4-high cells. However, Oct4 did not seem to be enriched in 
Tcf15-Venus-high cells, suggested that Tcf15-Venus marks primed ES cells 
within the pluripotent population rather than marking differentiated cells.  
To gain further insight into the relationship between Tcf15-Venus and 
Nanog, Klf4, or Oct4 in ES cells, an image analysis software developed by Dr. 
Guillaume Blin in the lab (http://www.eurostemcell.org/MultiCell3D) was 
used to quantify the immunofluorescence staining (Figure 3.8B and 3.8C). 
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Fluorescent signals were plotted to a FACS-like 2-dimensional scatter plot 
(Figure 3.8B) and pie charts were made to illustrate the percentage 
distribution of populations (Figure 3.8C). Tcf15-Venus was heterogeneously 
expressed within pluripotent cultures and most of the Venus-positive cells 
expressed Oct4, whereas the presence of double-positive Tcf15-Venus-high/ 
Nanog-high and Tcf15-Venus-high/ Klf4-high was low, as seen in the near 
absence of this population in the scatter plot and less than 10% in the pie 
chart. This indicates that Tcf15 marks an undifferentiated but 






Figure 3.6: Schematic representation of Tcf15-Venus reporter line (Adapted 
from Tanaka et al., 2008) 
(A) Gene-trap cassette used to generate Tcf15 reporter cell line. A bar at the 
bottom indicates 1 kb. Stop codons are indicated as asterisks (*). IVS, 
synthetic intervening sequence; pA, polyadenylation signals from bovine 
growth hormone; SA, adenoviral splice acceptor site; SD, HPRT splice 
donor site.  
(B) Gene-trap strategy for generating Tcf15 reporter line. White boxes: 
untranslated regions, grey boxes: coding region, diagonal lines: intronic 
DNA, straight lines: untranscribed intergenic regions. Trapped transcript 
will generate 3 mRNAs including truncated Tcf15 with only 1st exon 
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Figure 3.7: Differential Tcf15 expression between FACS sorted 216D1 
Tcf15-Venus reporter cells  
(A) Sequential FACS gating of 216D1 Tcf15-Venus cells and the control 
E14tg2a cells. 
(B) FACS profile of Tcf15-Venus reporter line. E14tg2a cells were used as 
negative control (black). Top and bottom 30% of Tcf15-Venus cells (green) 
were sorted as indicated in the figure. Venus-high (blue) and Venus-low 
(red) populations were analysed right after sort for purity check. 
(C) qPCR analysis of Tcf15 from FACS sorted Tcf15-Venus reporter cells.  
**: p<0.01  
(D) Western blot analysis of Tcf15 from FACS sorted Tcf15-Venus cells. 
Tubulin was used as internal control.   
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A)                             B)                    C) 
 
Figure 3.8: Tcf15-Venus is heterogeneously expressed within ES cells and 
is negatively correlated with Nanog and Klf4, but not Oct4 
(A) Immuno-staining of Tcf15-Venus reporter cells cultured five days from a 
single cell in pluripotent culture. Each row (a and b, c and d, and e and f) 
was same colony stained with different antibodies. Venus was stained 
with rabbit anti-GFP antibody to achieve better fluorescent signal. 
Tcf15-Venus was heterogeneous expressed within colonies (b, d and f). 
Naïve pluripotency markers Nanog (a, showed in red) and Klf4 (c, 
showed in red) expressed at higher levels in Venus-low cells, showing a 
negative correlation with Tcf15-Venus. However, Oct4 was expressed in 
both Venus-high and Venus-low cells (e, showed in red).  
(B) Quantitative immunofluorescence analysis of Tcf15-Venus reporter cells 
stained for Nanog, Klf4, or Oct4. 
(C) Proportion of cells positive for Tcf15-Venus only (green) or 
Nanog/Klf4/Oct4 (red) or both (yellow). Double negative cells were 
excluded. 
 
This image analysis is performed with the help from Dr. Guilluame Blin. 
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3.2.2.3.1.2: Gene expression analysis of FACS sorted Tcf15-Venus 
reporter cells indicates Tcf15 might mark cells primed for somatic 
lineages 
To further address the population heterogeneity of Tcf15, qPCR and 
western blot analysis were performed on FACS sorted Tcf15-Venus-high and 
Tcf15-Venus-low cells. Venus-high cells expressed lower Nanog and Klf4 at 
both protein and mRNA level, supporting our previous observation from 
immunostaining (Figure 3.9A and 3.9C). Venus-high cells also expressed 
lower level of naïve pluripotency markers Klf2 and Rex1 compared with 
Venus-low cells. The expression of pan-pluripotency marker Oct4 was similar 
between these two populations (Figure 3.9B), confirming the results of the 
immunostaining (Figure 3.8B). Moreover, Venus-high cells expressed slightly 
lower level of the extra-embryonic endoderm markers Hex (Canham et al., 
2010) and PdgfRa (Plusa et al., 2008) (Figure 3.9D) and slightly higher level of 
the epiblast markers Fgf5 and T (Toyooka et al., 2008) (Figure 3.9E). These 
differences may not be significant, but they do at least exclude the possibility 
that Tcf15 specifically marks cells that are primed for extra-embryonic 
endoderm differentiation (Canham et al., 2010).  
In conclusion, based on experiments described above, pluripotent ES 
cells contained both Tcf15-Venus-high and Tcf15-Venus-low populations. The 
Venus-high cells were neither in a naïve pluripotent state nor primed for 
extra-embryonic endoderm, based on marker analysis. This, together with 
the slightly higher expression of epiblast markers within the Venus-high 
population, lead to our hypothesis that Tcf15 is marking pluripotent cells 




A)                                 B) Pan-pluripotency marker 
                    
 
C) Naïve pluripotency markers 
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Figure 3.9: Differential expression between two populations of FACS 
sorted Tcf15-Venus reporter cells  
(A) Western blot analysis of Nanog and Klf4 from FACS sorted Tcf15-Venus 
cells. Tubulin was used as internal control. This blot is the same as that 
shown in figure 3.5D. 
(B) qPCR of pan-pluripotency marker Oct4.  
(C) Naïve pluripotency markers Nanog, Klf4, Klf2 and Rex1. 
(D) Extra-embryonic marker genes Hex and PdgfRα. 
(E) Epiblast markers Fgf5 and T.  
ns: non-significant; *: p<0.05; **: p<0.01 
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Figure 3.10: Hypothesis: Tcf15 might prime cells for somatic lineages 
Differential gene expression between Tcf15-high and Tcf15-low cells 
indicated Tcf15-high cells were not in a naïve pluripotent state (green circle, 
marked by Nanog expression) nor primed for extraembryonic endoderm 
(blue circle, marked by Hex expression). Therefore Tcf15 might mark cells 




3.2.2.3.1.3: Differential gene expression between Tcf15-high and 
Tcf15-low cells under conditions in which Id inhibition is reduced 
Experiments above describe changes in gene and protein expression, 
notably a down-regulation of Nanog and Klf4, which correlate with a high 
level of Tcf15 expression in pluripotent cells. 
However, in some cases Tcf15 may be expressed but held in an inactive 
state by Id proteins, thus complicating this type of analysis. Id proteins are 
present in pluripotent ES cell culture and generally act as inhibitors of bHLH 
transcription factors activity (Ying et al., 2003, Norton, 2000) (see section 
1.2.2). In the presence of Id proteins, Id dimerizes with and sequesters the 
ubiquitous bHLH transcription factor E12/E47, blocking its interaction with 
Tcf15. E12/E47 is an essential heterodimerisation partner for Tcf15 in its 
activation of downstream target genes, and so this effect of Id abolishes Tcf15 
activity (Wilson-Rawls et al., 2004) (Figure 3.11A). Hence, expression of Id 
within pluripotent cells is likely to render Tcf15 inactive. 
Therefore, the differential gene expression between Tcf15-Venus-high 
and Tcf15-Venus-low cells in the absence of Id proteins was being 
investigated. Id expression is sustained by BMP or serum in culture medium, 
and is lost within 24 hours of transferring to serum-free medium (Ying et al., 
2003). Tcf15-Venus cells were therefore switched to N2B27 basal medium 24 
hours before performing FACS analysis. As shown in Figure 3.11B, ES cells 
cultured in LIF and serum expressed higher Id1 than N2B27 due to functional 
BMP signalling machinery within undifferentiated ES cells induced by the 
presence of serum (Ying et al., 2003), although under these conditions Id1 is 
only expressed in around 50% of cells (Mattias Malaguti, manuscript in 
preparation). Higher Id expression is likely to sequester E12/E47 and 
therefore suppress the transcription activity of Tcf15 in at least some of the 
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cells within ES cell cultures. Id1 expression was down-regulated after cells 
were switched from culturing in LIF and serum to N2B27 (Figure 3.11B), as 
expected (Ying et al., 2003). Analysis of Oct4 expression suggested that cells 
were not committed to differentiation at this point. E47 expression was 
maintained after medium switch while Tcf15 expression was slightly 
downregulated.  The downregulation of Id1 expression in these conditions 
is expected to release E12/E47 proteins and to increase Tcf15 activity. 
Therefore, this condition may reveal additional transcriptional differences 
between Tcf15-high and Tcf15-low cells (Figure 3.11C). The top and bottom 
30 % of Venus-positive cells were sorted from PECAM1-positive population 
for further analyses. 
Gene expression analysis confirmed that the negative correlation 
between Tcf15 and Nanog/Klf4/Hex was still observed in cells sorted from 24 
hours N2B27 culture (Figure 3.12A), although the difference of Hex 
expression was not significant. Oct4 did not differ between the two 
populations, as had been previously observed for LIF and serum cultures 
(Figure 3.9). Moreover, expression of epiblast markers Fgf5 and T were both 
enriched in Venus-high cells (Figure 3.12B) compared with cells sorting from 
culturing in LIF and serum (Figure 3.9E), indicating the epiblast-priming 
effect of Tcf15 might be stronger when Id inhibition was removed.  
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Figure 3.11: Illustration for changing Id expression level in pluripotent ES 
cells to induce higher Tcf15 activity 
(A) The scheme for Id1 protein (showing in red) function in blocking 
lineage-specific transcription factor such as Tcf15 (showing in yellow) 
dimerization with ubiquitous E protein, E47 (showing in blue), therefore 
inhibits downstream gene expression. 
(B) qPCR analysis of Id1, Oct4, Tcf15 and E47 expression after switching from 
culturing in LIF and serum to N2B27 for 24 hours. 
(C) Graphic view showing different levels of Id expression controlling 
transcriptional activity of Tcf15. Id expression was decreased when cells 
were placed in N2B27 medium. Lower Id expression released more E47 
protein to dimerize with Tcf15 and induced more Tcf15 downstream 
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Figure 3.12: qPCR analysis of Tcf15-Venus reporter cells after down- 
regulation of Id1  
216D1 Tcf15-Venus reporter cells were maintained in LIF and serum 
complete medium and switched to N2B27 basal medium 24 hours before 
performing FACS. In this condition, Id-induced suppression of Tcf15 
transcription activity was reduced due to downregulation of Id1 expression. 
Gene expression was analysed from sorted Venus-high and Venus-low 
subpopulations. (ns: non-significant; *: p<0.05; **: p<0.01) 
(A) qPCR analysis of pluripotent and extra-embryonic genes showed similar 
results as cells were cultured in complete medium containing LIF and 
serum.  
(B) qPCR analysis of epiblast markers T and Fgf5 showed enrichment of 
expression when Id inhibition was reduced. 
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3.2.2.3.1.4: Tcf15 expression is dynamic within self-renewing ES cells 
Tcf15 was heterogeneously expressed in self-renewing ES cells and 
Venus-high and Venus-low populations displayed differential gene 
expression. In order to understand if Tcf15 heterogeneity was dynamic 
within ES cells, sorted Venus-high and Venus-low cells were analysed daily 
by flow cytometry for Venus expression until day three after sorting. E14tg2a 
cells were used as a negative control for non-fluorescent cell and unsorted 
Tcf15-Venus cells were a positive control and an indicator of the steady state 
distribution of Tcf15-Venus. As shown in Figure 3.13A, Venus-high and 
Venus-low cells were sorted from culturing in complete media containing 
LIF and serum. Cell purity was at least >90% immediately after sorting with 
no overlapping of the two populations. Cells were plated back to 6 well 
plates at 105 cells per well in complete medium containing LIF and serum 
plus pen/strep to prevent possible bacterial contamination after the sorting 
process. Cells from both Venus-high and Venus-low populations were both 
competent to re-establish a heterogeneous culture within 24 hours, as 
indicated by overlapping of Venus expression (Figure 3.13B). However, 
Venus-low cells contributed more Venus-negative cells after 3 days.  
An alternative method was used for analysing dynamic expression of 
Tcf15 to test whether heterogeneous expression of Tcf15-Venus could be 
rapidly established in a colony of cells that emerged from a single cell. 
Tcf15-Venus cells were plated at clonal density and cultured in LIF and 
serum condition for 6 days. Heterogeneous expression of Tcf15-Venus could 
be regenerated within a colony (Figure 3.13C) in > 90% of the colonies, 
suggesting that the heterogeneous expression of Tcf15 was in a dynamic 
rather than a stable state.  
These results indicated both Tcf15-high and Tcf15-low existed within 
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un-differentiated population and were able to interconvert when ES cells 
were cultured in self-renewing conditions. 
 
3.2.2.3.1.5: Tcf15 does not mark cells that have committed to 
differentiate 
The data presented above suggests that Tcf15 marks a population of cells 
that express low levels of naïve pluripotency markers but which can revert 
back to a Tcf15-low state. In order to address the question whether Tcf15 
marks cells that have committed to differentiate, experiments were designed 
to ask whether individual Tcf15-high cells had a reduced ability to form 
self-renewing colonies compared with Tcf15-low cells.  
Self-renewing, un-differentiated PECAM1-positive ES cells were sorted 
according to Venus expression. Cells were plated at single cell density and 
cultured in complete medium for 5 days to perform alkaline phosphatase 
(AP) staining: a commonly used phenotypic assessment for undifferentiated 
ES cells (Figure 3.14A) (Palmqvist et al., 2005). No obvious difference in 
colony numbers between unsorted, Venus-high and Venus-low populations 
could be detected.  
These results suggested that ES cells cultured in LIF and serum contain 
both Tcf15-high and Tcf15-low populations and these two populations were 
inter-changeable. In addition, Tcf15-high cells were not cells that had 
committed to differentiation, although based on the relative lower expression 
of naïve pluripotency markers they are likely to be cells that are primed for 








   
Figure 3.13: Tcf15 expression is dynamic within self-renewing culture 
conditions 
(A) Venus expression of sorted Venus-high (solid green), Venus-low (dashed 
blue) cells, unsorted Tcf15-Venus control cells (solid black with shadow) 
and negative control E14tg2a cells (solid red). 
(B) Daily flow cytometry analysis of Venus expression on FACS sorted 
populations. Venus-high and Venus-low cells return to heterogeneous 
expression within 48-72 hours. 
(C) Single colony from 216D1 Tcf15-Venus, cultured from a single cell in LIF 
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Figure 3.14: Tcf15-high cells were not early-differentiating cells  
(A) Alkaline phosphatase staining of unsorted (a), Venus-high (b) and 
Venus-low (c) populations after 5 days culture in complete medium with 
LIF and serum.  
(B) Model for Tcf15 heterogeneity within self-renewing ES cells. 
Self-renewing ES cells contain both Tcf15-high and Tcf15-low 





3.2.2.3.1.6: Tcf15 marks cells that are primed for rapid differentiation 
To test whether Tcf15-Venus-high cells are functionally primed for 
differentiation, FACS sorted Tcf15-Venus reporter cells were directed to 
differentiate into neural cells using monolayer neural differentiation protocol 
(Ying et al., 2003). The extent of differentiation into the neural lineage was 
then assessed daily by qPCR analysis. As shown in figure 3.15, Tcf15 
expression was down-regulated during neural differentiation and this 
down-regulation was more rapid when differentiation was initiated from a 
Venus-high state. Oct4 expression was also down-regulated during neural 
differentiation, slightly more efficiently in Venus-high cells, although these 
differences are not significant. Nanog was lost rapidly from both populations 
but the neural markers N-Cadherin and Sox1 were up-regulated more rapidly 
when differentiation was initiated from a Venus-high state. These data 
suggest that the Tcf15-Venus-high subpopulation is primed to undergo 
neural differentiation more efficiently than the Tcf15-Venus-low 
subpopulation. The more rapid down-regulation of Tcf15 from the 
Venus-high state is therefore likely to reflect the down-regulation of Tcf15 
during differentiation (Figure 3.5A). 
Next, to further examine if Tcf15-high cells progress more rapidly 
toward differentiation into other lineages, 3-dimentional embryoid body (EB) 
aggregates were generated in hanging drops in order to encourage 
multi-lineage differentiation. qPCR analysis was performed from day 1 to 
day 5 to monitor differential gene expression during early EB formation 
(Figure 3.16). Tcf15 was downregulated rapidly during EB formation. 
Venus-high cells also down-regulated Oct4 expression slightly more 
efficiently, although these differences are not significant. Expression of 
epiblast marker Fgf5 was up-regulated in Venus-high cells more rapidly at 
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day one. Both Venus-high and Venus-low cells up-regulated Sox1 
(neuroectoderm), T-Brachyury (mesoderm) and FoxA2 (endoderm) expression, 
indicating there was no differential bias of either population for commitment 
to any specific lineage. However, expression of Sox1 and T-Brachyury in 
Venus-low cells were about 24 hours delayed compared with Venus-high 
cells. The re-activation of Nanog during EB formation was also accelerated by 
around 24 hours: this peak of Nanog expression is thought to recapitulate the 
formation of proximal posterior epiblast prior to gastrulation (Osorno et al., 
2012, Malaguti et al., 2013).  
Taken together, these data suggest that Tcf15 marks cells that have low 
expression of naïve markers, are not committed to differentiate, but are 





Figure 3.15: qPCR analysis of FACS sorted Venus-high and Venus-low 
cells during neural differentiation  
FACS sorted Tcf15-Venus reporter cells were plated into N2B27 medium 
containing penicillin/streptomycin after sorting to perform neural 
differentiation with daily media change. Venus-high subpopulation 


























































































































Figure 3.16: qPCR analysis of FACS sorted Venus-high and Venus-low 
cells during EB formation 
qPCR analysis of FACS sorted Tcf15-Venus reporter cells underwent hanging 
drop EB formation. Venus-high subpopulation displayed rapid 
differentiation than Venus-low subpopulation without bias to any specific 






















































































































































3.2.2.3.2: Silencing effect within 216D1 Tcf15-Venus cells 
The 216D1 Tcf15-Venus cells served as a good tool for analysing Tcf15 
expression. However, there were some concerns after extensive studies on 
this reporter cell line. First, a Venus-negative population within pluripotent 
culture aroused after long-term (>15 passages) culture (Figure 3.17A). The 
sorted Venus-negative cells expressed intermediate level of Tcf15 between 
Venus-high and Venus-low cells and almost undetectable Venus expression 
(Figure 3.17B). This was first considered to be due to loss of the gene-trap 
cassette. However, genomic DNA qPCR analysis showed that Venus-negative 
cells still retained the Venus selection cassette (Figure 3.17C) but somehow 
lost mRNA and protein expression. This indicated that the Venus-negative 
population is likely to contain cells in which the gene-trapped allele has been 
silenced by an unknown epigenetic regulation. 
Furthermore, single cell sorting of Venus-positive cells was performed in 
order to re-clone the pure cells. However, after 15-20 passages culturing in 
the presence of G418 selection, the Venus-negative cells arise again. In 
addition, as shown in figure 3.13A above, the Venus-positive population was 
dynamic which Venus-high cells could regenerate Venus-low cells and vice 
versa. However, the Venus-negative population never switch-on Venus 
expression after sorting (Figure 3.17D) and could be maintained in 
pluripotent LIF and serum cultures for at least 10 passages. We concluded 
that the gene trap allele is reproducibly prone to irreversible silencing at a 
low but significant frequency.  
A second concern about this cell line came from the use of 
gtx-IRES-Venus cassette as a translational amplifier. This amplifier generates 
high levels of fluorescence, which is convenient for monitoring Venus 
expression in live cells. However, the strong amplification of Venus protein 
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expression under this amplifier might mask some subtle changes within cells 
and raises the concern that this reporting strategy may not be as strictly 
faithful as a strategy that relies entirely on an endogenous promoter in the 
absence of translational amplification. Therefore, I decided to make another 





















Figure 3.17: Analysis of Venus-negative population within 216D1 cells  
(A) Flow cytometry analysis of Venus expression in 216D1 Tcf15-reporter 
cells. “Old clone’ refers to cells cultured for more than 20 passages. “New 
clone” refers to cells re-cloned from single cell sorting from 
Venus-positive population. 
(B) qPCR analysis of sorted Venus-high, Venus-low and Venus-negative cells 
from old 216D1 Tcf15 reporter cells. (N=2, n=2) 
(C) qPCR analysis of gDNA isolated from sorted Venus-positive and 
Venus-negative population. Two different endogenous housekeeping 
controls were used to normalize genomic Venus expression. (N=2, n=2) 
(D) Flow cytometry analysis of Venus-negative cells after FACS. Sorted cells 
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3.2.2.3.3: Analyzing Tcf15 expression pattern in mES cells by 
Tcf15-Het (Tcf15+/Venus) reporter cells 
3.2.2.3.3.1: Generating Tcf15 heterozygous Venus knock-in cells as a 
new Tcf15-reporter cell line 
A targeting vector for generating Tcf15-Venus reporter cells was 
previously constructed in our lab by Aliaksandra Radzisheuskaya. Briefly, 
the targeting strategy was to remove exon 1 of Tcf15 allele and replace it with 
the fluorescence protein Venus followed by a FRT-flanked double selection 
cassettes containing a PGK-neomycin resistant gene for positive selection with 
G418 and a MC1-TK (thymidine kinase) for negative selection with ganciclovir 
(Figure 3.18). The targeting construct also contained a negative selection 
marker diphtheria toxin A (DTA) outside of the homology region to perform 
negative selection of non-homologous integrations. However, this targeting 
vector was found to inadvertently lack the coding sequence for placing a 
poly(A) tail after the Venus gene and was therefore likely to result in an 
unstable Venus mRNA and low protein expression. Therefore, the poly(A) 
sequence was inserted after the Venus gene through BsrGI site to obtain the 
final targeting construct, which been designated pSKO-Tcf15 (SKO stands for 
Straight Knock Out to indicate that this construct knocked out the first exon 
of Tcf15 allele). 
ScaI-linearized pSKO-Tcf15 (100 μg) was then electroporated into 
wild-type 129/Ola-derived mES cells (E14tg2a), and transfectants were 
selected with G418 (300 μg/ml) yielding over 103 colonies by day 8 of 
selection. Approximately 190 clones were picked and expanded to 96 well 
plates. Clones were expanded to 48 well plates whereupon replica plates 
were made and frozen at -80°C. Cells were pre-screened for Venus 
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expression before lysing for genomic DNA isolation. Genomic DNA of 83 
clones with positive Venus expression under microscopic examination were 
first isolated with the others frozen at -80°C. Southern blot was used for 
identifying corrected targeting clones. Correct targeting introduced an 
exogenous EcoRV site into the region of exon 1 replaced by the selection 
cassette, which allowed both wild-type and targeted alleles to be 
distinguished from each other by southern blot screening. A Tcf15-3’ external 
probe identified 2 bands, 9.5 kb and 8.3 kb, corresponding to wild-type and 
targeted alleles, respectively. An internal probe was also designed for 
identifying potential clones with random-integrated targeting construct. 
Random-integrated clones will contain additional bands other than the 
known 8.3 kb targeted allele. 
Southern blot analysis identified 10 heterogeneous clones (Tcf15+/Venus) 
with both wild-type and correct targeted band by Tcf15-3’ external probe 
(Figure 3.19A), giving a targeting efficiency of approximately 5%. Among 
these clones, clone E14 had an additional random-integrated fragment 
revealed by a 4.4 kb band after blotting with internal probe (Figure 3.19B). 
Therefore, 9 independent Tcf15 heterozygous clones were obtained, which 
were clones A29, D4, D22, D34, D43, E5, E6, E39 and E48 (now referred to as 
Tcf15-Het-A29, Het-D4, Het-D22, Het-D34, Het-D43, Het-E5, Het-E6, Het-E39 
and Het-E48, respectively). More detailed characterisation and phenotypic 
analysis of Tcf15-Het cells will be described in section 4.2.2.2.1. 
Tcf15-Het-E6-1 cells, in which the selection cassette had been 
successfully removed, displayed a normal complement of 40 chromosomes 
after karyotyping analysis (Figure 3.20). Therefore, this clone was selected as 




Figure 3.18: Schematic view of the wild type allele (Tcf15), Tcf15 
gene-targeting vector (pSKO), targeted allele (Tcf15Venus) and targeted allele 
after removing the selection cassette (Tcf15VenusFRT) 
pSKO Tcf15 gene-targeting vector contained Venus (shown in green), a 
PGK-Neo selectable marker and a negative selection marker MC1-TK flanked 
by FRT sties. Exon 1 in the wild-type Tcf15 allele was replaced to generate the 
Tcf15Venus allele. After FlpO recombinase mediated recombination, the 
selection cassette could be excised, leaving a FRT site at the allele Tcf15VenusFRT. 
Genomic DNA digestion with EcoRV followed by Southern blotting, using 
the Tcf15-3’ external probe and internal probe depicted in the diagram, 
resulted in a 9.5 kb band for the wild-type allele, and a 8.3 kb band for the 
Tcf15Venus targeted allele. After removing the selection cassette, EcoRV 
digestion of Tcf15VenusFRT allele will give rise to a 10.1 kb band by Southern 
blotting. The Tcf15VenusFRT allele could also be easily distinguished from the 
Tcf15Venus allele by probing with Venus probe, which gave rise to 10.1 kb and 
4.6 kb band, respectively. 
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A) Tcf15-3’ external probe 
 
 
B) Tcf15 internal probe 
 
Figure 3.19: Southern blot analysis of Tcf15 targeted cells  
E14tg2a ES cells were electroporated with the pSKO targeting construct. 
Genomic DNA was isolated and digested with EcoRV to perform a Southern 
blot using the targeting probes depicted in figure 3.18 on G418-resistant, 
Venus-positive clones.  
(A) Clones A29, D4, D22, D34 ,D43, E5, E6, E14, E39 and E48 appeared to be 
correctly targeted by pSKO as they had the wild-type band (black arrow) 
and a second band from targeted allele (red arrow).  
(B) Tcf15 internal probe identified clone E14 had an additional random 
integrated fragment of targeting vector (blue arrow), therefore was 




Figure 3.20: Karyotyping of Tcf15-Het-E6-1 cells 
Karyotyping of Tcf15-Het-E6-1 cells was carried out by treating cells with 
colcemid for 2 hours to arrest cells in metaphase. Cells were then dissociated 
into single cell suspension, fixed, and stained with Giemsa to reveal 
chromosomes. This figure showed two representative images for 







3.2.2.3.3.2: Expression pattern of Tcf15-Het cell lines  
After obtaining the new line of Tcf15-Het reporter cells, in vitro and in 
vivo studies were performed to verify if Tcf15-Hets were faithful Tcf15 
reporters. Clone E6-1 (now referred to as Tcf15-Het cells) was selected for 
further analyses.  
 
3.2.2.3.2.2.1: In vitro expression pattern of Tcf15-Het cells is similar to 
that of the 216D1 Tcf15-Venus cells 
Tcf15-Het cells express Venus protein driven by the endogenous Tcf15 
promoter with no translational amplification, and so as expected the Venus 
expression was lower than observed in the 216D1 Tcf15-Venus reporter 
which Venus protein expression was amplified by the gtx-IRES element 
(Figure 3.21A). Immuno-staining of Venus expression on Tcf15-Het cells 
plating at clonal density in complete medium containing LIF and serum 
showed Venus was heterogeneously expressed (Figure 3.21B), as expected 
from analysis of 216D1 Tcf15-Venus reporters (Figure 3.7A). Expression of 
Venus was gradually lost when cells spontaneous differentiated towards the 
edge of the colony, as expected. Also, when culturing in 2i medium for 48 
hours, expression of Venus dramatically decreased (Figure 3.21C), consistent 
with the down-regulation of Tcf15 mRNA under 2i conditions (Figure 3.4A). 
Furthermore, confocal microscopic analysis followed by quantification 
demonstrated that Venus expression was negatively correlated with Nanog 
expression but not with Oct4 (Figure 3.22), as had been previously observed 
in the 216D1 Tcf15-Venus cells (Figure 3.8). This confocal microscopic 









Figure 3.21: Venus expression pattern of Tcf15-Het-E6-1 cells 
(A) Flow cytometry analysis was used to compare Venus intensity between 
216D1 Tcf15-Venus cells and Tcf15-Het cells. 
(B) Immunostaining of Tcf15-Het cell plating at clonal density for 5 days. 
Venus was heterogenously expressed within colony and expression was 
loss when cell spontaneously differentiated outward the outside of the 
pluripotent colony (differentiation is assessed here by morphology). 
(C) Flow cytometry analysis of Tcf15-Het cells culturing in LIF + FCS or 2i 
medium.   
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Figure 3.22: Venus expression in Tcf15-Het cells was negatively correlated 
with Nanog, but not with Oct4 expression 
(A) Confocal microscopic analysis of Tcf15-Het cells culturing in LIF and 
serum, staining with Oct4 (top) and Nanog (bottom). 
(B) Quantitative immunofluorescence analysis of Tcf15-Het reporter cells 
stained for Oct4 and Nanog.  
(C) Proportion of cells positive for Tcf15-Het Venus only (green), Oct4 or 
Nanog only (red), or double positive (yellow). 
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To further analyse the population heterogeneity, Tcf15-Het cells were 
sorted by similar gating strategy as described in section 3.2.2.3.1.1. Briefly, 
cells were first gated with FSC and SSC for size and granularity, followed by 
cell doublets exclusion. Then, a live-dead gate was carried out to identify 
DAPI-negative live cells and PECAM1-satining to exclude differentiated cells 
(Figure 3.23A). Tcf15-Het cells were sorted into Venus-high and Venus-low 
populations by the top and bottom 30% of cells (Figure 3.23B). qPCR analysis 
of FACS sorted Venus-high and Venus-low cells showed a clear correlation 
between Venus and Tcf15 (Figure 3.23C). Furthermore, expression of 
pluripotency and differentiation markers showed a similar distribution 
between the two populations as had been previously observed for the 216D1 
Tcf15-Venus cells (Figure 3.7 and 3.9). For example, expression of naïve 
pluripotency genes Nanog and Klf4 and extra-embryonic endoderm marker 
Hex were lower in Venus-high cells and epiblast marker Fgf5 was higher in 
Venus-high cells, but there was no difference between the two populations in 
expression of Oct4 (Figure 3.23C).  
Venus expression within Tcf15-Het cells also displayed dynamic pattern. 
FACS sorted Venus-high and Venus-low cells re-establish heterogeneous 
population within 24 hours after sorting when culturing in self-renewing 
medium containing LIF and serum (Figure 3.23D). Furthermore, FACS sorted 
cells were differentiated under monolayer neural differentiation. qPCR 
analysis showed that Venus-high population in the Tcf15-Het cells 
up-regulated Sox1 expression more quickly than Venus-low population 
(Figure 3.23E), suggesting Venus-high cells in Tcf15-Het were also primed for 
differentiation more rapidly.  
Taken together, the in vitro expression of Tcf15-Het cells is similar in all 
the above-mentioned respects to that of the 216D1 Tcf15-Venus reporter cells, 
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suggesting that Tcf15-Het is a faithful reporter. Furthermore, although 
slightly less sensitive, the use of endogenous promoter to drive Venus 
expression in Tcf15-Het cells made it less subject to gene silencing. Also, the 
consistent results between Tcf15-Het and 216D1 Tcf15-Venus cells also 
















Figure 3.23: Venus expression in Tcf15-Het cells compared to 216D1 cells 
(A) Sequential FACS gating of Tcf15-Het cells and the control E14tg2a cells. 
(B) FACS profile of Tcf15-Het reporter line after PECAM1+ gating. E14tg2a 
cells were used as negative control (black). Top and bottom 30% of 
Tcf15-Het cells (green) were sorted as indicated in the figure. Venus-high 
(blue) and Venus-low (red) populations were analysed right after sort for 
purity check. 
(C) qPCR analysis of FACS sorted Tcf15-Het cells. Venus-high cells displayed 
lower Nanog and Klf4 expression and higher Fgf5 expression with no 
significant difference of Oct4 expression when compared with Venus-low 
cells. 
(D) Flow cytometry analysis of Tcf15-Het cells right after sorting (left) and 24 
hours culturing in LIF and serum after sorting (right). Both population 
re-generate overlapping expression of Venus with 24 hours after sorting. 
(E) qPCR analysis of FACS sorted Tcf15-Het cells under neural 
differentiation. Venus-high cells differentiated to neuronal lineage more 
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3.2.2.3.2.2.2: Lineage-labelled Tcf15-Het cells recapitulate somitic 
expression of Tcf15 in vivo 
In order to further validate if Tcf15-Het cells were faithful reporters of 
Tcf15 expression, an in vivo expression analysis was carried out by using the 
Tcf15-Het cells to generate high-contribution chimaeric embryos. In order to 
identify the Tcf15-Het cells within chimaeras, Tcf15-Het cells were 
transfected with pCAG-mKate2-NLS (NLS stands for Nucleus Localization 
Signal) in order to obtain nuclear mKate2 protein expression as a lineage 
label. mKate2 is a high-brightness, low toxicity far-red fluorescent protein 
suitable for imaging in living tissues (Shcherbo et al., 2009). Transfectants 
were selected with puromycin and 12 clones were picked and amplified. 
These cells lines were designated Tcf15-Het-mK2. In order to test whether the 
lineage label persisted in differentiated cells, the clones were directed to 
differentiate by LIF withdrawal condition for 4 days. Clone #2 was selected 
for morula aggregation (Figure 3.24A) based on its maintenance of high 
mKate2 expression within differentiated cells. 
Morula aggregation of Tcf15-Het-mK2 cells was performed with the help 
of the in house transgenic unit. Chimaeric embryos were dissected at 
somitogenesis stage on E10.5, when Tcf15 was known to be expressed 
specifically in the somites (Kokubu et al., 2004) (Figure 3.24B). The 
Tcf15-Het-mK2 cells contribute widely within the transgenic embryo, as 
shown by mKate2 expression (Figure 3.24C). Moreover, the expression of 
Venus was specifically located in the developing somites (Figure 3.24D), 
perfectly recapitulating the somitic expression of Tcf15 as reported by in situ 
hybridization.  
These results, observed with both in vitro and in vivo analyses, suggest 
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Figure 3.24: Tcf15-Het cells recapitulate the somitic expression of Tcf15 in 
mouse embryo 
(A) Lineage labelled Tcf15-Het-mKate2 cells after 4 days culture in 
complete medium without LIF. mKate2 remained highly expressed 
within nucleus of differentiated cells, as indicated by cell morphology 
in bright field.  
(B) ISH of E10.5 mouse embryo, taken from Kokubu et al., 2004. 
(C) Transgenic embryo at E10.5, mKate2 expression showed that Tcf15-Het 
cells contribute widely to the whole embryo. 




3.3.1: Tcf15 expression in mouse blastocysts 
In this chapter, the in vivo expression of Tcf15 in E4.5 pre-implantation 
mouse blastocysts was identified. Using in situ hybridization, Tcf15 
expression was specifically detected in the ICM compartment, consistent 
with its expression in the in vitro counterpart, ES cells. However, ICM 
consists of both epiblast and primitive endoderm (PrE) cells, which were 
distinct cell types but are not readily distinguishable when using ISH 
analysis. It would be interesting to verify whether Tcf15 is specifically 
expressed in the epiblast by generating reporter mouse line using the new 
Tcf15-Het reporter cells which faithfully reported the somitic expression of 
Tcf15 in vivo (Figure 3.24D). Generation of these reporter mouse lines is 
currently in progress. Our preliminary data indicate that our Tcf15-Het 
(clone E6-1) cells have contributed well to chimaeric mice (10/14 upon 
blastocyst injection, data not shown) and we are currently awaiting 
confirmation of germ line transmission. 
Once the Tcf15 reporter mice become available, immunostaining on the 
reporter blastocysts could be performed, and it would be possible to find out 
whether Tcf15 expression is restricted to a particular compartment of the 
ICM. In addition, although it had been described by single cell qPCR analysis 
that Tcf15 is predominantly associated with the Gata6-negative 
subpopulation during the E3.5 ICM outgrowth (Figure 3.3), only very few 
cells were analysed in the study (Tang et al., 2010).   Therefore, the previous 
RNA expression data could be further confirmed by perform protein-level 
analysis to investigate if Tcf15-Venus expression is associated with 
Nanog-low and Gata6-low population in vivo.    
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Two pieces of data presented in this chapter suggested that Tcf15 is 
expressed at significantly lower level in post-implantation embryos then in 
pre-implantation embryos: qPCR analysis in vivo showed expression of Tcf15 
declined dramatically after embryo implanted around E5.5 (Figure 3.1) and 
post-implantation EpiSCs expressed lower levels of Tcf15 in vitro (Figure 3.4). 
However, it could not be ruled out the possibility that Tcf15 is only 
expressed in a small subset of cells in the post-implantation embryos (e.g. 
epiblasts). It would be therefore informative to perform detailed 
investigation on expression of Tcf15 within post- implantation embryos at 
the single cell level using Tcf15-Venus chimaera. Two ES cell lines could be 
used for the morula aggregation experiments to analyse the expression of 
Tcf15 in vivo: the lineage-labelled line (Tcf15-Het-mKate2) could be used to 
assess the status of Tcf15 expression both in Tcf15-Venus expressing and 
non-expressing labelled cells throughout the embryo; the non-lineage 
labelled line (Tcf15-Het) could be used to assess whether Tcf15 is 
co-expressed with other transcription factors in the early post-implantation 
embryos. Any results from these analyses could then be confirmed in the 
Tcf15-Venus reporter mouse lines, once available. 
 
3.3.2: Tcf15 expression in pluripotent cultures 
Pluripotent cells can exist in a “naïve” state, possibly representing cells 
from the early blastocyst or in a “differentiation primed state” that may 
correspond to cells within the mature blastocyst or the early 
post-implantation epiblast (Nichols and Smith, 2009). Pharmacological 
inhibitors of MEK and GSK-3β can be used to maintain ES cells in a naïve 
state (Ying et al., 2008), whereas culture in FGF2 plus Activin A drives them 
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into differentiation-primed EpiSCs (Tesar et al., 2007, Brons et al., 2007). Tcf15 
expression was analysed in these different self-renewing pluripotent cultures 
from naïve to primed and post-implantation states (Figure 3.4). The results 
showed that cells in a primed state expressed higher levels of Tcf15 than cells 
in naïve pluripotent state or in EpiSC cultures. Time-course 2i to EpiSC 
transition in serum-free media was performed in order to monitor changes of 
Tcf15 as cells move between pluripotent naïve, primed and epiblast states 
whilst avoiding artifactual effects on Tcf15 expression that could result from 
exposure to growth factors present in serum. The transient peak of Tcf15 
expression at early time points during 2i to EpiSC transition raises the 
possibility that Tcf15 might play a role during the transition from a naïve 
pluripotent state to primed state. 
 
3.3.3: Expression level of Tcf15 during differentiation 
Tcf15 expression during cell differentiation including neural, non-neural 
and EB formation was analysed. The expression of Tcf15 persisted after naïve 
genes declined and was downregulated before lineage specific genes began 
to be expressed (Figure 3.5), suggesting any role played by Tcf15 must take 
place during the early stages of differentiation. It is worth noting that Tcf15 
expression slight decreased at day 1 of neural differentiation but was 
sustained at levels similar to ES cells in non-neural differentiation and EB 
formation at day 1. This difference might due to the presence of serum, 
which possibly contained some growth factors to sustain Tcf15 expression, in 




3.3.4: Tcf15 reporter cells 
Two Tcf15-Venus reporter cell lines were used in this study: the highly 
sensitive gene-trapped 216D1 Tcf15-Venus reporter, which Tcf15 transcripts 
were visualized based on the expression of Venus coupled to a unique 
translational amplifier, gtx-IRES, incorporated into the only intron of Tcf15 
(Tanaka et al., 2008) (Figure 3.6B); and the less-sensitive but directly 
gene-targeted Tcf15-Het Venus reporter, which the 1st exon of Tcf15 allele 
was replace by Venus (Figure 3.18). Both Tcf15 reporters exhibit 
heterogeneous Venus expression (Figure 3.8 and 3.22), with negative 
correlation between Tcf15-Venus and naïve pluripotency markers 
Nanog/Klf4, but no negative correlation with the pan-pluripotency marker 
Oct4 expression. The difference in Nanog and Klf4 expression between FACS 
sorted Tcf15-Het cells is smaller than 216D1 Tcf15-Venus cells (Figure 3.9C 
and 3.23). This might due to the experimental design, which was based on 
sorting cells within the top and bottom 30 % of Venus expression. The Venus 
expression in 216D1 cells was amplified by the gtx-IRES cassette where 
Venus expression in Tcf15-Het cells was driven by endogenous Tcf15 
promoter. Therefore, the same 30 % gate in 216D1 cells might be more 
stringent than in Tcf15-Het cells. Therefore, a tighter gating strategy could be 
tried for optimizing the sorting process in the Tcf15-Het reporter cells.  
Even in the continued presence of LIF, a subset of ES cells downregulate 
markers of naïve pluripotency. This subset of ES cells is consequently primed 
toward differentiation (Toyooka et al., 2008, Chambers et al., 2007, Kalmar et 
al., 2009). Recent work shows that some of these Nanog-low cells, marked by 
the endodermal transcription factor Hex, are primed for primitive endoderm, 
but a third population expresses neither Hex nor naïve pluripotency markers 
(Canham et al., 2010). It has been speculated (Canham et al., 2010, Lanner 
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and Rossant, 2010) that this third population is primed for differentiation 
into mature epiblast and therefore ultimately for differentiation into somatic 
cell types, but a marker of this early primed state has proved elusive. Gene 
expression analysis of FACS sorted Tcf15-Venus reporter cells indicate Tcf15 
might mark cells primed for somatic lineages, as Tcf15-high cells expressed 
lower level of naïve marker genes Nanog and Klf4, slightly higher level of the 
epiblast markers Fgf5 and T and slightly lower level of primitive endoderm 
gene Hex.  
Tcf15 activity is likely to be negatively regulated by Id proteins (Figure 
3.11A). The differential gene expression between Venus-high and Venus-low 
cells was intensified when cells were sorted from 24 hours N2B27 culture 
(Figure 3.12), in which Id inhibition is reduced, indicating the 
epiblast-priming effect of Tcf15 might be stronger when Id inhibition was 
removed.  It is known that Id1 overexpression delays the exit from a 
pluripotent epiblast-like state (Malaguti et al., 2013). Therefore, it would be 
very informative to generate a Tcf15/Id1 double reporter cell line to analyse if 
the truly active Tcf15 (Tcf15-high and Id-low population) is more tightly 
associated with the epiblast-primed state.  
Tcf15 heterogeneity was dynamic within pluripotent ES cells, as FACS 
sorted Venus-high and Venus-low cells could re-establish a heterogeneous 
culture within 24 hours in self-renewing conditions (Figure 3.13B and 3.23D).  
In pluripotent cultures containing LIF and serum, Tcf15-high cells were not 
cells that had committed to differentiation, as Venus-high and Venus-low 
cells were both capable to generate AP-positive colonies with no obvious 
difference in colony numbers (Figure 3.14A). However, Tcf15-Venus-high 
cells were functionally primed for differentiation, as cells differentiated more 
efficiently toward neural lineage than the Tcf15-Venus-low subpopulation 
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(Figure 3.15 and 3.23E). It would be therefore interesting to assess if 
Tcf15-Venus-high cells committed to differentiation more quickly when cells 
were released from pluripotent cultures. Commitment assays could be setup 
to challenge cells sorting from LIF and serum: any cell that is more primed to 
differentiation during the "challenge" phase (N2B27 culture for certain time, 
for example: 12, 24, or 48 hours) should be less able to form an 
alkaline-phosphatase-positive colony when plated at clonal density under ES 
cell self-renewal culture conditions (LIF + serum) (Zhou et al., 2013). If 
Tcf15-high cells are marking cells primed for differentiation, they were likely 
to commit to differentiation when releasing from pluripotent culture. 
Another experiment to test if Tcf15 primed ES cells to somatic lineages 
rather than extra-embryonic lineage is to test whether Tcf15-Venus-high cells 
are less efficient at primitive endoderm differentiation. Chimaeric EBs could 
be generated to test the extra-embryonic lineage differentiation ability of 
different Tcf15-Venus populations. Briefly, chimaeric EBs are made by 
mixing wild-type ES cells with FACS sorted mKate2-lineage-labelled 
Tcf15-reporter cells (Tcf15-Het-mK2). EBs are examined at day 4 for 
analysing the contribution of Tcf15-Het cells by assessing the mKate2 
expression. This type of approach was used to show that Hex-high ES cells 
move preferentially to the outside of EBs to form the presumptive visceral 
endoderm (Canham et al., 2010). Therefore, it would be predictable that 
Tcf15-Venuus-high cells should exhibit opposite phenotype compare to 
Hex-reporters, by localizing in the centre of EBs.  
The results of the EB differentiation experiments (Figure 3.16) suggest 
that differentiation is modestly accelerated when initiated from a 
Tcf15-Venus-high state. It is notable that the priming effect of Tcf15 is less 
striking during EB differentiation than in serum-free neural monolayer 
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differentiation (Figure 3.16). However, EB differentiation culture contains 
serum and so it is likely that Tcf15 will be less active in these conditions than 
in serum-free conditions due to presence of Id (see section 3.2.2.3.1.3 and 
figure 3.11C). A future experiment would be to try to identify a non-neural 
directed differentiation protocol where Id expression will be low (e.g. 
endoderm differentiation: N2B27 media containing Activin but without 
BMP). 
Taken together, in this chapter, the expression of Tcf15 during 
differentiation in vitro and during early mouse development in vivo were 
examined. Expression of Tcf15 during early stage of differentiation suggested 
that it might act as a pro-differentiation factor. Tcf15-high cells expressed 
lower level of naïve pluripotency and extraembryonic endoderm markers, 
indicating it might mark the epiblast-primed subpopulation of ES cells and 
identify cells taking the first step toward embryonic rather than 
extraembryonic lineages. To further validate if this differential Tcf15 
expression correlation to any functional difference, I would like to perturb 





Functional characterization of Tcf15 
in mouse embryonic stem (mES) cells 
4.1: Hypothesis: Tcf15 acts as a pro-differentiation factor priming 
mES cells toward somatic lineages 
In chapter 3, the expression pattern of endogenous Tcf15 was analyzed. 
At the single cell level, Tcf15 was expressed heterogeneously within colonies 
of undifferentiated ES cells. Expression of Tcf15 negatively correlates with 
expression of naïve pluripotency markers and extraembryonic markers, 
indicating Tcf15-high cells might represent a new subpopulation within 
pluripotent cell culture, distinct from both the naïve subpopulation 
(Chambers et al., 2003) and the primitive endoderm-primed subpopulation 
(Canham et al., 2010). Moreover, a transient expression window of Tcf15 as 
cells exit a naïve self-renewing state and before they start to acquire 
lineage-specific gene expression may suggest that Tcf15 might play a role in 
the early phase of differentiation. Furthermore, functional analysis of 
differentiation speed between Tcf15-Venus-high cells and Tcf15-Venus-low 
cells confirmed that Tcf15 expression marks a functionally differentiation- 
primed state. 
These observations raise the question of whether Tcf15 is simply a 
marker of primed cells or whether it plays a functional role in driving cells 
towards differentiation. In this chapter, the hypothesis that Tcf15 acts as a 
pro-differentiation factor within pluripotent population, priming mES cells 




Figure 4.1: Schematic diagram illustrating a hypothetical model of possible 
function of Tcf15 in priming cells toward somatic lineages  
ES cells contained Tcf15-high (dark green) and Tcf15-low (light green) 
populations and these two populations are dynamic in pluripotent culture 
(light blue box). However, Tcf15 activity within pluripotent culture was 
blocked by the presence of Id protein. Therefore, Tcf15 might act as a 
pro-differentiation factor within pluripotent population, without driving 
cells to exit pluripotency network. During cell differentiation, expression of 
Id decreased and Tcf15 was able to prime mES cells toward somatic but not 





4.2: Aims of this chapter 
The primary aim of this chapter was to use gain of function and loss of 
function approaches to perturb Tcf15 expression in mES cells in order to 
assess the function of Tcf15 in self-renewal and during differentiation. For 
gain of function studies, Tcf15 inducible cell lines were generated and 
validated. For loss of function studies, siRNA knockdown of Tcf15 
expression was attempted and a strategy to delete both alleles of Tcf15 from 
mouse ES cells was generated. 
 
4.3: Results 
4.3.1: Gain of function studies  
To investigate whether increasing the activity of Tcf15 within pluripotent 
mES cells was sufficient to induce cells toward somatic differentiation, gain 
of function studies were performed. An engineered form of Tcf15 that is 
tethered by a flexible linker of sequence TGSTGSKTGSTGS to its 
hetero-dimerization partner E47 was cloned into 3’-end of a Flag tag. As 
described in section 3.2.2.3.1.3, in the presence of Id proteins, Id dimerizes 
with and sequesters the ubiquitous bHLH transcription factor E12/E47, 
blocking its interaction with Tcf15 (Figure 3.11A). Therefore, this 
forced-dimerization of Tcf15-E47 strategy renders Tcf15 more resistant to 
inhibition by Id (Neuhold and Wold, 1993) and also avoids disrupting the 
balance of endogenous bHLH factors in the cell (Figure 4.2A).  
The Flag-Tcf15-E47 DNA fragment was then sub-cloned into recipient 
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vectors as below. This part of the cloning work was performed by 
Aliaksandra Radzisheuskaya and Paul Nistor in the lab. 
Two different strategies were selected to generate inducible mES cell 
lines over-expressing Tcf15. 
1) FKBP12-derived inducible stabilization system: This strategy is to induce 
Tcf15 expression at post-translational level, by Shld1-induced protein 
stabilization.  
Briefly, the CMV early enhancer/chicken β-actin (CAG) promoter was 
selected for maintaining long term expression of the transgene during 
stem cell differentiation (Alexopoulou et al., 2008). Flag-Tcf15-E47 was 
fused to the C-terminal of FKBP protein containing a destabilizing 
domain (DD) followed by a bicistronic hygromycin resistance gene to 
obtain effective expression. The FKBP-fusion protein was effectively 
targeted for proteasomal degradation unless a stabilizing ligand “Shld1” 
was added to bind and mask the destabilizing domain (Banaszynski et al., 
2006) (Figure 4.2B).  
2) Doxycycline inducible expression system: This strategy is to induce Tcf15 
gene transcription followed by protein expression upon addition of 
doxycycline. 
In short, Flag-Tcf15-E47 was placed under a Tet-responsive promoter 
TetO within a cell line (AW2) (Zhou et al., 2013) that has constitutive 
expression of a reverse tetracycline transactivator (rtTA). In the presence 
of doxycycline, a tetracycline analogue, doxycycline forms a complex 
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with the rtTA protein and this complex was then capable of binding to 
TetO and activating downstream gene expression (Figure 4.2C).  
 
4.3.1.1: Generation of FKBP12-Flag-Tcf15-E47 inducible cell lines 
using Oct4-GiP background 
To generate the FKBP12-Flag-Tcf15-E47 inducible mES cell line, Oct4-GiP 
cells were used. The Oct4-GiP cells expressed bicistronic green fluorescent 
protein (GFP) and puromycin resistance exclusively in pluripotent cells 
under direction of regulatory sequences of the mouse Oct4 gene (Ying et al., 
2002). Puromycin selection of Oct4-GiP cells eliminated differentiated cells 
and thus gave purer starting population when performing experiments on 
heterogeneous mES cells containing a number of spontaneous differentiating 
cells. 
The pCAG-FKBP-Flag-Tcf15-E47-IRES-Hygromycin plasmid was 
transfected into Oct4-GiP cells by liposome-mediated delivery. Cell 
transfectants were selected with hygromycin (50 μg/mL) for 10 days. 91 
hygromycin-resistant single colonies were picked into 96 well plates, 
expanded, and screened for Flag-Tcf15-E47 transgene expression. Clones 
were triplicated plated in 48 well plates: 1 plate was frozen down in -80°C for 
maintaining cell stock, 1 plate for non-stimulation control and the last plate 
was stimulated with 1 μM of Shld1. 
Screening of induction was not possible at mRNA level due to the fact 
that degradation of transgene occurred only at protein level. Therefore, both 
control and Shld1-stimulated plates were fixed with 4% paraformaldehyde 
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after 24 hours of Shld1 stimulation for immunocytochemistry-staining. 
Anti-Flag antibody was used to detect transgene expression. There should be 
no Flag staining in the absence of Shld1 stimulation but positive staining 
after Shld1-inducible stabilization of FKBP-fusion Flag-Tcf15-E47 fusion 
protein. A stable cell line expressing FKBP-Flag-Hes1 served as a positive 
control (Figure 4.3A).  
After screening all of the 91 clones, around 80% of those clones showed 
no induction of transgene expression as no Flag-positive staining could be 
detected after Shld-stimulation under microscopic examination. Very few 
clones, such as clone 25, displayed Flag-positive staining, although at 
relatively lower level when compared with FKBP-Flag-Hes1 cells. The 
nuclear localization of Flag staining suggested that Flag-Tcf15-E47 protein 
located within the nucleus, where it could function as a transcription factor. 
However, the Shld1 induced protein stabilization in clone 25 shown some 
expression of Flag even in the absence of Shld induction (Figure 4.3B), 
indicating some 'leakiness' of expression in un-induced cells. Due to not able 
to pick promising clones in 48 well plate format, the toxicity of transgene 
expression was not further analysed in this screening. 
Therefore, a doxycycline-induction method was selected to over-express 










Figure 4.2: Strategies for generating inducible mES cell lines 
over-expressing Tcf15 
(A) Dox-inducible, Id resistant dominant active Tcf15-E47.  
(B) FKBP12-derived inducible protein stabilization system: TP fused with 
DD undergo degradation in the absence of Shld1. Upon addition of 
Shld1, TP is then maintained in a stable state. DD: destabilizing domain, 
here FKBP1A-L106P, TP: target protein, here Flag-Tcf15-E47. 
(C) Doxycycline inducible gene expression system: Upon addition of 
doxycycline, doxycycline forms complex with rtTA protein and this 
complex is then capable for binding to TetO promoter for activating 




A) FKBP-Flag-Hes1  
 
B) FKBP-Flag-Tcf15-E47: clone 25 
 
Figure 4.3: Immunostaining on FKBP inducible cell lines  
(A) Flag staining (red) and nuclear DAPI staining (blue) of FKBP-Flag-Hes1 
cells +/- Shld1 stimulation. 10x objective lens. 
(B) Staining of FKBP-Flag-Tcf15-E47 clone 25, Flag staining (red) was 




4.3.1.2: Gain of function studies using doxycycline-inducible 
Flag-Tcf15-E47 cell line 
A doxycycline-inducible Flag-Tcf15-E47 cell line was previously made in 
the lab by introducing TetO-Flag-Tcf15-E47 construct into the E14tg2a_AW2 
cell line, which contains the coding sequence for the reverse tetracycline 
transactivator (rtTA) integrated into the Rosa26 locus and expressed from the 
Rosa26 promoter (Zhou et al., 2013). Clone TTE15 (TTE stands for Tet- 
inducible Tcf15-E47) was pre-selected after Flag-staining showed no 
leakiness in the absence of doxycycline induction. Expression of Tcf15 mRNA 
was then examined and compared with the parental E14tg2a_AW2 cell line. 
When compared with parental cells, TTE15 cells displayed negligible 
leakiness of Tcf15 expression without doxycycline induction, and moderate 
(2-3 times higher) overexpression in the presence of 1 μg/mL doxycycline 
(Figure 4.4A). All the following experiments were using 1 μg/mL doxycycline 
to induce transgene expression.  
The expression of Flag-Tcf15-E47 transgene was lost within 24 hours 
after removing doxycycline at both mRNA and protein level (Figure 4.4B). 
Furthermore, Tcf15 expression could be artificially maintained under neural 
differentiation conditions at levels similar to those in ES cells whilst the 
endogenous Tcf15 dramatically decreased after 3 days under the same 
differentiation conditions (Figure 4.4C). Therefore, the clone TTE15 was 
selected for Tcf15 gain of function studies in which Tcf15 expression could be 
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Figure 4.4: Characterization the expression of doxycycline-inducible TTE15 
cells  
(A) qPCR analysis for Tcf15 in dox-inducible TTE15 cells or parental control 
ES cells: 1 day treatment with doxycycline in culture medium containing 
LIF and serum. 
(B) qPCR and western blot to detect Flag-Tcf15-E47 expression in TTE15 ES 
cells after 24 hours induction with doxycycline and 24 or 48 hours after 
removal of doxycycline. 
(C) qPCR analysis for Tcf15 in TTE15 cells during N2B27 monolayer neural 
differentiation. Expression level of Tcf15 was maintained in dox-treated 









































































4.3.1.2.1: Artificially sustained of Tcf15-E47 fusion protein accelerates 
ES cells differentiation and suppresses primitive endoderm lineage 
in neural induction conditions  
TTE 15 cells were used to address the hypothesis that Tcf15 might act as 
a pro-differentiation factor priming ES cells for somatic differentiation. 
TTE15 cells were pre-treated with doxycycline in complete medium 
containing LIF and serum for 24 hours before starting the N2B27 monolayer 
neural differentiation and keep on for entire differentiation. In the presence 
of doxycycline, Tcf15-E47 promotes neural differentiation, as revealed by the 
presence of more neurites in the dox-treated culture compared with 
untreated control culture (Figure 4.5A). Immuno-staining of neuroepithelial 
progenitor cell marker nestin, an intermediate filament protein (Lendahl et 
al., 1990), and Tuj1 (Lee et al., 1990), a neuron-specific class III beta-tubulin, 
revealed that doxycycline-treated TTE15 cells expressed strikingly higher 
level of these two neural markers (Figure 4.5B). 
Tcf15 expression was maintained in dox-treated TTE15 cells at levels 
similar to those in untreated ES cells throughout the differentiation, whist 
untreated TTE15 cells down-regulated Tcf15 to a similar extent as parental 
cells (Figure 4.6A). In addition, up-regulation of neuronal markers Sox1 and 
N-cadherin could be detected from day 2 upon induction while in no-dox and 
parental cells the expression did not begin until one day later (Figure 4.6B). 
Sox1 and N-cadherin expression persisted at higher level until day 5. These 
data further confirm that Tcf15-E47 accelerates neural differentiation. 
Under neural differentiation conditions, a significant subpopulation of 
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cells usually differentiates into non-neural cells that morphologically 
resemble extraembryonic endoderm. To ask whether neural differentiation 
becomes more uniform in response to Tcf15 activation, TTE15 cells were 
induced with doxycycline throughout the neural differentiation process and 
compared with un-induced control cells. Tcf15-E47 therefore might maintain 
the robustness of neural differentiation by suppressing differentiation 
toward primitive endoderm fate, as assessed by morphology (Figure 4.7A) 
and qPCR analysis of primitive endoderm marker Sox7 (Futaki et al., 2004) 




A)                   
Dox day 4                          No dox day 4 
    
B)    
 
Figure 4.5: Forced over-expression of Tcf15-E47 fusion protein promotes 
neuronal differentiation 
(A) Morphology of dox-inducible TTE15 cells under 4 days of differentiation 
in monolayer N2B27 neural induction condition. In the presence of 
doxycycline, there was more neurites outgrowth compared with no-dox 
control cells. 
(B) Tuj1 (green) and nestin (red) staining to detect neurons and neural 
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Figure 4.6: Forced over-expression of Tcf15-E47 fusion protein accelerates 
ES cells differentiation in neural induction condition  
(A) qPCR of parental cells (light grey bars), TTE15 cells no-dox control (dark 
grey bars) and TTE15 cells induced with dox to over-express Tcf15-E47 
(black bars). Endogenous expression of Tcf15 decreased during the 
differentiation process. In the presence of doxycycline, Tcf15 expression 
was maintained at the same level as in the ES cell culture. 
(B) Sox1 and N-cadherin were up-regulated from day 2 in Tcf15-E47 
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Figure 4.7: Forced over-expression of Tcf15-E47 suppresses ES cells 
differentiation to primitive endoderm 
(A) Morphology of dox-inducible cells underwent N2B27 neural 
differentiation at day 4. Dox-treated TTE15 cells showed robust neural 
differentiation with neurites outgrowth from neural epithelium. In 
no-dox control cells, some cells differentiated toward triangular primitive 
endoderm-like lineage.  


























4.3.1.2.2: Transient induction of Tcf15-E47 was sufficient to drive 
differentiation 
Endogenous Tcf15 expression peaks during the first day of 
differentiation and is subsequently downregulated (Figure 3.4). In addition, 
Tcf15 is downregulated in vivo after implantation (Figure 3.1). This led us to 
propose that Tcf15 acts at the earliest stage of differentiation (Figure 4.1). In 
order to further test this hypothesis, it is worth asking whether exogenous 
Tcf15 was acting during the first day of differentiation. 
To answer this question, Tcf15-E47 transgene was induced only for the 
first 24 hours of neural differentiation and compared with induction 
throughout and control un-induced cells (Figure 4.8A). Tcf15 expression was 
sustained in dox-throughout cells, whereas in dox-day 1 withdraw cells 
induction was reduced to similar level to control cells at day 2 (Figure 4.8B). 
More Tuj1+ neurites in dox-treated cultures could be detected from day 2 and 
abundant by the third day in dox-treated, but not control cultures (Figure 
4.8C). This was consistent with previous qPCR analysis (Figure 4.6B), 
suggesting that induction of Tcf15-E47 accelerate neural induction. In 
addition, there were no significant difference between the numbers of 
neurites presenting in dox-throughout and dox treating in the first 24 hours 
cultures. Dox-induced cells also down-regulated Oct4 and E-cadherin 
expression more quickly than un-treated cells, although the speed was 
slightly slower in day 1 dox-withdraw cells. qPCR analysis of Sox1 and 
another neural marker Zfp521 (Kamiya et al., 2011) expression confirmed that 
neural differentiation occurred more rapidly in dox-treated cultures, even 
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when doxycycline was removed after the first 24 hours of differentiation 
(Figure 4.8D). Therefore, Tcf15-E47 is effective at accelerating differentiation 
even if expressed only during the first 24 hours of differentiation. Taken 
together, these results suggest that Tcf15 activity may be a limiting factor at 
an early stage of differentiation.  
 
4.3.1.2.3: Somatic lineage choice was not biased by activation of Tcf15 
The data above suggest that Tcf15 accelerates somatic differentiation and 
suppresses extraembryonic endoderm differentiation in neural inducing 
condition. The next question would be whether Tcf15 was specifically 
promoting the neural lineage or acting in a more general mode to promote 
differentiation into other somatic lineages. The working hypothesis (Figure 
4.1) that Tcf15 drives the initial transition towards somatic fates, would 
suggest that Tcf15 would favour differentiation into epiblast-derived somatic 
lineages without biasing the particular direction of differentiation. In order to 
test whether or not somatic lineage choice was biased by Tcf15, TTE15 cells 
were placed into N2B27 basal media supplied with BMP4 to investigate the 
function of Tcf15 during non-neural differentiation. BMP4 was known to 
suppress neural differentiation (marked by Sox1) in dose-dependent manner 
and instead promote non-neural differentiation (marked by T-Brachyury) 
(Finley et al., 1999). As shown in figure 4.9A, in the absence of BMP4, 
forced-overexpression of Tcf15 promotes neural differentiation whereas in 
the presence of 10 ng/mL of BMP4, Tcf15 promotes non-neural differentiation. 
Tcf15 promotes both neural and non-neural differentiation in the presence of 
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low dose (1 ng/mL) of BMP4, suggesting induction of Tcf15-E47 didn’t bias 
ES cells toward either lineage significantly. Tcf15 therefore does not appear to 
mediate the ability of BMP/Id to suppress neural induction (Ying et al., 2003) 
but may mediate the earlier role of Id to inhibit the transition of ES cells to 
differentiation-primed epiblast (Zhang et al., 2010) (see these two transitions 






































   
Figure 4.8: Transient induction of Tcf15-E47 is sufficient to drive 
differentiation  
(A) Experimental design to test how transient induction of Tcf15-E47 
expression affects cell differentiation.  
(B) qPCR of Tcf15 expression from day 2 to day 4 during neural 
differentiation. 
(C) Immunostaining of Tcf15-E47 dox-inducible cell line cultured in N2B27 
medium, showing neurite marker Tuj1 in green and nucleus stained by 
DAPI in blue.  
(D) qPCR analysis from day 2 to day 4 of neural differentiation. Neural 
differentiation was accelerated in dox-treated cells with up-regulation of 
Sox1 and Zfp521 and more rapidly loss of E-cadherin and pluripotent gene 
Oct4. Withdraw dox-treatment from day 1 of differentiation still 
promoted neural induction but the down-regulation of Oct4 was slower 









































































































    
B) 
 
Figure 4.9: Somatic lineage choice was not biased by activation of Tcf15 
(A) qPCR analysis of Tcf15-E47 inducible cells cultured in N2B27 medium 
containing different dose of BMP to block neural differentiation and 
promote non-neural differentiation. (N=2, n=2)  
(B) Tcf15 was acting at early stage of ES cells differentiation, possibly by 




















































4.3.1.2.4: Tcf15 drives the transition to primed epiblast 
In order to ask whether Tcf15 favours the transition to a 
differentiation-primed epiblast-like state, more directly experiments were 
setup to test this hypothesis. ES cells cultured in LIF and serum (FCS) or LIF 
and BMP are restrained from progressing to overt differentiation but free to 
explore naïve and primed states of pluripotency (Nichols and Smith, 2009). 
TTE15 cells were cultured in LIF and serum with induction of Tcf15-E47 for 3 
days to ask whether Tcf15-E47 can drive the transition to a primed state. 
Under this long term persistent activation of Tcf15, Tcf15-E47 was able to 
significantly down-regulate markers of naïve ES cells and up-regulate the 
epiblast marker Fgf5 (Figure 4.10). Tcf15-E47 also down-regulated 
extraembryonic endoderm marker Sox7 expression in the pluripotent culture. 
On the other hand, long-term induction of Tcf15-E47 expression in LIF and 
serum didn’t drive cells irreversibly toward differentiation, as cells could be 
passaged in the presence of doxycycline for several passages without losing 
pluripotency. This suggested that in this culture condition, Tcf15 only 
maturated cells toward primed state but did not drive cells toward 
differentiation.  
To further understand if Tcf15 drives pluripotent cells from naïve to 
primed epiblast, ES cells were converted into Epiblast stem cells (EpiSCs) by 
culturing cells from 2i/LIF to N2B27 + FGF2 + Activin (Hayashi et al., 2011). 
Endogenous Tcf15 expression was low in 2i culture and was up-regulated 
after cells were plating in the EpiSC medium (Figure 4.11A). Epiblast-like 
cells were achieved by monitoring the expression of epiblast determinant 
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gene Otx2 and epiblast marker Fgf5. Otx2 and Fgf5 were up-regulated during 
2i to EpiSC transition and induction of Tcf15-E47 promoted Fgf5 expression 
significantly at day 1 while slightly increased Otx2 expression. Tcf15-E47 did 
not appear to accelerate the loss of naïve pluripotency marker Klf4, but this is 
likely because Klf4 was down-regulated very rapidly under this EpiSC 
transition even in the absence of exogenous Tcf15. Nanog was 
down-regulated within 1 day of EpiSC transition, in consistent with 
published data (Hayashi et al., 2011). The expression was up-regulated again, 
which might indicate cells were maturating to more proximal posterior 
pre-gastrulating epiblast-like identity (Malaguti et al., 2013; Osorno et al., 
2012), as indicated by Wnt3 and Eomes expression (Brennan et al., 2001).  
Induction of Tcf15-E47 increased Otx2 and Fgf5 expression during the 2i 
to EpiSC transition suggested that Tcf15 might have an early function during 
the EpiSC transition. However, the rapid loss of naïve pluripotency marker 
and acquisition of epiblast marker genes expression during 2i to EpiSC 
transition indicated that the exit from a naïve state might occurs at an even 
earlier time point. Therefore, the 8 hour and 12 hour time points during the 
2i to EpiSC transition were selected for further investigation. Tcf15-E47 
significantly accelerates up-regulation of epiblast marker Fgf5 and 
suppresses expression of primitive endoderm marker Sox7 (Figure 4.11B), for 
which expression was only up-regulated transiently during these early time 
points. The transient up-regulation of Fgf5 and down-regulation of Sox7 
further suggest that Tcf15 acts during early stage of ES cells transition to 
differentiation-primed epiblast but not extraembryonic endoderm. 
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Unlike culturing in LIF and serum, induction of Tcf15-E47 expression in 
N2B27 + LIF + BMP drove irreversible commitment to differentiation in a 
significant proportion of cells even in the continued presence of LIF and BMP 
(Figure 4.12A). A 24 hour pulse of doxycycline induction also displayed 
similar phenotype. In 24 hours pulse-dox cells, cells differentiated into mixed 
cultures, these cells were morphologically similar to cells from which LIF 
had been withdrawn. This suggests that Tcf15-E47 may prime cells toward 
differentiation by driving the loss of LIF responsiveness, which is a 
characteristic feature of the transition toward post-implantation EpiSC 
(Brons et al., 2007; Tesar et al., 2007). Moreover, cells exhibit more 
mesenchymal-like phenotype when continuous inducing Tcf15-E47 
expression for 4 days, indicating Tcf15 might also promote EpiSC to further 
differentiation depend on environmental cues, although more experiments 
need to be performed to validate this hypothesis. 
Taken together, the gain of function studies confirmed that Tcf15 mature 
naïve pluripotent ES cells transit toward primed epiblast and later on 
epiblast-derived somatic lineages whilst suppressing differentiation towards 





Figure 4.10: qPCR analysis of dox-inducible TTE15 ES cells after 3 days in 
LIF and serum culture 
Persistent induction of Tcf15-E47 within ES cells down-regulated naïve 
pluripotency genes Nanog, Klf4 and Esrrb without changing Oct4 expression. 
Tcf15-E47 induction also up-regulated epiblast marker Fgf5 and reduced 
































































































































































































































































Figure 4.11: Tcf15 drives the transition to primed epiblast and suppresses 
cells toward extraembryonic lineage 
(A) Day 0 to day 2 qPCR analysis of TTE15 cells in 2i-to-EpiSC transition. 
(N=2, n=2). 
(B) qPCR analysis of TTE15 cells in 2i-to-EpiSC transition at 8 and 12 hours. 
Induction of Tcf15-E47 at early time point of EpiSC transition 
up-regulated epiblast marker Fgf5 expression and suppressed 
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Figure 4.12: Tcf15 drives the transition to primed epiblast 
(A) Dox-inducible Tcf15-E47 ES cells after 4 days in N2B27 + LIF + BMP4 
only, with 24 hours pulse of dox-treatment during the first day, and in 
N2B27 + LIF + BMP4 + Dox. 
(B) Possible function of Tcf15: Tcf15 promote ES cells transition to EpiSCs by 
suppression cells toward extraembryonic lineage. Tcf15 might also 
promote EpiSC to further differentiation, although more experiments 




4.3.2: Loss of Function studies  
4.3.2.1: siRNA knockdown of Tcf15 in mES cells 
Loss of function studies were perform to further test the hypothesis that 
Tcf15 primes pluripotent cells towards epiblast. siRNA was first used to 
knockdown Tcf15 expression in mES cells. Two strategies of 
liposome-mediated siRNA knockdown were used, with relative genomic 
orientation displayed in Figure 4.13:  
1) Single hairpin knockdown with 4 hairpins against mouse Tcf15 from 
Qiagen, with negative control siRNA conjugated with Alexa-488. 
2) Pooled hairpins against mouse Tcf15 from Dharmacon to achieve reduced 
off-target effect, with non-targeting negative control siRNA pool.  
 
4.3.2.1.1: Qiagen siRNA knockdown of Tcf15 in mES cells gives poor 
knockdown efficiency 
To test the knockdown efficiency of Qiagen siTcf15 hairpins, E14tg2a cells 
cultured in complete medium containing LIF and serum were transfected 
with siTcf15 hairpin 1-4 and negative control hairpin in different combination 
of siRNA concentrations and transfection reagents according to 
manufacturer’s instruction. A mock transfection was also included in the 
experiments. Transfection efficiency was observed by the cytosolic expression 
of Alexa-488 conjugated control siRNA (Figure 4.14A). Cells were collected 
after 24 hours of transfection for qPCR analysis of Tcf15 expression. As shown 
in figure 4.14B, among different combination of siRNA and transfection 
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reagent HiPerfect (HP), Tcf15 only had been knockdown in 10 nM siRNA 
with 6 μL HP treatments. Hairpin 1, 3 and 4 showed 30% of knockdown 
efficiency compared with Alexa-488 negative control. Therefore, this 10 nM 
siRNA with 6 μL HP combination was selected to further analyze the 
knockdown efficiency between 4 hairpins for longer time. However, the 
knockdown of Tcf15 was gradually lost after day 2 of transfection, with no 
significant difference with control and mock cells at day 3 (Figure 4.14C). In 
order to improve knockdown efficiency, cells were transfected with siRNA in 
different culture conditions from serum-containing ES complete medium to 
serum-free N2B27 based medium including LIF + BMP (self-renewing) or 
FGF2 + Activin (EpiSC) medium (Figure 4.15A). Nevertheless, the 
knockdown efficiency was poor and always lost after day 2 (Figure 4.15B and 
4.15C). Taken together, the knockdown efficiency of Qiagen hairpins were 






Figure 4.13: Genomic position of Tcf15 siRNAs on Tcf15 coding region  
Mouse Tcf15 mRNA transcript (NM_009328) consisted of 949 nucleotides. 
The mature mRNA was shown in green in this figure. GeneSolution Tcf15 
siRNAs 1-4 from Qiagen (sequence unknown) was labelled with blue bars 
with hairpin numbers indicated by the manufacturer. Dharmacon pooled 










Figure 4.14: Qiagen siRNA knockdown of Tcf15 in serum-containing 
cultures  
(A) Transfection efficiency by Alexa-488 expression within cells, showing 
here 10nM RNAi with 6μL HP. 
(B) qPCR analysis of Tcf15 expression after 24 hours of transfection in 
different combination of siRNA hairpins and transfection reagent 
HiPerfect (HP).  
(C) qPCR analysis of Tcf15 expression from ES cells transfected with 10 nM 


































































Figure 4.15: Qiagen siRNA knockdown of Tcf15 in serum-free cultures 
(A) Experimental design of transfecting cells in serum-free media. 
(B) qPCR analysis of Tcf15 expression on cells transfected with siRNA in 
N2B27 medium containing LIF and BMP. (N=2, n=2) 
(C) qPCR analysis of Tcf15 expression on cells transfected with siRNA in 


























































4.3.2.1.2: Dharmacon siRNA knockdown of Tcf15 in mES cells gives 
good knockdown efficiency at mRNA level but not at protein level 
 Dharmacon smart-pool hairpins against Tcf15 were purchased after I 
failed to knockdown Tcf15 expression using single siRNA hairpins from 
Qiagen. Pooled siRNA mixture was selected to decrease off-targets effect and 
enhance siRNA effectiveness, according to manufacturer’s instructions. 
E14tg2a cells were transfected with 25 nM pooled anti-Tcf15 siRNA or control 
non-targeting siRNA together with mock transfected cells in complete 
medium containing LIF and serum according to manufacturer’s instruction. 
Cells were collected after 2 and 3 days of transfection for qPCR analysis. 
Tcf15 mRNA was reduced by 75% at 2 days and 30% at day 3 after 
introducing siRNA into ES cells (Figure 4.16A). The transient knockdown of 
Tcf15 was lost after day 2 and expression of Tcf15 was restored at day 3 after 
transfection. Tcf15 protein expression was only slightly lower in knockdown 
cells at day 3 after siRNA transfection (Figure 4.16B). Despite this very 
moderate reduction of Tcf15 protein expression, I decided to go ahead and 
test whether this slight reduction in Tcf15 expression would affect the ES to 
EpiSC transition. Cells were re-plated from LIF + FCS into EpiSC medium 
after 2 days of siRNA transfection. Although knockdown of Tcf15 mRNA 
persisted until day 2 of EpiSC transition (4 days after transfection), Fgf5 
expression only had been slightly down-regulated at day 1 of EpiSC 
transition. In addition, no significant difference of Nanog and Klf4 expression 
could be observed (Figure 4.16C).  This suggested that although the 
knockdown on mRNA level was significant, the small and transient 
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suppression of Tcf15 at protein level might not be enough to generate any 
significant phenotype. Since functional analysis of Tcf15 was likely to require 
a stronger and more sustained knockdown during the differentiation 
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Figure 4.16: Dharmacon pooled siRNA knockdown of Tcf15  
(A) qPCR analysis of Tcf15 expression on E14tg2a cells transfected with 25 
nM pooled anti-Tcf15 siRNA or non-targeting control siRNA.  
(B) Western blot analysis of Tcf15 expression after 2 days of siRNA 
transfection, using tubulin as loading control. 
(C) Gene expression from EpiSC transition of siRNA-transfected cells. 0 hour 
EpiSC time point equaled to 2 days after siRNA transfection in ES 







































































































































4.3.2.2: Generating Tcf15 knockout cell lines 
Chapter 3 described Tcf15-Het reporter cells which were generated by 
introducing the targeting construct pSKO to remove exon 1 of Tcf15 allele 
and replace it with the coding sequence for the fluorescence protein Venus 
followed by FRT-flanked double selection cassettes including a PGK-neomycin 
resistant gene for positive selection with G418 and a MC1-TK (thymidine 
kinase) for negative selection with ganciclovir (Figure 3.18). This targeting 
strategy created a heterozygous Tcf15 allele. Therefore, the same pSKO 
targeting construct could be used to target the second Tcf15 allele within 
Tcf15-Het cells and make Tcf15 knockout cells.  
In this section, gene expression in Tcf15-Het clones was analysed to see 
whether loss one allele of Tcf15 has any phenotypic consequence on 
pluripotent cells. Next, a strategy to remove the selection cassette of 
Tcf15-Het clones and perform new round of gene targeting was described. 
All the different targeted Tcf15 alleles with or without selection cassette are 




A) Wild-type: Tcf15+/+ 
 
 
B) Tcf15-Het: Tcf15+/Venus  
 
C) Tcf15-Het-Frted: Tcf15+/VenusFRT 
 
 
D) Tcf15-KO: Tcf15Venus/VenusFRT 
 
 






Figure 4.17: Illustration of all the different targeted Tcf15 alleles in ES cells 
Genomic orientation of wild-type and Tcf15-targeted cells with specific 
location of southern blot probes: Tcf15-3’, Tcf15-internal and Venus. Venus 
and Tcf15-internal probe recognized sequence within the targeting construct 
(showing in figure 3.18). Tcf15-3’ probe recognized sequence outside the 
targeted region. EcoRV: EcoRV cutting sites. 
(A) Wild-type Tcf15 allele. 
(B) Tcf15-Het cells before removing selection cassette. 
(C) Tcf15-Het-FRTed cells are Tcf15-Het cells after removing the selection 
cassette. This is the Tcf15-Het-Venus reporter cells been analysed in this 
thesis (clone E6-1). 
(D) Tcf15 knockout (Tcf15-KO) cells before removing selection cassette. 





4.2.2.2.1: Expression of Tcf15 in heterozygous Tcf15-Het cell lines 
As described in chapter 3, 9 independent Tcf15 heterozygous clones 
(Tcf15-Het clones, Figure 4.17B) were obtained after a first round of gene 
targeting, which were clone A29, D4, D22, D34, D43, E5, E6, E39 and E48 
(now referred to as Het-A29, Het-D4, Het-D22, Het-D34, Het-D43, Het-E5, 
Het-E6, Het-E39 and Het-E48, respectively). Gene expression of Tcf15-Het 
cells (Tcf15+/Venus) was analyzed in order to see if there was any difference 
between Tcf15-Het cells and wild-type cells. Tcf15-Het cells expressed 30-40% 
of Tcf15 transcript compared with parental E14tg2a cells (Figure 4.18A). This 
result, together with the heterogeneous Venus expression as shown in figure 
3.20, indicated that both Tcf15 alleles were actively transcribed within 
pluripotent LIF and serum culture and loss of one allele reduced half of Tcf15 
expression compared with parental wild-type control. Nanog expression was 
increased by 30% in Tcf15-Het clones whist Oct4 expression was not affected 
(Figure 4.18B). Expression of naïve pluripotency maker Nanog and Klf4 were 
increased in Tcf15-Het clone E6 and expression of the epiblast marker Fgf5 
was lower (Figure 4.18C). These data are in keeping with the decrease in 
Nanog and Klf4 and the increase in Fgf5 observed after overexpression of 
Tcf15 in ES cells (Figure 4.10A). These data indicate that loss one allele of 











Figure 4.18: Gene expression of Tcf15-Het cells 
(A) and (B) qPCR analysis of gene expression on Tcf15-Het cells culturing in 
LIF and serum. (N=2, n=2) 
(C) Comparison of gene expression between Tcf15-Het-E6 cells and parental 















































































































































































































































































4.2.3.2.2: Using FlpO/FRT to remove the selection cassette from 
Tcf15-Het cells 
To carry on generating Tcf15 knockout cell line, 3 independent Tcf15-Het 
clones A29, D4 and E6 were selected for deletion of the second Tcf15 allele. 
The selection cassette was first excised from Tcf15+/Venus cells by 
FlpO-mediated recombination (details described in section 2.2.4.8) so that the 
same targeting vector could be reused for targeting the second allele of the 
Tcf15 gene. Only clones which were G418-sensitive and ganciclovir-resistant 
were selected for further analysis. 
Genomic DNA was digested with EcoRV to perform Southern blot. Cells 
losing the selection cassette displayed a 10.1 kb band whilst cells retaining 
the selection cassette display an 8.3 kb band when probing with 
Tcf15-internal probe (Figure 4.17 and Figure 4.19A). The blot was stripped 
and re-probed with Venus probe to better distinguish the Tcf15Venus and 
Tcf15VenusFRT alleles, which were 4.6 kb or 10.1 kb respectively (Figure 4.19B). 
Southern blot analysis of Tcf15-Het-Frted cells (Tcf15+/VenusFRT, Figure 4.17C) 
identified 2 clones from Tcf15-Het-A29 (Het-A29-2 and Het-A29-10), 2 clones 
from Tcf15-Het-D4 (Het-D4-4 and Het-D4-5) and 7 clones from Tcf15-Het-E6 
(Het-E6-1 to Het-E6-7) with correct 10.1 kb band for Tcf15-internal probe and 





A) Tcf15 internal probe 
 
B) Venus probe 
 
Figure 4.19: Southern blot analysis of Tcf15-Het cells after FlpO 
transfection to remove the selection cassette (Tcf15VenusFRT/+ cells) 
(A) gDNA from Tcf15-Het-Frt cells, wild-type E14tg2a cells and Tcf15-Het 
cells (clone A29, D4 and E6) probing for Tcf15 internal probe. In addition 
to 9.5 kb band for wild-type Tcf15 allele (black arrow), Tcf15-Het-Frt cells 
with selection cassette correctly removed will display a 10.1 kb band 
(green arrow) for Tcf15VenusFRT allele instead of an 8.3 kb band (red arrow) 
for Tcf15Venus allele. Clones which had 10.1 kb Tcf15VenusFRT allele were 
marked with *.  
(B) gDNA from Tcf15-Het-Frt cells, wild-type E14tg2a cells and Tcf15-Het 
cells (clone A29, D4 and E6) probing for Venus probe. Wild-type Tcf15 
allele showed no Venus band, Tcf15-Het-Frt cells displayed a 10.1 kb 
band (green arrow) for Tcf15VenusFRT allele instead of a 4.6 kb band (red 
arrow) for Tcf15Venus allele. Clones which had 10.1 kb Tcf15VenusFRT allele 
were marked with *.  
 
Both Tcf15-internal probe and Venus probe identified same Tcf15-Het-Frt 




4.2.3.2.3: Generating Tcf15-null cells (Tcf15Venus/VenusFRT)  
Tcf15-Het-A29-2, Het-D4-4 and Het-E6-1 cells were electroporated with 
100 μg of ScaI-linearized pSKO to perform a second round of Tcf15 gene 
targeting. Electroporated cells were selected with G418 (300 μg/ml) and over 
103 colonies were formed by day 8 of selection. Owing to the same targeting 
construct being used for targeting, there were longer homology arms in the 
targeted allele than the wild-type allele. Therefore, a lower targeting 
efficiency of the wild type allele was expected. As a result, approximately 300 
clones were picked from each Tcf15-Het-Frted cells and overall 900 clones 
were expanded from 96 well formats. Clones were passaged to 24 well plates 
whereupon replica plates were made and frozen at -80°C. Genomic DNA of 
these Tcf15-KO (KO stands for knockout) cells was isolated and digested 
with EcoRV.  
In order to save time and perform high efficiency Southern blot 
screening of 900 Tcf15-KO clones, 90 digested samples were run in the same 
agarose gel simultaneously and transferred on a membrane. However, the 
DNA resolution of agarose gel was reduced due to shortened separation 
distance. Therefore, instead of probing with Tcf15 probes, membranes were 
pre-screened by hybridization with the Venus probe which gave a 4.6 kb 
band for Tcf15Venus allele and 10.1 kb band for Tcf15VenusFRT allele (Figure 4.17D). 
A significant proportion of KO cells (around 25%) gave double bands which 
might indicate correct targeting of the second allele with the pSKO construct 
(data not shown). However, after probing with Tcf15 3’-probe, only 3 clones 
displayed correct 8.3 kb band for Tcf15Venus allele and 10.1 kb band for 
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Tcf15VenusFRT allele (Figure 4.20), indicating all the other non-targeted clones 
with correct Venus bands might be cells with random-integration of targeting 
construct. Taken together, the targeting efficiency decreased from 5% of 
Tcf15-Het cells (9/190) to about 0.33% of Tcf15-KO cells (3/900). 
The three Tcf15-KO clones were named as shown in figure 4.21. Clone 
I10 was made from Tcf15-Het-D4-4 (Now refer to Tcf15-KO-DI10 to indicate 
the parental Tcf15-Het-D4 line) and clone A9 and E8 were made from 
Tcf15-Het-E6-1 (Now refer to Tcf15-KO-EA9 and Tcf15-KO-EE8 to indicate 
the parental Tcf15-Het-E6 line). After further validation (e.g. characterizing if 
clone DI10 is normal or not, as additional band was identified by Southern 
blot) of these Tcf15-KO clones, these cells will be analysed in future studies to 




















Figure 4.20: Southern blot analyses identified Tcf15-KO cells 
(A) gDNA from wild-type E14tg2a cells, Tcf15-Het cells (Het-E6 and Het-D4), 
Tcf15-Het-Frt cells (Het-E6-1 and Het-D4-4) and Tcf15-KO cells were  
hybridized with Venus probe. Targeted Tcf15Venus allele which retained the 
selection cassette displayed 4.6kb band (red arrow). Tcf15VenusFRT allele 
which selection cassette had been correctly removed displayed a 10.1 kb 
band (green arrow). The correctly targeted Tcf15-KO cells (KO-EA9, 
KO-EE8 and KO-DI10) contained a 10.1 kb band (green arrow) for 
Tcf15VenusFRT allele and a 4.6 kb band (red arrow) for Tcf15Venus allele. 
Corrected Tcf15-KO clones were marked with *. 
(B) gDNA from wild-type E14tg2a cells, Tcf15-Het cells, Tcf15-Het-Frt cells 
and Tcf15-KO cells were  hybridized with Tcf15-3’ probe. Wild-type 
Tcf15 allele displayed a 9.5 kb band (black arrow). Tcf15-Het cells (Het-E6 
and Het- D4) which retain the selection cassette displayed 8.3 kb band 
(red arrow) for Tcf15Venus allele and a wild-type Tcf15 allele. Tcf15-Het-Frt 
cells (Het-E6-1 and Het- D4-4) with selection cassette correctly removed 
will display a 10.1 kb band (green arrow) for Tcf15VenusFRT allele instead of 
Tcf15Venus allele. The correctly targeted Tcf15-KO cells contained a 10.1 kb 
band (green arrow) for Tcf15VenusFRT allele and an 8.3 kb band (red arrow) 






Figure 4.21: Three Tcf15-KO cells from two independent parental 
Tcf15-Het lines 
The three Tcf15-KO cell lines identified by southern blot are named 
according to their parental Tcf15-Het clones. D stands for Tcf15-Het-D4 and E 





4.4: Discussion:  
In this chapter, gain of function studies and preliminary loss of function 
studies were used to validate the hypothesis that Tcf15 acts as a 
pro-differentiation factor within pluripotent population, priming mES cells 
toward somatic but not extraembryonic lineages (Figure 4.1).  
 
4.4.1: Generation of Tcf15-E47 inducible cell lines 
To perform gain of function studies, two different inducible systems 
were selected for investigating the function of Tcf15 in a regulated and 
reversible manner. However, the FKBP12-Flag-Tcf15-E47 inducible cell lines 
exhibited some extent of ‘leakiness’ in the absence of stabilizer Shld1 (Figure 
4.3B). This insufficient target protein degradation might due to steric 
hindrance generated within the fusion FKBP12-Flag-Tcf15-E47 protein. Also, 
the protein expression was not homogeneous, as seen in figure 4.3B. 
Therefore, a doxycycline-induction method was selected to over-express 
Tcf15 within ES cells.   
The doxycycline inducible TTE15 cell line displayed negligible leakiness 
of Tcf15 expression and moderate overexpression in the presence of 
doxycycline (Figure 4.4A). The addition of doxycycline induced Tcf15 mRNA 
and protein expression within 24 hours (Figure 4.4B). To obtain sufficient 
induction of Tcf15 expression at the onset of differentiation, TTE15 cells were 
pre-treated with doxycycline in complete medium containing LIF and serum 
for 24 hours before initiating differentiation. Without pre-treatment of 
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doxycycline to induce Tcf15-E47 expression (i.e. when doxycycline was only 
added at the time that differentiation was initiated), the promotion of neural 
differentiation was reduced (data not shown). This is likely because 
doxycycline takes time to induce protein expression and the up-regulation of 
Tcf15-E47 after cells proceed to differentiation is less effective compared to 
pre-treated cells. This is consistent with the idea that Tcf15-E47 is acting at 
early stage of neural differentiation and serves as a pre-deposited 
pro-differentiation factor. 
 
4.4.2: Tcf15-E47 accelerates somatic differentiation and suppresses the 
primitive endoderm lineage 
4.4.2.1: Tcf15-E47 fusion protein accelerates ES cells differentiation in 
neural induction conditions  
Forced overexpression of the Id-resistant Tcf15-E47 fusion protein 
promoted ES cells to differentiate into the neural lineage, as shown by cell 
morphology and marker gene/protein expression (Figure 4.5 and 4.6). It has 
been proposed that ES cells neural differentiation occurs in two stages: first 
from ES cells to differentiation-primed EpiSCs-like stage and then from 
primed EpiSCs to neural precursor cells (NPCs) (Zhang et al., 2010). These 
two transitions correspond to the ICM to egg cylinder-epiblast transition and 
the egg cylinder-epiblast to neural ectoderm transition, respectively.  
Tcf15-E47 is effective at accelerating differentiation even if expressed 
only during the first 24 hours of differentiation (Figure 4.8), suggesting the 
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function of Tcf15 in promoting ES cells to differentiation-primed EpiSCs-like 
stage during neural differentiation. It might also be interesting to analyse if 
Tcf15 could promote EpiSCs to NPCs differentiation, although endogenous 
expression of Tcf15 in EpiSCs was much lower than in ES cells cultured in LIF 
and serum (Figure 3.4A). However, the window of EpiSC to NPC 
differentiation was hard to capture in the direct ES cells neural differentiation 
protocol. Therefore, it would be better, in future studies, to generate 
doxycycline-inducible Tcf15-E47 EpiSC lines in vitro and perform direct 
EpiSC to neural differentiation (Najm et al., 2011).   
 
4.4.2.2: Tcf15-E47 fusion protein suppresses primitive endoderm gene 
expression  
In vitro, ES cells can generate primitive endoderm (PrE)-like cells either 
in response to LIF withdrawal (Niwa et al., 2000) or through forced 
expression of the transcription factors Gata4 or Gata6 (Fujikura et al., 2002; 
Shimosato et al., 2007). These background levels of PrE gene expression 
might lead to subpopulation of cells differentiating into non-neural cells that 
morphologically resemble extraembryonic endoderm in direct N2B27 neural 
differentiation condition. Induction of Tcf15-E47 maintained the robustness 
of neural differentiation by suppressing differentiation toward primitive 
endoderm fate (Figure 4.7). Moreover, persistent induction of Tcf15-E47 
within ES cells cultured in LIF and serum also down-regulated 
extraembryonic endoderm marker Sox7 expression, suggesting Tcf15-E47 
push pluripotent cells away from extraembryonic endoderm-primed 
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population (Figure 4.1).  
 
4.4.2.3: Somatic lineage choice was not biased by activation of Tcf15 
The ability of Tcf15 to accelerate differentiation was not restricted to the 
neural lineage. Somatic lineage choice did not appear to be biased 
significantly by Tcf15 as measured by the dose-dependent ability of BMP to 
suppress neural differentiation and instead promote non-neural 
differentiation (Figure 4.9). Induction of Tcf15-E47 expression promotes 
neural differentiation in the absence of BMP and promotes non-neural 
differentiation in the presence of BMP. However, BMP is known to induce Id 
expression and Id protein acts as negative regulator of Tcf15 activity. 
Therefore, this doxycycline-induced Tcf15-high and BMP-induced Id-high 
situation is likely unable to exist in vivo. Thus, in future studies, it would be 
informative to use a BMP-free non-neural differentiation condition such as 
endoderm differentiation using serum free medium supplemented with 
Activin in order to provide an Id-low condition to further test if Tcf15 
promotes ES cells differentiation in this condition as well. 
 
4.4.2.4: Induction of Tcf15-E47 expression in different pluripotent 
cultures 
The effect of induction Tcf15-E47 expression in pluripotent ES cells 
cultures, either in LIF + serum condition or in serum-free N2B27 + LIF + BMP 
condition was investigated. Persistent activation of Tcf15-E47 in LIF + serum 
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culture didn’t drive cells toward differentiation, but significantly 
down-regulates naïve pluripotency markers expression and up-regulates 
epiblast marker in ES cells (Figure 4.10). However, induction of Tcf15-E47 
expression in N2B27 + LIF + BMP drove irreversible commitment to 
differentiation in a significant proportion of cells (Figure 4.12A). This 
indicates that Tcf15-E47 could functionally antagonize the extrinsic 
anti-differentiation signals. I propose that Tcf15-E47 may drive the loss of LIF 
responsiveness, which is a characteristic feature of the transition toward 
post-implantation EpiSCs (Brons et al., 2007; Tesar et al., 2007). Future 
experiment would be to verify if induction of Tcf15-E47 expression affects 
phospho-STAT3 activation after LIF stimulation with or without JAK 
inhibitor pre-treatment (Tesar et al., 2007). 
It was also observed that pulse-induction of Tcf15-E47 in ES cells 
cultured in N2B27 + LIF + BMP displayed distinct phenotype when 
compared with induction throughout (Figure 4.12A). When continuous 
inducing Tcf15-E47 expression for 4 days, some cells exited pluripotency and 
displayed mesenchymal-like morphology. This observation gave the 
possibility that in addition to triggering the loss of LIF responsiveness, Tcf15 
might also promote cells to further differentiation depend on environmental 
cues. More experiments would be needed to test this hypothesis (Figure 
4.12B), for example, as described in section 4.4.2.1, in vitro derivation of 





4.4.2.5: Tcf15 drives the transition to primed epiblast 
It is demonstrated that induction of Tcf15-E47 during 2i to EpiSC 
transition promoted epiblast marker gene Otx2 and Fgf5 expression at day 1 
(Figure 4.11A). Also, during early time point of 2i to EpiSC transition, 
Tcf15-E47 up-regulated Fgf5 expression and suppressed expression of 
primitive endoderm marker Sox7 (Figure 4.11B).  The re-activation of Nanog 
and up-regulation of Wnt3 and Eomes expression at later time points 
indicated that cells were maturating to more proximal posterior 
pre-gastrulating epiblast-like identity. Induction of Tcf15-E47 did not 
up-regulated Nanog expression at day 2 but dox-treated cells expressed 
higher levels of Wnt3 and Eomes.  
The preliminary loss of function data displayed reciprocal results to the 
overexpression data: loss of one allele of Tcf15 expression in Tcf15-Het cells 
within pluripotent population seems to promote at least some aspects of a 
naïve pluripotent gene expression signature (Figure 4.18). Based on our 
results from generation of Tcf15-Het chimaeric mice (Section 3.3.1), ES cells 
that have lost one allele of Tcf15 are capable of proceeding normal 
developmental process. However, minor effects on the kinetics or efficiency 
of development in these cells would not have been picked up in these 
experiments. 
Tcf15-null ES cells have not yet been examined. Tcf15-null embryos do 
survive to birth, but die shortly afterward as a consequence of 
muscular-skeletal defects due to the failure in somite morphogenesis earlier 
in development (Burgess et al., 1996). Is it possible that there is an earlier 
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phenotype that has been overlooked? According to my model, we may 
predict that Tcf15-null embryos have a delay in epiblast formation and 
consequently some disruption in the kinetics of subsequent lineage allocation. 
However, the early embryo is highly regulative, and such phenotypes may 
therefore not be readily apparent when examining mutant embryos at late 
stages in vivo. Or, there might be some functional redundancy existed during 
development between Tcf15 and other HLH transcription factors. This will be 
further discussed in chapter 6. 
The Tcf15-KO cells will provide a sensitive tool for studying early 
function of Tcf15 during peri-implantation stages. Tcf15-KO cells express 
Venus under endogenous Tcf15 promoter to map the region where Tcf15 was 
expressed during development without functional protein expression. 
Chimaeric embryos generated from lineage-labelled Tcf15-KO cells will serve 
as good tool for future studies to examine whether Tcf15-null cells are less 
capable to transit to post-implantation epiblast or displayed a delay of 
epiblast formation compared with wild-type cells. 
Taken together, in this chapter, it is shown that Tcf15 can accelerate ES 
cells somatic differentiation by driving the transition to primed epiblast and 
suppressing primitive endoderm differentiation. Moreover, Tcf15 is acting at 
early stage of cell differentiation. How Tcf15 can drive pluripotent cells away 
from naïve pluripotency and toward epiblast? To understand this, the next 
step would be to investigate the mechanism by which Tcf15 expression 
becomes associated with this epiblast-primed state, by identifying upstream 
regulators and downstream targets of Tcf15. These experiments are described 




Mechanism controlling Tcf15 expression and  
possible downstream targets 
 
5.1: Aims of this chapter 
In chapter 4, gain of function and preliminary loss of function studies 
suggest that Tcf15 is able to prime cells for differentiation by driving the 
transition to a mature epiblast-like state as well as suppressing 
differentiation of cells toward extra-embryonic endoderm fate. Since the 
transcriptional activity of Tcf15 is negatively regulated by Id proteins 
(Wilson-Rawls et al., 2004), my data may explain why Id is able to suppress 
the conversion of ES cells into EpiSCs (Zhang et al., 2010). In the experiments 
described in this chapter, the mechanism by which Tcf15 expression becomes 
associated with this primed state will be investigated, by identifying 





5. 2: Results 
5.2.1: Upstream regulators of Tcf15 
5.2.1.1: Tcf15 expression is down-regulated by a MEK inhibitor and a 
GSK-3β inhibitor 
As shown in figure 3.3A, Tcf15 expression was suppressed when ES cells 
were cultured in 2i medium, which contained PD0325901 (a MEK inhibitor, 
referred to hereafter as PD03) and CHIR99021 (a GSK-3β inhibitor, referred 
to hereafter as Chiron) (Ying et al., 2008). Tcf15-Het reporter cells were used 
to investigate which of the components of 2i culture is responsible for 
suppressing Tcf15 expression. These reporter cells were cultured in complete 
medium containing LIF and serum in the presence of 1 µ M PD03 or 3 µ M 
Chiron for 48 hours before harvesting them for analysis. Flow cytometry 
analysis revealed that both PD03 and Chiron treatment down-regulated 
Venus expression (Figure 5.1A), suggesting that Tcf15 promoter activity was 
reduced after culturing in these inhibitors. In support of this, qPCR analysis 
of Tcf15 mRNA expression showed down-regulation to around 30% under 
PD03 and Chiron treatment compared with control cells. This 
down-regulation of Tcf15 mRNA expression was positively correlated with 
Venus mRNA expression (Figure 5.1B) as expected. 
In order to further confirm these results, immunocytochemistry staining 
of Venus protein and the pluripotent cell marker Oct4 on cultured cells 
(Figure 5.2A) was performed. Venus expression was relatively weak in 
PD03-treated cells compared with control cells cultured in LIF and serum. 
However, Venus expression in Chiron-treated cells appeared to remain at 
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similar levels to control untreated cells. The much stronger signal in DAPI 
and Oct4 staining within Chiron-treated cells compared to control untreated 
cells suggested that this might due to a general accumulation of fluorescent 
signal from fluorescence microscope in this condition, perhaps due to the 
change in colony morphology that is induced by Chiron. As seen in the 
bright field image, cells were very densely packed under Chiron treatment 
and formed “dome-shaped” colonies. Therefore, the increase of local cell 
density together with cell stacking is likely to result in the high Venus 
intensity seen in Chiron-treated cultures. 
To further validate Venus expression within cultured cells and to 
eliminate any artificial increase in fluorescence due to cell stacking, confocal 
microscopic analysis was performed by Julia Oh, an undergraduate project 
student within Dr. Sally Lowell lab, under my supervision. Tcf15-Het cells 
were cultured on glass coverslips in complete medium containing PD03 or 
Chiron for 48 hours before fixed for immunocytochemistry staining. Cells 
were stained with Venus and co-stained with Oct4 to identify pluripotent 
cells. Venus was heterogeneously expressed in cells culturing in LIF and 
serum (Figure 5.2B). Using this detection method, it became clear that 
transfer to medium containing PD03 or Chiron both reduced Venus to very 
low levels. This highlights the importance of using confocal analysis when 
assessing changes in fluorescence intensity under conditions that may also 
induce changes in colony morphology.  
In conclusion, MEK and GSK-3β signalling are both required for 
maintaining high levels of Tcf15 expression in ES cells. Due to time constraint, 







Figure 5.1: Tcf15 expression was down-regulated in PD03 and Chiron 
treated cultures 
(A) Flow cytometry analysis of E14tg2a cells (Venus negative control) and 
Tcf15-Het cells culturing in LIF and serum (untreated) in the presence of 
1 µ M PD03 or 3 µ M Chiron for 48 hours.  
(B) qPCR analysis of Tcf15 and Venus mRNA expression after PD03 and 
Chiron treatments for 48 hours. Expression of Tcf15 and Venus were 




































Figure 5.2: Immunofluorescence analysis of Tcf15-Het cells under 
indicated inhibitor treatments 
Tcf15-Het cells were cultured in LIF and serum only, 1 µ M PD03 or 3 µ M 
Chiron for 48 hours. Cells were fixed with 4% paraformaldehyde and stained 
for Oct4 (red), DAPI (blue) and Venus (green). Antibody staining for each 
condition was performed side by side, and images were taken with the same 





Figure 5.3: Confocal immunofluorescence analysis of Tcf15-Het cells under 
stated inhibitor treatments 
Tcf15-Het cells were cultured in LIF and serum only, 1 µ M PD03 or 3 µ M 
Chiron for 48 hours on glass coverslips. Cells were fixed with 4% 
paraformaldehyde and stained for Oct4 (red), DAPI (blue) and Venus 




5.2.1.2: Tcf15 expression is dependent on FGF signalling 
FGF signalling is required not only for self-renewing mES cells to 
differentiate into somatic cell types (Kunath et al., 2007) but also for primitive 
endoderm differentiation (Nichols and Smith, 2009; Yamanaka et al., 2010). 
Fibroblast growth factor 4 (FGF4) stimulation of ERK1/2 is an auto-inductive 
stimulus for naïve mES cells to exit the self-renewal programme and progress 
to a post-implantation epiblast-like state (Kunath et al., 2007). Previous 
unpublished microarray data from Dr. Tilo Kunath’s lab in University of 
Edinburgh showed that expression of Tcf15 increased at 6 hours after adding 
exogenous FGF4 into Fgf4-null ES cell culture (Figure 5.3A). To further 
validate this result, ES cells were cultured in the presence of 1 µ M PD03 or 
100 ng/ mL PD173074 (a Fibroblast growth factor receptor inhibitor, referred 
to hereafter as PD17) for 48 hours, the inhibitors were washed away and then 
inhibitor-free medium was added back to cultures. The fibroblast growth 
factor receptor (FGFR) inhibitor PD17 was also able to suppress Tcf15 
expression (Figure 5.3B). The response of Tcf15 to the restoration of autocrine 
FGF signalling is quite rapid: Tcf15 is strongly up-regulated within 6 hours of 
removing FGFR or MEK inhibitors. Taken together, Tcf15 expression is likely 
dependent on auto-inductive FGF signalling within pluripotent culture and 
that it responds rapidly to increases in FGF activity. FGF could therefore 
prime cells for differentiation by up-regulating the pro-differentiation factor 
Tcf15, whereas BMP/Id may restrain progression to overt differentiation 









Figure 5.4: Tcf15 expression is under FGF signaling 
(A) Microarray data from Dr. Tilo Kunath’s lab (unpublished), showing Tcf15 
expression was up-regulated after adding FGF4 into Fgf4-null ES cells.  
(B) qPCR analysis of ES cells pre-treated 48 hours in PD03- or 
PD17-containing medium showed that Tcf15 expression was 
down-regulated when MEK or FGFR was inhibited, but restored rapidly 






















































5.2.2: Downstream targets of Tcf15 
5.2.2.1: Microarray analysis of possible Tcf15 down-stream targets 
To identify downstream targets of Tcf15, we carried out a time-course 
microarray analysis aimed at capturing the earliest changes in gene 
expression in response to Tcf15 activity. Using the TTE15 dox-inducible 
Tcf15-E47 ES cell line (described in chapter 4, section 4.3.1.2), it is showed 
that Tcf15 mRNA is up-regulated within 8 hours after addition of doxycycline 
(Figure 5.5A). Tcf15-E47 protein is weakly detectable at around 8 hours after 
addition of doxycycline and reaches robust levels after 12 hours (Figure 5.5B). 
Therefore, 8 hours and 12 hours were selected as suitable time points for 
identifying Tcf15-responsive genes by microarray analysis. A 24 hours’ time 
point was also included in order to profile the longer term response of Tcf15 
activation. 
An Illumina TotalPrepTM RNA amplification kit was used for generating 
cRNA from RNA samples for microarray analysis of gene expression 
according to manufacturer’s instruction. cRNA hybridization was performed 
on a MouseWG-6 v2 BeadChip (Illumina) by the WTCRF MRC Human 
Genetics Unit (University of Edinburgh). Genes which had an FDR-adjusted 
p-value of at most 0.05 and a fold change of 1.5 or more for at least one time 
point in comparison to the 0-hour baseline were considered as differentially 
expressed. According to these criteria, a total of only 89 genes changed 
significantly over these early time points, with global transcriptional changes 
after TTE15 cells stimulation with doxycycline as indicated in figure 5.5C. 
Figure 5.5D shows the top and bottom 20 genes ranked by fold-change at 12 












































Figure 5.5: Microarray analysis to identify Tcf15-E47 responsive genes 
(A) (B) TTE15 and parental control AW2 cells were stimulated by 1 μg/mL 
doxycycline for the indicated time, Tcf15-E47 induction were confirmed 
at mRNA (A) and protein level (B).  
(C) Microarray analysis was performed on a MouseWG-6 v2 BeadChip 
(Illumina). Low-quality probes were removed from the input data and 
data was subsequently quantile-normalized and log2-transformed before 
assessing differential expression. Fold change in all genes within the 
microarray probe set were plot in (C).  
(D) Heat-map showing the top and bottom 20 candidate genes which were 
differentially expressed upon doxycycline-treatment. Genes are ranked 
by fold change at 12 hours of doxycycline treatment.  
 
The GEO accession number for the microarray data reported in this 
thesis is GSE42539.  
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5.2.2.1.1: Up-regulated genes after Tcf15-E47 induction 
Table 5.1 displays a list of genes which were up-regulated after inducing 
Tcf15-E47 expression. qPCR analysis was performed on Tcf15 and Tcf3 (Tcfe2a) 
to validate successful induction of Tcf15-E47 transgene expression (Figure 
5.6A). The up-regulation of Tcf3 (Tcfe2a) gene, which generates E47 and E12 
proteins through alternative pre-mRNA splicing, was one of the top 
up-regulated genes, indicating that doxycycline induced Tcf15-E47 transgene 
expression as expected. Tcf15 was, however, not identified as an up-regulated 
gene in the microarray. This is because the Illumina probe against Tcf15 
(ILMN_1231030) is partially located at the 3’-UTR of Tcf15 gene, which is 
absent in the Tcf15-E47 transgene construct.  
To verify whether any of the genes that respond to Tcf15 activation are 
also enriched in the Tcf15-high subpopulation of ES cells, qPCR analysis was 
performed on Tcf15-Venus reporter cells sorted by differential Venus 
expression. The top and bottom 30% of Venus-expression cells were labeled 
as Venus-high or Venus-low, respectively. Expression of Tcf15 was first 
confirmed at higher level in Venus-high cells, whereas the expression of Tcf3 
(E47) was similar between Venus-high and Venus-low cells (Figure 5.6B). 
To ask whether any of the genes that respond to Tcf15 activation show a 
similar expression profile to Tcf15 during differentiation, ES cells were 
differentiate in monolayer neural conditions. It is first confirmed that the 
neural marker Sox1 was up-regulated as expected during the differentiation 
process (Figure 5.7A), and that Tcf15 was downregulated after day 1, as 
previously observed (Figure 5.7B and Figure 3.5A). Since Tcf15 activity is 
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inhibited by Id1, the expression of Id1 was also checked in this differentiation 
time course (Figure 5.7C). Id1 expression was strongly reduced on day 1, 
whilst Tcf15 expression remains high. Therefore, it would be expected that 
any Tcf15-responsive genes to show a peak of expression at day 1 of neural 
differentiation. 
In order to further validate candidate Tcf15-responsive genes by qPCR 
and ask whether they are enriched in Tcf15-high ES cells or on day 1 of 
neural differentiation, genes which were up-regulated by induction of 
Tcf15-E47 were first manually categorized into 4 groups. The first group 
encodes transcription factors/regulators, which included Hes6, Id1, Id3, Irf1, 
Otx2 and WT1. The second group encodes signaling modulators, including 
Dusp4 and Dusp6. The third group encodes adhesion molecules, which 
includes Cdh3, Itga3, Itgb1 and Zyx. And the fourth group is genes cannot be 
categorized as any of the above, including Ccno, Emp1, Prr19, Raet1b and 
Vegfc.  
 
Table 5.1: Genes upregulated in response to Tcf15 activation 
      
















ILMN_1216541 Prr19 Proline rich 19 0.3851* 1.0142* 0.9380* Yes ＝ 
ILMN_2736471 Ccno Cyclin O, Ung2 0.5332* 0.9383* 0.6154* Yes － 
ILMN_2470646 Wt1 Wilm’s tumor 1 homolog 0.1717 0.7024* 0.6061* Yes ＋ 
ILMN_2642913 Emp1 Epithelial membrane protein 1 0.2593 0.6907* 0.8447* Yes ＝ 
ILMN_2615096 Dpp4 Dipeptidylpeptidase 4 0.1393 0.6189* 0.4734* 
  
ILMN_2791952 Hes6 Hairy and enhancer of split 6 (Drosophila) 0.3703 0.6025* 0.3163 Yes ＋ 
ILMN_2596278 Tcf3 Transcription factor E2a 0.4973 0.6016* 0.3698 Yes ＝ 
ILMN_2691752 Otx2 Orthodenticle homolog 2 (Drosophila) -0.0244 0.5989* 0.5397* Yes － 
ILMN_2687169 Id3 Inhibitor of DNA binding  (differentiation) 3 0.3137 0.5848* 0.6617* Yes ＝ 
ILMN_2689731 Dusp4 Dual specificity phosphatase 4 0.0737 0.5764* 0.8564* Yes ＋ 
ILMN_2890357 Fam176b Family with sequence similarity 176, member B 0.3848 0.5559* 0.7123* 
  
ILMN_3079461 Raet1b Retinoic acid early transcript 1 beta 0.2525 0.5453* 0.0667* Yes ＋ 
ILMN_2661422 Ramp2 Receptor (calcitonin) activity modifying protein 2 0.0884 0.5283* 0.9055* Yes 
 
ILMN_2486573 Vegfc Vascular endothelial growth factor C 0.3180 0.5200* 0.3912* Yes ＋ 
ILMN_2834379 Tgfbi Transforming growth factor, beta induced 0.2138 0.4519* 0.6093* 
  
ILMN_2722902 Amfr Autocrine motility factor receptor 0.3017 0.4308* 0.7006* 
  
ILMN_2672190 Id1 Inhibitor of DNA binding (differentiation) 1 0.1520 0.4281* 0.6107* Yes ＋ 
ILMN_2870965 Dusp4 Dual specificity phosphatase 4 0.0354 0.3623* 0.6152* Yes ＋ 
*: p-value  < 0.05 
(+): positive correlation, (-): negative correlation, (=): no difference, between Tcf15-Het-Venus and target gene expression 
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Table 5.1: Genes upregulated in response to Tcf15 activation (continued) 
















ILMN_2834777 Irf1 Interferon regulatory factor 1 0.0476 0.3541* 0.6280* Yes ＝ 
ILMN_2660466 Ldhb Lactate dehydrogenase B 0.2030 0.3451* 0.9496*   
ILMN_2616164 Itga3 Integrin, alpha 3 (antigen CD49C) 0.0384 0.3413 0.2416* Yes ＋ 
ILMN_2514292 Zyx Zyxin 0.0759 0.2767 0.6047* Yes ＋ 
ILMN_3156246 Cdh3 Cadherin 3 0.3109 0.2743 0.5327* Yes － 
ILMN_2450767 
 
ILMN_2450767 -0.0295 0.2300 0.6516* 
  
ILMN_1226546 Iffo2 Intermediate filament family orphan 2 0.1218 0.1582 0.5851* 
  
ILMN_2708477 Spink3 Serine peptidase inhibitor, Kazal type 3 0.1111 0.1577 -0.6103* 
  
ILMN_1248537 Dusp6 Dual specificity phosphatase 6 -0.0990 0.1045 0.4921* Yes ＋ 
ILMN_2789077 Itgb1 Integrin, beta 1 (antigen CD29) -0.0141 0.0066 0.1443* Yes ＋ 
*: p-value  < 0.05 





A) Expression in doxycycline-treated inducible TTE15 cells 
 
B) Expression in FACS sorted Tcf15-Het reporter cell line 
 
Figure 5.6: qPCR validation of Tcf15 and E47 expression 
(A) Expression of Tcf15 and E47 (showing in Table 5.1 as Tcf3) upon 
doxycycline induction of Tcf15-E47 expression in TTE15 cells. Tcf15 and 
E47 were up-regulated at similar level.  
(B) qPCR analysis of Tcf15 and E47 on FACS sorted Tcf15-Venus-high and 
Tcf15-Venus-low cells. Tcf15 was differentially expression between V-
high and V-low cells and E47 was not enriched in Tcf15-Venus-high 
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A)                                       B)                                         C) 
    
Figure 5.7: Gene expression during neural differentiation 
qPCR analysis of Sox1, Tcf15 and Id1 during serum-free monolayer neural 
differentiation. Id1 expression was strongly reduced on day 1, whilst Tcf15 
expression remains high. Expression of Tcf15 was down-regulated after day 2 


























































































5.2.2.1.1.1: Transcription factors/regulators up-regulated after Tcf15-
E47 induction 
Hes6 (hairy and enhancer of split 6), Id1 (Inhibitor of differentiation/DNA-
binding 1), Id3 (Inhibitor of differentiation/DNA-binding 3), Irf1 (Interferon 
regulatory factor 1), Otx2 (Orthodenticle homeobox 2) and WT1 (Wilms' tumor 1) 
were transcription factors/regulators up-regulated after inducing Tcf15-E47 
expression (Table 5.1).  
qPCR analysis on doxycycline-treated TTE15 cells was performed to 
validate the response of these genes to Tcf15 activation (Figure 5.8A). All of 
these transcription factors/regulators could be detected by qPCR in ES cells. 
Hes6 responded rapidly upon Tcf15 induction from 8 hours and persisted 
until 24 hours. Id1, Id3, Irf1, Otx2 and WT1 expression were gradually up-
regulated from 8 hours to 12 hours after adding doxycycline.  
Expression of these genes in FACS sorted Tcf15-high and Tcf15-low 
subpopulations of ES cells were then examined. Id3, Irf1 and Otx2 were 
almost equally expressed between Venus-high and Venus-low cells. 
Expression of Hes6, Id1 and WT1 were enriched in Venus-high cells (Figure 
5.8B).  
Gene expression during N2B27 monolayer neural differentiation was 
then analyzed in order to ask which if these genes shows a similar expression 
profile to Tcf15 (Figure 5.8C). Id1 was down-regulated immediately when 
cells began differentiation, as shown in figure 5.7C. Irf1 expression was also 
down-regulated during neural differentiation. Id3 was down-regulated at 
day 1 and day 2 of neural differentiation and expression was restored to 
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levels similar to ES cells after day 3. Expression of Hes6, Otx2 and WT1 were 
up-regulated at day 1, correlating with the up-regulation of Tcf15 during 
early stages of neural differentiation. Hes6 and WT1 expression were down-
regulated when cells started express neural marker Sox1 (Figure 5.7A). 
Expression of WT1 was lost when cells committed to differentiation, with 
similar pattern as Tcf15 (Figure 5.7B). Hes6 and Otx2 were still expressed at 
day 4, consistent with their reported roles in regulating neural development 
(Acampora et al., 1995; Bae et al., 2000).  
Table 5.2 summarized genes of interest which fulfill at least two of our 
analyses: responds to Tcf15 activation (gene expression changed for 1.5 fold 
or more for at least one time point in comparison to the un-induced cells), 
enriched in Tcf15-high subpopulation or displayed similar expression profile 
to Tcf15 during neural differentiation. Therefore, Id1, Hes6, Otx2 and WT1 are 








Figure 5.8: Gene expression of transcription factors/regulators up-regulated 
after induction of Tcf15-E47 expression 
(A) Gene expression after doxycycline induction of Tcf15-E47 expression in 
TTE15 cells.  
(B) Gene expression of FACS sorted Tcf15-Venus-high and Tcf15-Venus-low 
cells from Tcf15-Het cells. ns: non-significant; *: p<0.05. 
(C) Gene expression during serum-free monolayer neural differentiation. Id1 
expression is the same data as displayed in figure 5.7C.  
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A) Expression of Tcf15-responsive genes in doxycycline-treated inducible 
TTE15 cells 
  
B) Expression of Tcf15-responsive genes in FACS sorted Tcf15-Het 
reporter cell line 
  
C) Expression of Tcf15-responsive genes during neural differentiation 
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Table 5.2: Summarizing results from transcription factors/regulators of 
interest 
 
Gene Of Interest Id1 Hes6 Otx2 WT1 
























Similar profile to 



















5.2.2.1.1.2: Signaling modulators up-regulated after Tcf15-E47 
induction 
Dual specificity phosphatases 4 (DUSP4) and DUSP6 were two signaling 
molecules up-regulated after inducing Tcf15-E47 expression (Table 5.1). 
DUSPs are members of the mitogen-activated protein kinase phosphatase 
(MKP) family and potential tumor suppressor. DUSPs inhibit MAPK 
(mitogen-activated protein kinases) signaling by dephosphorylating 
activated MAPKs, thus negatively regulate the MAPKs including ERK, p38 
and JNK (Keyse, 2008).   
DUSP4 and DUSP6 were both up-regulated upon Tcf15-E47 induction 
(Figure 5.9A) and preferentially expressed in FACS sorted Tcf15-Venus-high 
population (Figure 5.9B). Expression of DUSP4 was up-regulated at day 1 of 
neural differentiation and remained at levels similar to undifferentiated cells 
from day 2 onward (Figure 5.9C). DUSP6 was down-regulated during neural 
differentiation.  
Table 5.3 summarized DUSP4 and DUSP6 expression according to the 





A) Expression of Tcf15-responsive genes in doxycycline-treated inducible 
TTE15 cells 
 
B) Expression of Tcf15-responsive genes in FACS sorted Tcf15-Venus 
reporter cell line 
 
C) Expression of Tcf15-responsive genes during neural differentiation 
 
Figure 5.9: Gene expression of signalling modulators up-regulated after 
induction of Tcf15-E47 expression 
(A) Gene expression of DUSP4 and DUSP6 after doxycycline induction of 
Tcf15-E47 expression in TTE15 cells.  
(B) Gene expression of FACS sorted Tcf15-Venus-high and Tcf15-Venus-low 
cells, showing both DUSP4 and DUSP6 were enriched in Tcf15-Venus- 
high population in Tcf15-Venus reporter cells. *: p<0.05. 


























































Table 5.3: Summarizing results from signaling modulators of interest 
 
Gene Of Interest Dusp4 Dusp6 




Maybe yes (nearly 









Similar profile to 













5.2.2.1.1.3: Adhesion molecules up-regulated after Tcf15-E47 
induction 
Cdh3 (Cadherin 3, P-cadherin), Itga3 (Integrin alpha3), Itgb1 (Integrin beta1) 
and Zyx (Zyxin) were adhesion molecules up-regulated after inducing Tcf15-
E47 expression.  
qPCR analysis showed that Cdh3 and Zyx were up-regulated upon 
doxycycline induction of Tcf15-E47 expression (Figure 5.10A), whilst a 
modest change in Itgb1 was seen. Itga3, Itgb1 and Zyx were enriched in Tcf15-
Venus-high cells. Cdh3 expression was, however, lower in Tcf15-Venus-high 
cells, showing negative correlation with Tcf15 expression (Figure 5.10B).  
All the genes examined in this section showed dynamic changes during 
neural differentiation (Figure 5.10C), with cells progressively switching from 
an E-Cadherin (Cdh1)-high, P-Cadherin (Cdh3)-high state to an N-Cadherin 
(Cdh2)-high state (Figure 5.10D). Of these genes, none showed a peak of 
expression at day 1, although P-Cadherin was downregulated with similar 




A) Expression of Tcf15-responsive genes in doxycycline-treated inducible 
TTE15 cells 
  
B) Expression of Tcf15-responsive genes in FACS sorted Tcf15-Venus 
reporter cell line 
 
C) Expression of Tcf15-responsive genes during neural differentiation 
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D) Expression of cadherins during neural differentiation 
 
Figure 5.10: Gene expression of adhesion molecules up-regulated after 
induction of Tcf15-E47 expression 
(A) Gene expression of adhesion molecules after doxycycline induction of 
Tcf15-E47 expression in TTE15 cells.  
(B) Gene expression of FACS sorted Tcf15-Venus-high and Tcf15-Venus-low 
populations from Tcf15-Venus cells. *: p<0.05. 
(C) Gene expression of Tcf15-responsive adhesion molecules during serum-
free monolayer neural differentiation. 
(D) Expression of Cdh1 (E-cadherin), Cdh2 (N-cadherin) and Cdh3 (P-cadherin) 
during neural differentiation. Cdh3 was down-regulated gradually 
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5.2.2.1.1.4: Other genes up-regulated after Tcf15-E47 induction 
Ccno (Cyclin O), Emp1 (Epithelial membrane protein 1), Prr19 (Proline rich 
19), Raet1b (retinoic acid early transcript 1 beta) and Vegfc (vascular endothelial 
growth factor C) are up-regulated after inducing Tcf15-E47 expression (Table 
5.1) that do not fall into any of the above categories. 
qPCR analysis confirmed that Ccno, Emp1, Prr19, Raet1b and Vegfc were 
up-regulated after doxycycline induction (Figure 5.11A). Expression of 
Raet1b was however very low in ES cells cultured in LIF and serum, therefore 
it was difficult to obtain reproducible data on gene expression (see large 
error bars in figure 5.11A). None of these genes showed strong enrichment in 
the FACS sorted Tcf15-Venus-high subpopulation of ES cells (Figure 5.11B). 
For this reason, the expression analysis of these genes during neural 




A) Expression of Tcf15-responsive genes in doxycycline-treated inducible 
TTE15 cells 
 
B) Expression of Tcf15-responsive genes in FACS sorted Tcf15-Het 
reporter cell line 
 
Figure 5.11: Expression of other genes up-regulated after induction of 
Tcf15-E47 expression 
(A) Gene expression after doxycycline induction of Tcf15-E47 expression in 
TTE15 cells. 
(B) Gene expression of FACS sorted Tcf15-Venus-high and Tcf15-Venus-low 




































5.2.2.1.2: Down-regulated genes after Tcf15-E47 induction 
5.2.2.1.2.1: Naïve pluripotency marker Nanog was down-regulated by 
Tcf15-E47 
Table 5.4 displays the list of the 18 genes that are most strongly down-
regulated after inducing Tcf15-E47 expression and ranked by fold change at 
12 hours of doxycycline treatment. Among these, the most strongly down-
regulated gene at the two earliest time points is Nanog. This further validates 
the hypothesis that Tcf15 activation represents the first step toward 
differentiation (Figure 4.12B) and suggests a mechanism by which it drives 
cells away from a naïve pluripotent state. 
qPCR analysis of mature Nanog mRNA confirms that Nanog expression 
was down-regulated after inducing Tcf15-E47 expression by doxycycline 
(Figure 5.12A). To further assess the transcriptional activity of the Nanog 
locus, qPCR analysis was performed by using five primer pairs located 
within a region of Nanog intron 1 to determine the level of pre-mRNA 
produced by the Nanog locus. Nanog pre-mRNA expression was also 
downregulated, confirming the level of transcription of the endogenous 
Nanog locus was reduced after Tcf15-E47 induction. In addition, consistent 
with data shown in figure 3.9C, Nanog expression was negatively correlated 
with Tcf15-Venus expression (Figure 5.12B).  
Taken together, data presented in this chapter support a model in which 
FGF signalling pathway upregulates Tcf15 expression and drives the 
transition to epiblast-primed state by activation of Otx2 and suppression of 
Nanog expression (Figure 5.13). 


















ILMN_2706623 Nanog Nanog homeobox -0.4298* -1.0768* -0.9348* Yes － 
ILMN_2458765 Ahnak AHNAK nucleoprotein (desmoyokin) -0.1327 -1.0251* -0.4996*   
ILMN_1230176  RIKEN cDNA 1810032O08 gene -0.1514 -0.9603* -0.6039*   
ILMN_2740902 Mki67 Antigen identified by monoclonal antibody Ki 67 -0.1190 -0.9543* -0.5564*   
ILMN_2502996 Tpr Translocated promoter region 0.0516 -0.9380* -0.2619*   
ILMN_2624622 Akap12 A kinase (PRKA) anchor protein (gravin) 12 -0.0333 -0.9112* -0.3344   
ILMN_2627299 Akap9 A kinase (PRKA) anchor protein (yotiao) 9 -0.0562 -0.9077* -0.5355*   
ILMN_3159435 Mid1 Midline 1 -0.0533 -0.9029* -0.3571   
ILMN_2939012  RIKEN cDNA 1500012F01 gene 0.0115 -0.8966* -0.4293*   
ILMN_2520249 Hspg2 Perlecan (heparan sulfate proteoglycan 2) 0.0531 -0.8645* -0.5365*   
ILMN_2608933 Tcof1 Treacher Collins Franceschetti syndrome 1, homolog -0.4026 -0.8531* -0.6286   
ILMN_1229455 Rnf213 Ring finger protein 213 -0.0531 -0.8470* -0.3064*   
ILMN_2672626 Myh9 Myosin, heavy polypeptide 9, non-muscle -0.2157 -0.8309* -0.1547   
ILMN_2599997 Ncor1 Nuclear receptor co-repressor 1 -0.0410 -0.8180* -0.3944   
ILMN_2933692 Upf1 UPF1 regulator of nonsense transcripts homolog -0.1810 -0.7833* -0.5433*   
ILMN_2721385 Dst Dystonin -0.1228 -0.7507* -0.4336*   
ILMN_1231490  2410006H16Rik -0.1091 -0.7461* -0.4270*   
ILMN_2678373 Myst4 MYST histone acetyltransferase monocytic leukemia 4 -0.0597 -0.7382* -0.6337*   
*: p-value  < 0.05 





A) Expression of Tcf15-responsive genes in doxycycline-treated inducible 
TTE15 cells 
 
B) Expression of Tcf15-responsive genes in FACS sorted Tcf15-Venus 
(Tcf15-Het) reporter cell line  
 
Figure 5.12: Nanog expression after induction of Tcf15-E47 expression 
(A) Gene expression of Nanog and Nanog pre-mRNA after doxycycline 
induction of Tcf15-E47 expression in TTE15 cells. Nanog pre-RNA 
expression was analysed by averaging 5 pairs of primers within 1st exon 
of Nanog locus. 
(B) Nanog expression of FACS sorted Tcf15-Venus-high and Tcf15-Venus-low 


































Figure 5.13: Proposed model of Tcf15 function in pluripotent ES cells 
FGF4/ERK signaling drives expression of Tcf15. Tcf15 thus maturated naïve 
pluripotent stem cells toward epiblast-primed state, by activating epiblast-
determinant gene Otx2, or by suppressing Nanog. 
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5.2.3: Adhesive properties of Tcf15-Venus-high and Tcf15-Venus-low 
subpopulations  
As described in section 3.2.2.3.1.6, the Tcf15-Venus-high subpopulation 
is primed to undergo neural differentiation more efficiently than the Tcf15-
Venus low subpopulation (Figure 3.15). It also been observed that gene 
expression of adhesion molecules changed in response to Tcf15 activation, 
and expression of Itga3, Itgb1 and Zyx were enriched in Tcf15-Venus high 
cells (Figure 5.10B). Therefore, it would be interesting to ask whether the 
Tcf15-high subpopulation showed any obvious difference in colony 
morphology that may reflect differences in adhesive properties. 
In order to test this, Venus-high and Venus-low populations were FACS 
sorted and plated for one day in serum-free media (N2B27) in order to allow 
Id1 to be downregulated and thus allow the endogenous Tcf15 to become 
activated. Clear morphological differences were seen between the two 
subpopulations (Figure 5.14). Tcf15-Venus-high cells attached to the plate 
more quickly than Tcf15-Venus-low cells and tend to form more spreading 
colonies containing more cells with epiblast-like epithelium morphology 
(Figure 5.14A). In contrast, Tcf15-Venus-low cells formed more compact 
colonies containing fewer cells with naïve “dome”-like morphology (Figure 
5.14B).  
qPCR analysis was performed to further characterise expression of genes 
encoding adhesion regulators in the two subpopulations. Epithelial-
mesenchymal-transition (EMT) markers Zeb2 (but not Zeb1), Vimentin and N-
cadherin were enriched in FACS sorted Tcf15-Venus-high cells (Figure 5.15A), 
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as well as the polarity regulator Crb2 (Figure 5.15B).  
These data suggest that changes in Tcf15 expression are associated with 
changes in the expression of particular regulators of adhesion and 
morphology, and with a change in the morphological appearance of cell 
colonies. These preliminary observations could be an interesting area for 




A) Venus-high cells 
 
B) Venus-low cells 
 
Figure 5.14: Morphological differences between Venus-high and Venus-
low cells after 1 day of neural differentiation  
Venus expression of FACS sorted Tcf15 reporter cells after 24 hours culture in 
serum-free N2B27 medium.  
(A) Venus-high cells formed larger flatten colonies containing more cells 
with epithelium morphology.  
(B) Venus-low cells formed more compact colonies containing fewer cells 




A) EMT markers 
 
B) Polarity regulator 
 
Figure 5.15: Differential expression of EMT-related genes and polarity 
regulators in FACS sorted Tcf15-Het reporter cells  
Tcf15-Het reporter cells were cultured in LIF and serum before sorting. The 
top and bottom 30 % of cells were sorted from PECAM1-positive population 
and labelled as Venus-high or Venus-low, respectively. 
(A) Differential gene expression of EMT markers in FACS sorted Tcf15-Het 
cells. 
(B) Expression of polarity regulator Crb2 in FACS sorted Tcf15-Het cells. 





5.3.1: ERK and GSK-3β signalling regulating Tcf15 expression 
ES cells can be maintained in a naïve state if the cells are shielded from 
autocrine FGF/ERK signalling and subjected to GSK-3β inhibition by using 
two pharmacological inhibitors PD03 and Chiron (Ying et al., 2008). 
Expression of Tcf15 was downregulated in 2i culture (Figure 3.4A). Therefore, 
Tcf15-Het reporter cells were used to investigate the effect of 2i components 
on the expression of Tcf15. To prevent over degeneration and differentiation 
of cells culturing in serum-free N2B27 medium supplemented only with 
PD03 or Chiron (Ying et al., 2008), the experimental strategy was designed to 
add inhibitors into LIF + FCS culture conditions. Addition of PD03 and 
Chiron into LIF + FCS cultures reduced Tcf15 expression, as measured by 
Venus protein expression (Figure 5.1A and 5.3) and by qPCR analysis of both 
Tcf15 and Venus expression (Figure 5.1B). This down-regulation of Tcf15 and 
Venus suggested that Tcf15 is expressed biallelically within ES cells, as both 
Tcf15 alleles in the Tcf15-Het cells (Tcf15VenusFRT/+) were down-regulated at 
similar extent.  
PD03 and Chiron did not downregulate Tcf15 expression completely, as 
some cells still express Venus. One possibility could be the MEK and GSK-3β 
pathways were not fully inhibited in the presence of serum in the culture, as 
the concentration used in these experiments were adapted from the serum-
free 2i protocol (Ying et al., 2008). Other possibilities are that PD03 or Chiron 
alone is not sufficient to downregulate Tcf15, or, there might be other factors 
controlling basal transcription of Tcf15 within LIF + FCS culture. 
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GSK-3β is inactivated by the canonical Wnt signalling pathway, resulting 
in the nuclear accumulation of β-catenin (Wu and Pan, 2010). Although 
inhibition of GSK-3β might have a Wnt-independent function in promoting 
proliferation and cell survival in 2i ES culture (Ying et al., 2008), it is possible 
that Tcf15 expression is downstream of canonical Wnt pathway, as has been 
proposed in the somites (Linker et al., 2005). It would be interesting to assess 
if Tcf15-Venus expression could be modulated by addition of Wnt agonist or 
antagonists (Dkk or WIF-1) into self-renewing cultures. 
Autocrine FGF4/ERK signalling is needed for ES cells to exit from self-
renewal and initiate differentiation (Kunath et al., 2007). Both PD03 (MEK 
inhibitor) and PD17 (FGFR inhibitor) were capable of suppressing Tcf15 
expression (Figure 5.3B). However, addition of FGF4 protein directly into 
cells cultured in self-renewing conditions such as LIF + FCS or N2B27 + LIF + 
BMP failed to upregulate Tcf15 expression (data not shown), which is 
perhaps due to autocrine production of saturating levels of FGF4 by 
undifferentiated ES cells (Ma et al., 1992, Rathjen et al., 1999).  
 
5.3.2: Downstream responsive genes of Tcf15 
Genes which were up-regulated by induction of Tcf15-E47 were 
manually categorized into 4 groups, as discussed below. Candidate genes 
which satisfied at least two of the following experiments were considered as 
possible Tcf15 direct or indirect targets: responds to Tcf15 activation, 
enriched in Tcf15-high subpopulation or displayed similar expression profile 




5.3.2.1: Transcription factors/regulators  
Hes6, Id1 and Id3 are basic helix-loop-helix (bHLH) transcriptional 
factors/regulators. Hes6 alone does not bind to DNA but acts as an inhibitor 
of Hes1 to suppress Hes1 from repressing transcription and promotes 
neuronal cell differentiation (Bae et al., 2000). Id1 and Id3 are dominant 
negative antagonists of the bHLH family of transcription factors, which 
positively regulate differentiation in many cell lineages. It has been reported 
that BMP4-induced Id proteins inhibit ES cells from differentiating toward 
the neural lineage, and sustain self-renewal of ES cells in collaboration with 
LIF/STAT3 (Ying et al., 2003). A recent study suggested that Id proteins are 
also able to block the transition of ES cells to epiblast stem cells (EpiSCs) 
(Zhang et al., 2010).  
IRF-1 is associated with regulation of interferon α and β transcription. 
IRF-1 activates a set of target genes associated with regulation of the cell 
cycle, apoptosis and the immune response (Chen et al., 2013).  
Otx2 is a homeobox transcription factor, which is required at multiple 
steps in brain development and neuronal differentiation, especially in 
anterior neuroectoderm specification (Acampora et al., 1995). It has been 
reported that Otx2 acts as a novel intrinsic determinant controlling ES cells 
transition into EpiSCs (Acampora et al., 2012).  
WT1 is a zinc-finger-containing transcription factor. It is essential for the 
development of certain mesoderm-derived tissues and also for the 
proliferation of certain neuronal progenitors (Wagner et al., 2002). The 
biological function of WT1 appears paradoxical. WT1 induced 
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mesenchymal–epithelial transition (MET) in the developing kidneys, but in 
the developing heart, WT1 drove the epithelial-mesenchymal transition 
(EMT) in the epicardium (Hohenstein and Hastie, 2006). These data 
suggested that WT1 is involving in the cellular epithelial-mesenchymal 
balance. 
In summary: qPCR analyses validated that Tcf15-E47 induced 
transcription factors Hes6, Id1, Id3, Irf1, Otx2 and WT1. Of these genes, only 
Hes6, Id1 and WT1 were enriched in Tcf15-Venus-high cells. Hes6, Otx2 and 
WT1 showed a similar expression profile to Tcf15 during neural 
differentiation. Although further experiments, including chromatin immuno-
precipitation (ChIP) need to be performed to confirm if these genes were 
direct Tcf15 targets, these data might suggest the hypotheses that Tcf15 
specifically favors epiblast rather than primitive endoderm differentiation by 
up-regulating Otx2, a known epiblast determinant (Acampora et al., 2012), 
and that Tcf15 promotes robust neural differentiation by up-regulating Hes6, 
a known pro-neural factor (Bae et al., 2000). It is also speculated that the 
ability of Tcf15 to modulate expression of the MET regulator WT1, which 
may relate to the changes in adhesion that accompany the formation of the 
post-implantation epiblast (Rossant and Tam, 2009) (see also chapter 6). 
 
5.3.2.2: Signalling modulators  
Dual specificity phosphatases 4 (DUSP4) and DUSP6 were two signaling 
molecules up-regulated after inducing Tcf15-E47 expression and both were 
downstream transcriptional targets of the FGF pathway (Lanner et al., 2010).  
259 
 
In mouse ES cells, DUSP4 and DUSP6 are down-regulated when FGF 
signalling is inhibited by the FGFR inhibitor, generating a more naïve and 
homogenous ES cells state (Lanner et al., 2010). This indicated that active 
FGF signalling not only promotes a primed state but also induces the 
expression of inhibitors of FGF signalling to generate a negative-feedback 
loop that would facilitate reversion back to the original naïve state (Figure 
5.16) (Lanner and Rossant, 2010). 
In addition, it is found that several Tcf15 target candidates were down-
regulated in a previous microarray analysis, where cells were cultured in 
another FGFR inhibitor SU5402 which generates a naïve and homogenous ES 
cell state (Lanner et al., 2010) (Table 5.5). All of these genes, including Dpp4, 
Hes6, WT1, DUSP4, DUSP6 and Nanog, showed negatively correlated 
expression between induction of Tcf15-E47 and addition of FGFR inhibitor, 
suggesting these genes might play certain roles in FGF-regulated naïve to 
epiblast-primed transition.  
 Taken together, although DUSPs function at the protein level to 
negatively regulate the ES cell to EpiSC transition, these data might indicate 
that Tcf15, as a FGF-inducing gene, might also trigger negative feedback 
mechanisms in FGF signalling pathway. Alternatively, these changes in 
DUSP4 and DUSP6 may occur as an indirect consequence of Tcf15-activated 
cells converting to a more epiblast-like state, which may perhaps be more 
responsive to autocrine FGF and therefore have higher expression of these 
FGF target genes. It will therefore be interesting in future to test whether 
DUSP4 and DUSP6 are direct or indirect targets of Tcf15, and whether other 




Figure 5.16: Diagram of possible function of DUSPs in negative regulating 
pluripotent cells transit to epiblast-primed state (Adapted from Lanner et 
al., 2010) 
As described in chapter 3, pluripotent ES cells exhibit great heterogeneity, 
whereby some cells appear to be transiently primed for differentiation to 
either extraembryonic endoderm or somatic lineages. FGF4 signalling has 
been shown to maintain both primed states. DUSP4 and DUSP6 may 
promote the reversion of primed ES cells to the naïve state, indicated by 





Table 5.5: List of Tcf15 and Tcf15-responsive genes which expression was 
under FGFR signalling pathway  
 
 
Data of ES + FGFR inhibitor was retrieved from Lanner et al., 2010. 
 
  
Gene Of Interest TTE15 + Dox ES + FGFRi 
Tcf15 up down 
Dpp4 up down 
Hes6 up down 
WT1 up down 
DUSP4 up down 
DUSP6 up down 
Nanog down up 
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5.3.2.3: Adhesion molecules  
Several adhesion molecules were up-regulated after inducing Tcf15-E47 
expression.  
Members of the integrin family are expressed in spatially discrete 
patterns that reflect their function in early mouse embryogenesis (Hynes, 
2002). Integrin α3 mRNA was expressed from late-blastocyst/ peri-
implantation stage and mice lacking Itga3 expression could survive until 
perinatal stage (Sutherland et al., 1993). Integrin β1 is essential for inner cell 
mass development and deletion of Itgb1 result in peri-implantation lethality 
(Stephens et al., 1995, Fassler and Meyer, 1995).  
Zyxin, a focal adhesion-associated LIM protein, is essential for actin 
reorganization for cell migration in TGF-β1-Twist1–induced EMT in normal 
murine mammary gland cells (Mori et al., 2009). Although zyxin-null mice 
are viable and fertile (Hoffman et al., 2003), there are no published data 
regarding zyxin function in ES cells differentiation and early mouse 
development.  
Cdh3 is a known surface marker for trophectoderm (TE) (Niwa et al., 
2005), but its function in the pluripotent epiblast has not been reported.  
Although Tcf15-E47 up-regulated Cdh3, Itga3, Itgb1 and Zyx expression, 
only Itga3, Itgb1 and Zyx were enriched in Tcf15-Venus-high cells.  In 
addition, all the genes showed dynamic changes during neural 
differentiation. Therefore, it is at present not clear whether these genes are 
Tcf15 targets or not, and further experiments are required to test this.  
Whether or not these adhesion molecules are direct targets of Tcf15, they 
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are interesting as candidate mediators of the adhesive changes that 
accompany epiblast maturation (Rugg-Gunn et al., 2012). Since adhesion 
molecules function at the protein level and are often subject to considerable 
post-transcriptional and post-translational regulation, it would be more 
informative to analyze, in future studies, whether protein expression of these 
molecules correlated with Tcf15 expression, by flow cytometry analysis on 
surface expression of Cdh3, Itga3 or Itgb1, by immunostaining to identify 
cellular localization of Zyxin, or Western blot analysis on FACS sorted 
populations. 
 
5.3.2.4: Other genes  
Ccno (cyclin O) is a cyclin protein family member which can bind and 
activate CDK2 to respond to DNA damage-induced intrinsic apoptosis 
stimuli in in mouse lymphoid cells (Roig et al., 2009). Ccno was reported as a 
maternal factor gene that mainly transcribed in oocytes and zygotes and 
played an important role in oocyte meiotic resumption in mouse oocytes (Ma 
et al., 2013).  
EMP-1 (also named as tumour-associated membrane protein, TMP) is a 
junctional protein in blood-brain barrier and in liver (Bangsow et al., 2008, 
Lee et al., 2005). EMP-1 is highly expressed in undifferentiated ES cells, but 
its expression is markedly down-regulated when ES cells are differentiated 
into embryoid bodies (Ben-Porath and Benvenisty, 1996).  
VEGF-C has been characterized as an essential lymphangiogenic growth 
factor that promotes cancer metastasis by activating phosphorylation of its 
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receptor VEGF-R3 and triggers downstream activation of PI3K-Akt and PKC-
MAPK pathway; thus protecting lymphatic endothelial cells from apoptosis 
and stimulating proliferation and migration in vitro (Makinen et al., 2001). It 
has been reported that VEGF-C was required for the proliferation of 
neuroepithelial cells expressing VEGF-R3 in both Xenopus and mouse 
developing brain (Le Bras et al., 2006).   
There is no literature reporting function of Prr19 and Raet1b to my 
knowledge. 
The expression of these genes requires further characterisation, as it is 
currently unclear whether they are expressed in ES cells and how the 
expression changes during differentiation.  
 
5.3.2.5: Tcf15 down-regulates the naïve pluripotency marker Nanog  
In chapter 3, a negative relationship between Tcf15-Venus and Nanog in 
ES cells was identified at both mRNA and protein level. In chapter 4, it was 
demonstrated that modulating Tcf15 expression level within ES cells changed 
expression of Nanog but not Oct4, thus influencing the naïve to primed-
epiblast states within cultures of pluripotent cells (Figure 4.10 and 4.18). In 
this chapter, down-regulation of Nanog mRNA expression upon induction of 
Tcf15-E47 was observed (Figure 5.12). Taken together, this suggested that 
Tcf15 might regulate Nanog expression, either directly or indirectly. Future 
experiments will be conducted to test how Tcf15 regulates Nanog expression. 
The first step will be to confirm that Tcf15 down-regulates Nanog expression 
at the protein level. A time course co-immunostaining of Nanog and Flag-
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Tcf15-E47 after doxycycline induction would be a good approach for 
analysing protein expression at the single cell level. Alternatively, to test if 
Tcf15 directly regulates Nanog expression at transcription level, ChIP analysis 
of Flag-Tcf15-E47 on Nanog regulatory elements could also be performed. 
The relationship between Tcf15, Id1 and Nanog will be discussed in chapter 6. 
 
5.3.3: Adhesive properties of Tcf15-Venus-high and Tcf15-Venus-low 
subpopulations 
Changes in Tcf15 expression are seen to be associated with changes in 
the morphological appearance of cell colonies (Figure 5.14), which might due 
to differential expression of adhesion molecules, EMT-related genes or the 
polarity regulator, Crb2, pre-existing in the Tcf15-Venus-high population. 
Crumbs homolog 2 (Crb2) is one of the three mammalian homologues of the 
Drosophila Crumbs (Crb) protein that involves in the control of cell–cell 
adhesion and epithelial cell polarity. In Crb2 deficiency mice, the primary 
defect appears to be disturbed epiblast cell polarity, which affects the EMT at 
the primitive streak (Xiao et al., 2011).  
To address whether Tcf15-Venus-high cells exhibit different adhesive 
properties than Tcf15-Venus-low cells, an image quantification tool is now 
being developed in the lab. In brief, this macro plug-in in ImageJ software 
could detect cell spreading by identifying cells in phase contrast images and 
track them over time to follow the increase in surface area.  To address if 
Tcf15-Venus-high cells exhibit more epithelialized/polarized character, an 
automated image analysis tool developed by Dr. Guilluame Blin within our 
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lab could be used, which could measure the orientation of each individual 
cell within a group of cells. In short, this software calculates the angel θ of 
epithelialisation/polarisation (Figure 5.17A), which is the angle between 
nucleus to centrosome vector (v1) and the unit vector in the Z dimension (in 
2D culture: from bottom to top). The epithelialization/ polarisation angel θ of 
each cell within a colony will be reported on a rose diagram (Figure 5.17B) to 
determine the extent of epithelialization of a cell population.  
In summary, it was been observed that Tcf15-Venus-high cells displayed 
more epiblast-like epithelium morphology. Moreover, Tcf15 induced genes 
which were associated with cell adhesion/cell polarity, suggesting possible 
function of Tcf15 to mature ES cells toward primed epiblast-like state might 
be regulating epithelialization during this transition. 
The adhesive changes in Tcf15 cells and how this relates to adhesive 








Figure 5.17: Measuring the orientation of cells using homemade image 
analysing software (developed by Dr. Guillaume Blin) 
(A) Single cell orientation can be assigned using the nucleus to centrosome 
vector v1 (red arrow). The polarisation angle θ is defined by the angle 
between v1 and the top (apical) of the culture dish (vector Z). The more 
epithelialized a cells is, the smaller angle θ it has. 
(B) Rose diagrams to address orientation of a cell population (top), showing 
here as disorganized naïve cells culturing in 2i and epithelialized EpiSCs. 
Each blue pie piece represents a range (here for example, 15° interval of 
angle θ) and the size is the percentage of occurrences. (Bottom) Confocal 
images of tight junction protein ZO1 staining to confirm the EpiSCs are 









In this study, the function of transcription factor Tcf15 in pluripotent 
cells was characterized by analysing its expression pattern followed by 
perturbing its expression in mES cells and identifying its upstream regulators 
and downstream targets. My data suggested that Tcf15 is acting as pro-
differentiation factor priming pluripotent cells for differentiation. 
 
6.1: Function of Tcf15 from naïve to primed pluripotency 
6.1.1: Hypothesis: Tcf15 regulates cell adhesion and epithelialisation 
during naïve to primed transition 
Embryonic stem cells are heterogeneous mixture of cells in a metastable 
state, shifting between naïve ICM-like (ground state) and epiblast-like 
(primed state) states while remaining pluripotent (Chambers et al., 2007; 
Hayashi et al., 2008; Toyooka et al., 2008). ES cells navigate a route toward 
lineage commitment through a complex network of positive and negative 
cues. The negative cues that restrain cells in a naïve pluripotent state include 
transcription factors Nanog and Klf4 and signalling pathways activated by 
BMP and LIF. In contrast, less is known about the positive gene regulatory 
mechanisms that drive cells toward commitment to differentiation.  
The transition from naïve to mature differentiation-primed epiblast 
spans the peri-implantation period and is therefore technically challenging to 
study in vivo. The in vitro conversion of ES cells to EpiSCs in defined culture 
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recapitulates the progression from naïve pre-implantation epiblast to post-
implantation epithelialized egg cylinder (Rossant and Tam, 2009) and 
provides a useful tool for investigating this process. This system has 
identified Id1 as a key negative regulator during ES cells to EpiSCs transition 
(Zhang et al., 2010), which implicating unknown bHLH transcription factors 
in priming pluripotent cells for differentiation. 
Our previous yeast-two-hybrid screening identified Tcf15 as a possible 
pro-differentiation transcription factor which activity is likely to be 
negatively regulated by Id1 in ES cells. Tcf15 was heterogeneously expressed 
within the pluripotent culture and Tcf15-high cells were predominantly 
associated with the Nanog-low/Klf4-low population but not enriched in Hex 
and PDGFRα expression, suggesting the Tcf15-high cells were not in a naïve 
pluripotent state nor primed for extraembryonic endoderm. I proposed that 
Tcf15 is marking cells priming for somatic differentiation. Two key pieces of 
my data support this hypothesis: First, a FACS sorted Tcf15-Venus-high 
subpopulation was found to undergo differentiation more efficiently than the 
Tcf15-Venus-low subpopulation. Second, using doxycycline-inducible, Id-
resistant dominant active form of Tcf15-E47 fusion protein, it was 
demonstrated that Tcf15 promotes somatic differentiation, possibly by 
accelerating the ES cell to EpiSCs transition. 
How to link these findings to development of the epiblast in vivo? Tcf15 
is well known as a regulator of somite development (Burgess et al., 1996), 
and somitogenesis shares some intriguing parallels with epiblast formation. 
In somites, Tcf15 is not required for cell fate specification; rather, Tcf15 is 
necessary and sufficient for remodelling of mesenchyme into an N-cadherin+ 
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polarized epithelial structure (Burgess et al., 1996; Linker et al., 2005; 
Takahashi et al., 2005). Epithelialization in the somites is a consequence of N-
cadherin-mediated cell-cell adhesion (Duband et al., 1987). Transition of the 
ICM of the blastocyst undergoes a similar remodelling process as it matures 
into post-implantation epiblast, including the upregulation of N-cadherin 
(Bao et al., 2009; Hatta et al., 1987) and formation of a polarized N-cadherin/ 
E-cadherin double-positive epithelium. Therefore, Tcf15 may play a similar 
role in both scenarios to help trigger the morphological remodelling events 
that characterize these changes in cell identity. 
N-cadherin was recently identified as a cell surface maker expressed in 
the EpiSCs at much higher levels than in ES cells (Rugg-Gunn et al., 2012). 
Tcf15-Venus-high cells are enriched in N-cadherin, as well as EMT-associated 
genes (Zeb1, Zeb2 and Vimentin) and polarity marker Crb2. Microarray 
analysis also identified several adhesion molecules including Itga3, Itgb1, 
Cdh3 and Zyx being up-regulated after induction of Tcf15-E47 expression. 
Tcf15 also up-regulated transcription factor WT1 expression, which is known 
regulator controlling the epithelial-mesenchymal balance during kidney and 
heart development. The function of WT1 during early ES cells differentiation 
has not been characterized. Although only mRNA expression analysis was 
performed, these data had provided clues for supporting follow-up 
investigation at the protein level. Based on the morphological differences 
between Tcf15-Venus-high and Tcf15-Venus-low cells upon day 1 of neural 
differentiation (Figure 5.14), I propose that Tcf15 is likely to regulate cell 
adhesion and epithelialisation during early time point of differentiation, 
possibly the ES cells to EpiSCs transition stage in vitro, or peri-implantation 
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stage in vivo (Figure 6.1A).  
In order to further investigate the hypothetical role of Tcf15 in 
controlling epithelialization of the epiblast, it would be helpful to have access 
to an in vitro system that better models the morphological changes of the 
epiblast in vivo. It was recently reported that the first major morphogenetic 
step in the transition of the epiblast cells from pre- to post-implantation 
stages is its progressive re-organization from a relatively simple ball of cells 
to a more complex rosette-like structure that is built of polarized cells (Figure 
6.1B) (Bedzhov and Zernicka-Goetz, 2014). It was further shown that 
epithelialization of the epiblast during peri-implantation development can be 
mimicked by culturing ES cells suspended in a matrix of extra-cellular matrix 
(ECM) proteins. The ECM/basal membrane-stimulated integrin signalling 
therefore provide polarization cues for the coordinated orientation of the 
apical-basal axis of these cells and cells self-organized into spheres 
recapitulating the epiblast (Bedzhov and Zernicka-Goetz, 2014). This 
technique could provide a great in vitro tool to study whether Tcf15 regulate 
cell polarisation and epithelialization. I could take advantage of currently 
available doxycycline-inducible Tcf15-E47 cell line and Tcf15-Het-Venus 
reporter cell lines to establish self-organizing ES cells spheres. By 
manipulating Tcf15 expression level, it would be possible to analyse if the 
formation of polarized rosettes correlates with endogenous or exogenous 
Tcf15 expression. Therefore, the in vitro data would help us to gain more 








Figure 6.1: Tcf15 might regulate cell polarization and epithelialization in 
vivo 
(A) Hypothetical function of Tcf15 in regulating differentiation-primed 
cellular epithelialisation. The in vivo function of Tcf15 might be 
regulating the epithelialisation of epiblast during peri-implantation stage. 
Adapted from (Takaoka and Hamada, 2012). 
(B) A model for the sequence of the morphogenic events that drive the peri-
implantation development (Bedzhov and Zernicka-Goetz, 2014). The pre-
implantation blastocyst is comprised of unpolarized epiblast cells (EPI). 
The cells of the extraembryonic lineages secrete ECM proteins that 
assemble a basal membrane, which wraps around the EPI. The ECM 
proteins provide polarization cues that orient the establishment of a 
basal-apical axis of the EPI cells through β1-integrin receptors on the 
basal surface of EPI.  The EPI cells change their shape as a result of 
actomyosin constriction, coupled to apical localization of adherens 
junctions and forming a rosette-like structure (E4.75–E5.0).   
273 
 
6.1.2: Hypothesis: Tcf15 upregulates Otx2 expression during naïve to 
primed transition 
ES cells and EpiSCs are molecularly and epigenetically distinct and 
therefore represent discrete pluripotent states recently termed naïve and 
primed pluripotent states, respectively. In vivo, development of post-
implantation epiblast cells from pre-implantation ICM cells involves 
significant transcriptional and epigenetic changes, including DNA 
methylation and X chromosome inactivation (Surani et al., 2007). Recently, it 
has been reported that the transition between naïve and primed pluripotent 
states is associated with global re-organization of the chromatin landscape 
and distinct enhancer element usage (Factor et al., 2014). A key mediator for 
remodelling the gene regulatory networks as cells exit from ground state 
pluripotency is Otx2, which drives enhancer activation through affecting 
chromatin marks and the activity of associated genes in cooperating with 
Oct4 (Buecker et al., 2014; Yang et al., 2014). What remained unclear is 
whether Otx2 is acting as a pioneer factor capable of initiating chromatin 
opening by itself or whether additional factors which are activated by FGF 
signalling might be required to collaborate with Otx2 to access DNA and lead 
to enhancer activation (Buecker et al., 2014). In this study, it was found that 
Tcf15-E47 is able to upregulated Otx2 expression. Moreover, expression of 
Tcf15 is regulated by FGF signalling. Future works including genetic and 
epigenetic approaches could be performed to analyse if the epiblast-priming 
function of Tcf15 is Otx2-dependent. Moreover, it would be interesting to 
investigate whether there is any difference of chromatin marks between 
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Tcf15-high and Tcf15-low cells, and, if there is difference, does this correlate 
to known differences between naïve and primed pluripotent cells.   
 
6.2: The interplay between Tcf15, Nanog and Id1 
My time-course microarray analysis has identified several genes which 
expression in response to Tcf15 activity. Among these genes, the naïve 
pluripotency marker Nanog is the transcript displaying the strongest level of 
downregulation following the induction of Tcf15-E47 expression suggested 
that Tcf15 might regulate Nanog transcription, either directly or indirectly. 
The negatively correlated expression of Tcf15 and Nanog in pluripotent 
culture could also imply that Nanog repress Tcf15 expression. Festuccia et al. 
performed a microarray on Nanog-null ES cells following tamoxifen-induced 
nuclear translocation of a transgenic Nanog-ERT2 fusion protein. Analysis of 
this dataset reveals that both Id1 and Tcf15 were the transcripts displaying 
the strongest level of downregulation following the nuclear translocation of 
Nanog (Festuccia et al., 2012). The observation that Nanog promotes a rapid 
and strong downregulation of Id1 and Tcf15 transcription upon nuclear 
localisation suggests Nanog can inhibit Id1 and Tcf15 expression through the 
direct binding and repression of the Id1 and Tcf15 locus. 
Analysis of published ChIP-Seq data (Chen et al., 2008; Marson et al., 
2008; Whyte et al., 2013) reveals the potential presence of Nanog binding 
sites at the Id1 locus (Figure 6.2). However, ChIP-Seq data analysis of Nanog 
binding targets in same studies (Chen et al., 2008; Marson et al., 2008; Whyte 
et al., 2013) does not indicate any binding of Nanog around the Tcf15 locus. 
275 
 
This suggests Nanog could directly repress Id1 expression but might not 
directly repress Tcf15 expression. Further analysis of published ChIP-Seq 
data indicates the presence of Oct4 and Esrrb binding sites at the Tcf15 locus 
(Chen et al., 2008; Marks et al., 2012) (Figure 6.3). Esrrb is a direct Nanog 
target gene that can substitute for Nanog function in pluripotent cells 
(Festuccia et al., 2012). The putative Oct4 binding site overlapped with RNA 
polII binding site at transcription start site (TSS) of Tcf15 locus, whereas 
potential Esrrb binding sites located slightly upstream of TSS in addition to a 
small peak at TSS. Therefore, I propose the speculative hypothesis that 
Nanog itself does not bind to Tcf15 locus, and, the Nanog-induced 
downregulation of Tcf15 is Esrrb-mediated.  
The microarray analysis described in chapter 5 showed that Tcf15-E47 
down-regulated Nanog expression in ES cells cultured in LIF and serum. 
However, Tcf15-E47 was not able to repress Nanog expression in cells 
cultured in 2i/LIF (Figure 4.11). The lack of Nanog repression by Tcf15-E47 in 
2i/LIF culture might due to: a) a strong core pluripotency transcription 
network presence in the 2i/LIF culture which masks the effect generated by 
Tcf15-E47, or, b) the possibility that Tcf15-E47 down-regulates Nanog 
expression indirectly or in cooperation with another factor, and this mediator 
for repressing Nanog expression is not expressed or activated sufficiently in 
2i/LIF cultures.  
Id1 is one of the transcriptional regulators factors up-regulated after 
inducing Tcf15-E47 expression. Our yeast-two-hybrid screening results of Id1 
and E proteins binding partners suggests that in ES cells, Id dimerizes with 
and sequesters the ubiquitous bHLH transcription factor E12/E47, blocking 
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its interaction with Tcf15. Therefore, expression of Id within pluripotent cells 
is likely to render Tcf15 inactive. The Tcf15-induced Id1 up-regulation is 
likely to occur through Tcf15-induced Nanog downregulation, as described 
above. However, the published phenotype of Id1-null ES cells included lower 
expression levels of Nanog and Rex1 and higher expression levels of T-
Brachyury (Romero-Lanman et al., 2012). Analysis of the microarray data 
comparing Id1-/- ES cells to wild-type ES cells confirms that other post-
implantation epiblast markers, such as Fgf5 and Otx2, are upregulated in the 
knockout cells (Romero-Lanman et al., 2012). Taken together, the gain of 
EpiSC-like gene expression in Id1-/- ES cells might due to the loss of Id1 
expression-induced Tcf15-inactive state within pluripotent culture. 
The interplay between Tcf15, Nanog and Id1 is summarized in figure 6.4. 
What remains unclear is that whether Tcf15 could directly control Nanog 
expression at transcription level. In order to gain further insight into how 
Tcf15 primes pluripotent cells to differentiation and how Tcf15 drives cells 
exit pluripotent state, future experiments will be to characterize how the 






Figure 6.2: ChIP-Seq identified Nanog binding sites at the Id1 locus 
Analysis of the Nanog ChIP-Seq data (Chen et al., 2008; Marson et al., 2008; 
Whyte et al., 2013) with the GeneProf online resource (Halbritter et al., 2012) 
reveals peaks of Nanog binding upstream and downstream of the Id1 exonic 




Figure 6.3: ChIP-Seq analysis at the Tcf15 locus 
Analysis of the ChIP-Seq data (Chen et al., 2008; Marks et al., 2012) at Tcf15 
locus using the GeneProf online resource (Halbritter et al., 2012). RNA polII 
binding is displayed to reveal the transcription start site (TSS) of Tcf15 locus. 
ES cells cultured in serum displayed increased RNA polII occupancy over 
coding body, which fits the observation that Tcf15 expression is higher in 
serum culture than in 2i. Putative Oct4 binding site overlapped with TSS, 
whereas potential Esrrb binding sites located slightly upstream of TSS in 





Figure 6.4: Cross repression and activation of Tcf15, Nanog and Id1 
expression 
Tcf15 activates Id1 expression and represses Nanog expression according to 
the time-course doxycycline induction of Tcf15-E47 microarray analysis 
performed in chapter 5. Expression of Id1 and Tcf15 were downregulated 
following the nuclear translocation of Nanog (Festuccia et al., 2012). Tcf15 is 
active as a heterodimer with E proteins and is therefore functionally inactive 
in the presence of Id proteins, which bind and sequester E proteins (Wilson-
Rawls et al., 2004).  
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6.3: Possible functional redundancy between Tcf15 and Scleraxis 
during embryo development 
As described in section 4.4.2.5, Tcf15-null embryos survive to birth, but 
die shortly afterward as a consequence of muscular-skeletal defects due to 
the failure in somite morphogenesis earlier in development (Burgess et al., 
1996). The loss of Tcf15 in highly regulative early embryos, before 
somitogenesis, might therefore only be delayed epiblast formation during 
peri-implantation stage and lowering the robustness of early developmental 
process. Furthermore, any putative Tcf15 mutant phenotype may be masked 
by compensatory premature upregulation of the closely related transcription 
factor Scleraxis (Scx), which shares an almost identical DNA binding domain 
with Tcf15 (Burgess et al., 1995) (Figure 6.5). Scx has an established role in 
later stages of epiblast maturation: the epiblast of Scx mutant embryo failed 
to develop further after E6.5 and does not properly epithelialize. At later 
stages, Scx mutant failed to gastrulate properly and mesoderm was unable to 
form (Brown et al., 1999).  
Scx is not consistently detectable by qPCR in ES cells maintained in LIF 
and serum (data not shown) although it does become upregulated in EpiSCs. 
As shown in figure 6.6, during the 2i to EpiSCs transition, Scx was 
upregulated at later time point than Tcf15. Intriguingly, the Scx mutant 
phenotype begins to manifest itself shortly after Tcf15 is downregulated after 
implantation (Brown et al., 1999) (Figure 3.1), supporting the idea that these 
two transcription factors act sequentially during development and may 
exhibit some functional redundancy. However, since Scx is not expressed in 
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ES cells and therefore, unlike Tcf15, does not mark an early epiblast-primed 
pluripotent state. It will be of interest in future studies to explore the 




Figure 6.5: Protein sequence alignment between Tcf15 and Scleraxis 
The protein sequence of mouse Tcf15 (ENSMUSP00000086511) and Scleraxis 
(ENSMUSP00000043668) are retrieved from Ensembl genome database. 
Sequences are  aligned using Multalign website (Corpet, 1988). Tcf15 and 
Scleraxis shared almost identical bHLH DNA binding domain sequences, as 
computationally predicted by InterProScan software (Jones et al., 2014) and 





Figure 6.6: Tcf15 is expressed earlier than Scleraxis during the transition to 
epiblast-like state 
qPCR analysis for Tcf15 (black) and Scx (grey) during the transition from 
































6.4: Concluding remarks 
The transcriptional circuits that enable ES cells to maintain naïve 
pluripotency have been extensively characterized (Jaenisch and Young, 2008; 
Niwa, 2007). In comparison, less is known about the transcription factors that 
guide cells out of the pluripotent ground state toward commitment to 
differentiation. This study identified that Tcf15 could be a marker of a 
transient cell state that stands midway between naïve pluripotency and 
somatic lineage commitment. 
The work presented in this thesis has shown that Tcf15 is expressed in 
the ICM of pre-implantation embryos. In pluripotent ES cells, Tcf15 is 
heterogeneously expressed and is negatively correlated with naïve 
pluripotency markers. Tcf15-high cells are not committed to differentiation, 
but are functionally primed for rapid differentiation. Moreover, a transient 
expression window of Tcf15 as cells exit a naïve self-renewing state and 
before they start to acquire lineage-specific gene expression suggested that 
Tcf15 may play a role in the early phase of differentiation. 
Gain of function analysis revealed that Tcf15 acts as a pro-differentiation 
factor within pluripotent populations, priming ES cells to differentiate 
toward somatic lineages. The priming effect of Tcf15 is possibly acting 
during an early stage of ES cells transition to differentiation-primed epiblast 
but not extraembryonic endoderm. This rose the question of what would be 
the mechanism by which Tcf15 expression becomes associated with this 
epiblast-primed state and how does Tcf15 accelerate ES cells differentiation.  
Tcf15 expression is dependent on FGF signalling. Microarray analysis 
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identified that Tcf15 downregulated expression of the naïve pluripotency 
marker Nanog. Tcf15 activation is also been observed to be associated with 
changes in the expression of particular regulators of cell adhesion and 
polarity, and with a change in the morphological appearance of cell colonies. 
The ability of Tcf15 to prime ES cells toward differentiation could therefore 
be explained either by its ability to downregulate Nanog or through its 
putative effects on the epithelialization of epiblast (Figure 6.7) or both. 
In summary, this study identified Tcf15 as a transcription factor that can 
be used to monitor exit from the pluripotent state toward somatic lineages 
and which could serve as a valuable tool for monitoring and interrogating 
early developmental transitions. Tcf15 acts as a marker of this transition state: 
Tcf15 expression is driven by FGF signalling, whereas its activity is 
suppressed by Id proteins, which are direct targets of BMP signalling 
(Nakashima et al., 2001; Ying et al., 2003; Wilson-Rawls et al., 2004); this helps 
explain how these extrinsic signals allow pluripotent cells to become primed 











Figure 6.7: Proposed model of Tcf15 function in priming ES cells toward 
differentiation 
Tcf15 expression is driven by FGF4/ERK signalling pathway. The mechanism 
by which Tcf15 maturates naïve pluripotent stem cells toward epiblast-
primed state and further toward differentiation is likely due to: Tcf15 
downregulates naïve pluripotency marker Nanog or, Tcf15 activates changes 
of adhesion molecules expression and thus affects the epithelialization of 
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